
<html lang="en"     class="pb-page"  data-request-id="14696cae-31d4-463c-b46c-36b98d2d774c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;article:article:10.1021/acs.jmedchem.0c01020;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure" /></meta><meta name="dc.Creator" content="Juraj  Velcicky" /></meta><meta name="dc.Creator" content="Rainer  Wilcken" /></meta><meta name="dc.Creator" content="Simona  Cotesta" /></meta><meta name="dc.Creator" content="Philipp  Janser" /></meta><meta name="dc.Creator" content="Achim  Schlapbach" /></meta><meta name="dc.Creator" content="Trixie  Wagner" /></meta><meta name="dc.Creator" content="Philippe  Piechon" /></meta><meta name="dc.Creator" content="Frederic  Villard" /></meta><meta name="dc.Creator" content="Rochdi  Bouhelal" /></meta><meta name="dc.Creator" content="Fabian  Piller" /></meta><meta name="dc.Creator" content="Stephanie  Harlfinger" /></meta><meta name="dc.Creator" content="Rowan  Stringer" /></meta><meta name="dc.Creator" content="Dominique  Fehlmann" /></meta><meta name="dc.Creator" content="Klemens  Kaupmann" /></meta><meta name="dc.Creator" content="Amanda  Littlewood-Evans" /></meta><meta name="dc.Creator" content="Matthias  Haffke" /></meta><meta name="dc.Creator" content="Nina  Gommermann" /></meta><meta name="dc.Description" content="G-protein-coupled receptor SUCNR1 (succinate receptor 1 or GPR91) senses the citric cycle intermediate succinate and is implicated in various pathological conditions such as rheumatoid arthritis, l..." /></meta><meta name="Description" content="G-protein-coupled receptor SUCNR1 (succinate receptor 1 or GPR91) senses the citric cycle intermediate succinate and is implicated in various pathological conditions such as rheumatoid arthritis, l..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 28, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01020" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01020" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01020" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01020" /></link>
        
    
    

<title>Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01020" /></meta><meta property="og:title" content="Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0017.jpeg" /></meta><meta property="og:description" content="G-protein-coupled receptor SUCNR1 (succinate receptor 1 or GPR91) senses the citric cycle intermediate succinate and is implicated in various pathological conditions such as rheumatoid arthritis, liver fibrosis, or obesity. Here, we describe a novel SUCNR1 antagonist scaffold discovered by high-throughput screening. The poor permeation and absorption properties of the most potent compounds, which were zwitterionic in nature, could be improved by the formation of an internal salt bridge, which helped in shielding the two opposite charges and thus also the high polarity of zwitterions with separated charges. The designed compounds containing such a salt bridge reached high oral bioavailability and oral exposure. We believe that this principle could find a broad interest in the medicinal chemistry field as it can be useful not only for the modulation of properties in zwitterionic compounds but also in acidic or basic compounds with poor permeation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01020"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01020">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01020&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01020&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01020&amp;href=/doi/10.1021/acs.jmedchem.0c01020" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9856-9875</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01016" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01039" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Juraj Velcicky</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juraj Velcicky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7e140b0c1f1450081b121d171d15073e1011081f0c0a170d501d1113"><span class="__cf_email__" data-cfemail="7319060112195d05161f101a10180a331d1c051201071a005d101c1e">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juraj++Velcicky">Juraj Velcicky</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6564-1448" title="Orcid link">http://orcid.org/0000-0001-6564-1448</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rainer Wilcken</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rainer Wilcken</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rainer++Wilcken">Rainer Wilcken</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6159-1460" title="Orcid link">http://orcid.org/0000-0002-6159-1460</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simona Cotesta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simona Cotesta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simona++Cotesta">Simona Cotesta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philipp Janser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philipp Janser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philipp++Janser">Philipp Janser</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Achim Schlapbach</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Achim Schlapbach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Achim++Schlapbach">Achim Schlapbach</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Trixie Wagner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Trixie Wagner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Trixie++Wagner">Trixie Wagner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philippe Piechon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philippe Piechon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Piechon">Philippe Piechon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frederic Villard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederic Villard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederic++Villard">Frederic Villard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rochdi Bouhelal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rochdi Bouhelal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rochdi++Bouhelal">Rochdi Bouhelal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fabian Piller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabian Piller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabian++Piller">Fabian Piller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephanie Harlfinger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephanie Harlfinger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie++Harlfinger">Stephanie Harlfinger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rowan Stringer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rowan Stringer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rowan++Stringer">Rowan Stringer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dominique Fehlmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dominique Fehlmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dominique++Fehlmann">Dominique Fehlmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Klemens Kaupmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Klemens Kaupmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Klemens++Kaupmann">Klemens Kaupmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amanda Littlewood-Evans</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amanda Littlewood-Evans</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amanda++Littlewood-Evans">Amanda Littlewood-Evans</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Haffke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Haffke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Haffke">Matthias Haffke</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Nina Gommermann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nina Gommermann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nina++Gommermann">Nina Gommermann</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01020&amp;href=/doi/10.1021%2Facs.jmedchem.0c01020" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9856–9875</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 28, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 June 2020</li><li><span class="item_label"><b>Published</b> online</span>28 August 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01020" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01020</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9856%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJuraj%2BVelcicky%252C%2BRainer%2BWilcken%252C%2BSimona%2BCotesta%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.0c01020%26title%3DDiscovery%2Band%2BOptimization%2Bof%2BNovel%2BSUCNR1%2BInhibitors%253A%2BDesign%2Bof%2BZwitterionic%2BDerivatives%2Bwith%2Ba%2BSalt%2BBridge%2Bfor%2Bthe%2BImprovement%2Bof%2BOral%2BExposure%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9875%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01020"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1930</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01020" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Juraj&quot;,&quot;last_name&quot;:&quot;Velcicky&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;Wilcken&quot;},{&quot;first_name&quot;:&quot;Simona&quot;,&quot;last_name&quot;:&quot;Cotesta&quot;},{&quot;first_name&quot;:&quot;Philipp&quot;,&quot;last_name&quot;:&quot;Janser&quot;},{&quot;first_name&quot;:&quot;Achim&quot;,&quot;last_name&quot;:&quot;Schlapbach&quot;},{&quot;first_name&quot;:&quot;Trixie&quot;,&quot;last_name&quot;:&quot;Wagner&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Piechon&quot;},{&quot;first_name&quot;:&quot;Frederic&quot;,&quot;last_name&quot;:&quot;Villard&quot;},{&quot;first_name&quot;:&quot;Rochdi&quot;,&quot;last_name&quot;:&quot;Bouhelal&quot;},{&quot;first_name&quot;:&quot;Fabian&quot;,&quot;last_name&quot;:&quot;Piller&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;Harlfinger&quot;},{&quot;first_name&quot;:&quot;Rowan&quot;,&quot;last_name&quot;:&quot;Stringer&quot;},{&quot;first_name&quot;:&quot;Dominique&quot;,&quot;last_name&quot;:&quot;Fehlmann&quot;},{&quot;first_name&quot;:&quot;Klemens&quot;,&quot;last_name&quot;:&quot;Kaupmann&quot;},{&quot;first_name&quot;:&quot;Amanda&quot;,&quot;last_name&quot;:&quot;Littlewood-Evans&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Haffke&quot;},{&quot;first_name&quot;:&quot;Nina&quot;,&quot;last_name&quot;:&quot;Gommermann&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9856-9875&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01020&quot;},&quot;abstract&quot;:&quot;G-protein-coupled receptor SUCNR1 (succinate receptor 1 or GPR91) senses the citric cycle intermediate succinate and is implicated in various pathological conditions such as rheumatoid arthritis, liver fibrosis, or obesity. Here, we describe a novel SUCNR1 antagonist scaffold discovered by high-throughput screening. The poor permeation and absorption properties of the most potent compounds, which were zwitterionic in nature, could be improved by the formation of an internal salt bridge, which helped in shielding the two opposite charges and thus also the high polarity of zwitterions with separated charges. The designed compounds containing such a salt bridge reached high oral bioavailability and oral exposure. We believe that this principle could find a broad interest in the medicinal chemistry field as it can be useful not only for the modulation of properties in zwitterionic compounds but also in acidic or basic compounds with poor permeation.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01020&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01020" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01020&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01020" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01020&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01020" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01020&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01020&amp;href=/doi/10.1021/acs.jmedchem.0c01020" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01020" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01020" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01020%26sid%3Dliteratum%253Aachs%26pmid%3D32856916%26genre%3Darticle%26aulast%3DVelcicky%26date%3D2020%26atitle%3DDiscovery%2Band%2BOptimization%2Bof%2BNovel%2BSUCNR1%2BInhibitors%253A%2BDesign%2Bof%2BZwitterionic%2BDerivatives%2Bwith%2Ba%2BSalt%2BBridge%2Bfor%2Bthe%2BImprovement%2Bof%2BOral%2BExposure%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9856%26epage%3D9875%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291301" title="Salts">Salts</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">G-protein-coupled receptor SUCNR1 (succinate receptor 1 or GPR91) senses the citric cycle intermediate succinate and is implicated in various pathological conditions such as rheumatoid arthritis, liver fibrosis, or obesity. Here, we describe a novel SUCNR1 antagonist scaffold discovered by high-throughput screening. The poor permeation and absorption properties of the most potent compounds, which were zwitterionic in nature, could be improved by the formation of an internal salt bridge, which helped in shielding the two opposite charges and thus also the high polarity of zwitterions with separated charges. The designed compounds containing such a salt bridge reached high oral bioavailability and oral exposure. We believe that this principle could find a broad interest in the medicinal chemistry field as it can be useful not only for the modulation of properties in zwitterionic compounds but also in acidic or basic compounds with poor permeation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SUCNR1 (succinate receptor 1, initially named GPR91) is a G-protein-coupled receptor (GPCR), which was deorphanized in 2004 by He et al.,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> identifying succinate as its endogenous ligand.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Succinic acid is a small dicarboxylic acid deprotonated under physiological conditions, thus acting in its anionic form, succinate. While used under the code E363 as a dietary supplement (flavor enhancer and acidifier), it is a crucial citric acid cycle intermediate and therefore an important part of the ATP formation and energy supply of the cell. As such, succinate is normally located in the mitochondria. However, under certain pathological conditions, succinate can be released into the extracellular space and function as a signaling molecule<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> that is recognized as a danger signal<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> by SUCNR1 located on the plasma membrane.</div><div class="NLM_p">Succinate and SUCNR1 signaling were implicated in local stress conditions including ischemia, hypoxia, toxicity, and hyperglycemia.<a onclick="showRef(event, 'ref2 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref5">(2,5)</a> Moreover, the activation of SUCNR1 by succinate has been linked to several other pathological conditions such as liver fibrosis,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> atherothrombosis,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> hypertension,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> obesity,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> or retinal vascularization.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Succinate also plays an important role in inflammation as it serves as an inflammatory signal inducing IL-1β through HIF1α stabilization in macrophages.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Furthermore, dendritic cells express high levels of SUCNR1 and succinate proved to be required for dendritic cell trafficking<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and T<sub>h</sub>17 cell expansion.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In arthritis patients, extracellular succinate accumulates in high concentration in the synovial fluid.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The importance of succinate in this disease could further be demonstrated using SUCNR1-deficient mice that were protected not only from the development of the disease but also from the activation of macrophages and IL-1β production compared to the wild-type animals.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Moreover, SUCNR1-deficient mice demonstrated reduced neutrophil infiltration, lower amounts of proinflammatory cytokines in the joints, and a decreased number of antigen-specific T<sub>h</sub>17 cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Based on these data, SUCNR1 represents an interesting pharmacological target and SUCNR1 antagonists could be useful for the treatment of various diseases. Despite the importance of succinate and its receptor in the pathology of various diseases, so far only one class of SUCNR1 antagonists has been disclosed by the Advinus/Merck group<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> represented by compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Interestingly, succinate analogs, which act as SUCNR1 agonists, were recently disclosed by two independent groups, demonstrating that succinate seems to bind to SUCNR1 in its cis-conformation.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> In this article, we describe the discovery and optimization of a novel class of SUCNR1 antagonists for which our group has recently disclosed an X-ray structure resolving their binding into this GPCR.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> While in the previous publication we focused on the structural biology aspects, here, we describe hit-to-lead efforts as well as optimization of the properties in our zwitterionic lead.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known SUCNR1 antagonist <b>1</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and HTS hit (<b>2</b>) to lead (<b>5</b>) optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To identify novel SUCNR1 antagonists that are structurally different from the known compound series, we performed a high-throughput screening (HTS) campaign using CHEM-1 cells stably expressing human SUCNR1. Out of several interesting hits identified, <b>2</b> (JC-59-GF68,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) stood out due to its good drug-like properties,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> especially its rather low molecular weight (381 Da), good water solubility (>286 g/L), and low intrinsic clearance (25 μL/min/mg) in rat liver microsomes. In addition, there was a clear preference for the (<i>S</i>)-enantiomer (<b>3</b>, 12 μM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), while the corresponding (<i>R</i>)-enantiomer (not shown) did not inhibit SUCNR1 signaling even at 100 μM concentration. This enantiodifferentiaton indicated real binding into SUCNR1, making the scaffold rather appealing for further investigation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Optimization of the Hit <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as a mean (<i>n</i> ≥ 3) in the [<sup>35</sup>S]GTPγS assay run with membranes prepared from stably transfected SUCNR1 in human CHEM-1 cells.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Permeability determined by high-throughput PAMPA.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></div><div></div></div><div class="NLM_p">During early hit optimization, the scaffold could be simplified without losing potency by moving the carboxylate onto the aryl ring while replacing the pyridine by a phenyl ring (<b>4</b>). Further homologation of the carboxylate led to phenylacetic acid <b>5</b> (PB-20-OV24,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) with almost 20-fold improvement in SUCNR1 inhibition compared to <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compared to the original hit <b>2</b>, the lead compound <b>5</b> also displayed an improved permeability by 1.5 log units as determined by the parallel artificial membrane permeability assay (PAMPA)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> while keeping the lipophilicity in a rather polar range (log <i>D</i><sub>7.4</sub><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> of 1.9). The addition of a fluorine atom into the <i>ortho</i>-position of the amide group on B-ring (for the annotation of the three rings, see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was tested for its possible introduction of a conformational lock<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> that could further help in improving the potency. Unfortunately, this proved not to be the case since both the fluorinated analog <b>6</b> and nonfluorinated <b>5</b> showed the same potency (1.3 μM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, the permeability was slightly enhanced, thus following a known effect of a fluorine atom placed into close proximity of a polar NH such as an amide<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> or pyrrole group.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Counterintuitively, the fluorine atom in <b>6</b> also led to decreased lipophilicity (by 0.5 log unit), potentially as a result of an increased dipole moment in such a molecule.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> This was in line with the calculated dipole moment from quantum chemical calculations being higher for <b>6</b> (4.8) than for <b>5</b> (3.1). A fruitful modification of the scaffold could be achieved by the introduction of basic amines in the <i>para</i>-position of the C-ring because such analogs, as exemplified by <b>7</b> (NF-58-EJ40,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), inhibited SUCNR1 with high potency. Unfortunately, these derivatives became highly polar and hence poorly permeable.</div><div class="NLM_p">Due to a pronounced similarity of this scaffold to the complement factor D (FD) inhibitors recently described by our colleagues,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> it became obvious to test some of the <i>meta</i>-benzylamine-containing FD inhibitors (<b>8</b> and <b>9</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) for their inhibition of SUCNR1. Although beneficial in the <i>para</i>-position, as demonstrated by the potency of <b>7</b> and its X-ray structure<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> showing a direct interaction of the adjacent piperazine nitrogen with E18<sup>1.31</sup>, the basic amine in the <i>meta</i>-position of the C-ring (<b>8</b>) proved much less potent (27 μM) compared to <b>7</b> (0.025 μM) or even compound <b>5</b> (1.3 μM) missing the basic amine (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A second FD inhibitor, the nonamide analog <b>9</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), lost SUCNR1 potency completely (>100 μM), while it was highly potent against FD<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and also factor XIa (FXIa).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Rather surprisingly, an additional chlorine atom in the <i>para</i>-position in the C-ring of <b>8</b> (<b>10</b>) could rescue the SUCNR1 potency, whereas it completely prevented binding of such analogs to FD but not to FXIa (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selectivity Profile of Selected Analogs against Selected Serine Proteases</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as a mean (<i>n</i> ≥ 3) in the [<sup>35</sup>S]GTPγS assay run with membranes prepared from stably transfected SUCNR1 in human CHEM-1 cells.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> (<i>n</i> ≥ 2) determined by the recombinant human complement factor D time-resolved fluorescence resonance energy transfer (TR-FRET) assay.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> (<i>n</i> ≥ 2) determined by the human factor XIa TR-FRET assay.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></p></div></div><div></div></div><div class="NLM_p">The negative effect of the chlorine atom on binding to FD can be explained when analyzing the published X-ray structure of <b>8</b> bound to FD (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT">6QMT</a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Whereas the C-ring is nicely filling the S1 pocket of this serine protease and its benzylamine is interacting with Asp189 and Ser190 as well as two water molecules, the Ser190 side chain is rather close to the <i>para</i>-position of the C-ring with a distance of 3.4 Å. This indicates that an additional chlorine atom in this position would not be favorable, which was confirmed by docking of a chloro-analog <b>10</b> into FD. This study demonstrated that to accommodate the chlorine atom in <b>10</b>, the compound had to shift away from Ser190 by roughly 1 Å and, as a consequence, the amine was not able to interact with Asp189 and Ser190 anymore (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). Gratifyingly, compound <b>10</b> also showed improved potency against SUCNR1 compared to the simple chloro-analog <b>5</b>, thus indicating a synergistic effect of these two substituents for inhibition of SUCNR1. The <i>meta</i>-benzylamine in FD- and FXIa-inhibitors was shown to be crucial for these serine proteases<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> as it participates in an interaction with an essential aspartate.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Therefore, our strategy to avoid cross-reactivity with these proteases was to keep the potency-boosting chlorine atom in the <i>para</i>-position as well as to probe larger substituents in the <i>meta</i>-position varying the position of the basic amine.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Crystal structure of <b>8</b> in complex with factor D (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT">6QMT</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The protein is in surface representation, the ligand as well as amino acids/water involved in polar interactions with the ligand are shown as sticks. Yellow: polar interactions between the compound and the protein. Magenta: the distance between the phenyl carbon of <b>8</b> in the <i>para</i>-position to Ser190 side chain equals 3.4 Å. (b) <b>10</b> (yellow sticks) docked in factor D cavity (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT">6QMT</a>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> superimposed on the co-crystal structure of <b>8</b> (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar to analog <b>7</b>, the presence of the amine in compound <b>10</b> led to much lower permeability (logPAMPA: −5.3 cm/s) compared to nonamine analog <b>6</b> (logPAMPA: −3.6 cm/s, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The reason for such behavior could be in the zwitterionic nature of such compounds.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> The carboxylic acid in this scaffold was shown to be essential for binding to SUCNR1 as it makes several interactions with the receptor: Tyr26<sup>1.39</sup>, Tyr79<sup>2.64</sup>, and Arg276<sup>7.39</sup> residues (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Arg276<sup>7.39</sup> (Arg281<sup>7.39</sup> in human SUCNR1) is one of the four amino acids implicated in the binding of succinate by SUCNR1<sup>1</sup>, which illustrates the importance of the carboxylic acid group in these antagonists. The amine could potentially be omitted to avoid the amphiphilicity of these inhibitors; however, its presence not only helped in increasing the potency (<b>10</b><i>vs</i><b>5</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) but the zwitterionic nature of the compounds also had a positive effect on plasma protein binding (PPB). Whereas the single ionic compound <b>5</b> was bound tightly (>99%) to the human plasma, its zwitterionic analog <b>10</b> displayed a reduced human PPB of 97.9%. Since the free drug concentration is crucial for the action of a bioactive compound,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> we wished to keep the zwitterionic nature of this class of SUCNR1 inhibitors. Despite options to improve the permeability and bioavailability of zwitterions by formulations, e.g., using salts or delivery systems,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> we preferred to explore possibilities for the improvement of the intrinsic properties rather than to rely on such efforts.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key interactions of amide carbonyl and carboxylate in <b>7</b> with SUCNR1 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RNK">6RNK</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. ADME Properties of Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0014.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Permeability determined by high-throughput PAMPA.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Oral bioavailability calculated as the dose-normalized ratio of extravascular AUCextrap to IV AUCextrap; both parameters were determined as a mean of 3 animals (male C57BL/6 mice).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Exposure (AUC; dn = dose-normalized to 1 mg/kg) measured as a mean of three animals (male C57BL/6 mice) after po dosing (3 mg/kg) using MC:Water:Tween80 (0.5:99:0.5) formulation.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Clearance measured as a mean of three animals (male C57BL/6 mice) after iv dosing (1 mg/kg) using an NMP:plasma (10:90) formulation.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">F and AUC po dn determined in three animals (male C57BL/6 mice) after po dosing (10 mg/kg) using 30% PEG300, 50% of (20% Cremophor EL), and a PBS formulation.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">F and AUC po dn determined in three animals (male C57BL/6 mice) after po dosing (10 mg/kg) using an MC:water:Tween80 (0.5:99.4:0.1) formulation.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></div><div></div></div><div class="NLM_p">As previously observed,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> the two close analogs <b>8</b> and <b>9</b> differ significantly in their permeability and oral bioavailability despite showing similar clearance in mice (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This is really interesting, especially because also the p<i>K</i><sub>a</sub> values<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> for both compounds were measured to be rather similar (4.4 and 9.4 for <b>9</b>; 4.0 and 9.5 for <b>8</b>), indicating that at neutral pH both of them should be doubly charged (zwitterionic) and hence poorly permeable.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Nevertheless, <b>9</b> with the methyleneoxy linker was fully absorbed in mice, whereas the bioavailability of its amide analog <b>8</b> was only 10% (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This comparison could suggest that the amide might be responsible for these unfavorable properties, a well-known phenomenon in peptides.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, the good oral absorption of nonzwitterionic amide <b>6</b>, again with a comparable clearance to <b>8</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), demonstrated that the poor permeability and bioavailability of <b>8</b> was not necessarily caused by the amide group alone but rather by a combination of amide and the zwitterion. Whereas the amide was not required for binding of this scaffold to FD and could therefore be replaced by the methyleneoxy linker, in our case, the amide carbonyl was needed for a water-mediated interaction with His99<sup>3.33</sup> residue as well as the Arg95<sup>3.29</sup> backbone carbonyl of SUCNR1<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). In human SUCNR1, these amino acids (Arg99<sup>3.29</sup> and His103<sup>3.33</sup>) were shown to be required for the binding of its endogenous ligand succinate.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Therefore, the amide replacement by methyleneoxy linker (<b>9</b>) resulted in a complete loss of potency against SUCNR1 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">Being puzzled by such a significant difference in the permeability and oral absorption of the zwitterions <b>9</b> and <b>10</b>, low molecular weight X-ray structures of both compounds (as HCl salts) were generated (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), which revealed a substantial difference in the conformations of the two closely related analogs. While <b>10</b> showed an HCl-mediated interaction of the amine with the acid moiety, <b>9</b> displayed a charge-assisted hydrogen bond between these two functional groups, which corresponds to the formation of a salt bridge in the aqueous phase. Intramolecular salt bridges as electrostatic interactions are known to contribute to peptide stabilization, protein folding, flexibility, and function.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Similar to the effect of intramolecular hydrogen bonds,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> we speculated that the presence of the intramolecular salt bridge in <b>9</b> could explain its superior permeation and absorption properties because it would allow for significant shielding of the polarity of the two charged groups. Apparently, the formation of the intramolecular salt bridge was feasible in <b>9</b> thanks to a greater flexibility of the methyleneoxy linker, whereas in <b>10</b>, the salt bridge seemed to be prevented by the rigid amide bond. In addition, even the HCl-mediated interaction in <b>10</b> did not seem optimal (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). To get engaged in such an interaction (HCl-mediated), the A-ring got significantly twisted (60°) toward the amide bond,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> whereas the biaryl group was unusually bent (10°)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and the two phenyl rings displayed a somewhat lower torsion angle than usual (24°). Of course, such a conformation could also be caused by crystal packing; nevertheless, it clearly demonstrated that the rigidity of the amide group made it difficult in <b>10</b> to bring the two charged groups into close proximity of 4 Å as required for a productive electrostatic interaction.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of the hydrochlorides of <b>10</b> (left) and <b>9</b> (right) in the crystal. Hydrogen bonds are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on these observations, we decided to explore the feasibility of salt bridge formation within the amide scaffold to study whether such an intramolecular salt bridge could rescue the poor permeability and absorption properties of the amide zwitterions. We envisaged to investigate different types of amines attached to a <i>meta</i>-alkoxy group. Gratifyingly, the simplest analog <b>11</b> retained SUCNR1 potency, although permeability was not changed (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization toward the Formation of a Salt Bridge for Improved Permeability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as a mean (<i>n</i> ≥ 3) in the [<sup>35</sup>S]GTPγS assay run with membranes prepared from stably transfected SUCNR1 in human CHEM-1 cells.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Permeability determined by high-throughput PAMPA.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></div><div></div></div><div class="NLM_p">Interestingly, conformationally restricted amines such as azetidine (<b>12</b>), pyrrolidine (<b>13</b>), and the two possible piperidine isomers (<b>14</b> and <b>15</b>) showed similar potency as the flexible amine <b>11</b>, indicating that the amino-substituent was devoid of any crucial interaction with the receptor. With respect to permeability, these derivatives also did not show any improvement, except for <b>15</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). With only a marginal change in the structure compared to the 4-piperidyl analog <b>14</b>, but also to pyrrolidine <b>13</b>, the 3-piperidyl compound <b>15</b> demonstrated quite a remarkable increase (1 log unit) in permeability as well as lipophilicity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Based on compound <b>9</b>, this improvement was interpreted by a successful formation of an intramolecular salt bridge being mediated by the 3-piperidyloxy substituent but not by any other substituent tried. Apparently, this particular substituent allowed for the right geometry and distance to bring the two charged groups in this scaffold into close proximity (<4 Å).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> As a consequence, the intramolecular salt bridge may be responsible for shielding of the charges, similar to an intramolecular hydrogen bond,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and the compound may appear as much less polar and hence more permeable than analogs with separated charges. Another hint for the existence of the salt bridge in <b>15</b> arose from the ionic profile for the two piperidine isomers. The p<i>K</i><sub>a</sub> values for the acid and base of 4-piperidine analog <b>14</b> were determined to be 4.1 and 9.9, respectively, being virtually the same as for 3-piperidine <b>15</b> (4.1 and 9.4). For this reason, both compounds were expected to be in the zwitterionic form at neutral pH and, as such, to display similar permeation properties. This was clearly not the case, as evidenced by the observed log <i>D</i> and permeability data for these two analogs. We concluded that to explain the difference in permeability for these two analogs, <b>15</b> must have displayed a different conformational behavior compared to <b>14</b>, allowing for shielding of the two opposite charges. Applying an in-house-developed quantum chemical workflow (ReSCoSS, described elsewhere)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> for the elucidation of conformational behavior and associated changes in polarity revealed that <b>14</b> and <b>15</b> populated remarkably different shapes in aqueous solution (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). While <b>14</b> preferred an elongated conformation, <b>15</b> was predominantly folded with an intramolecular salt bridge formed between the piperidyl moiety and the carboxylic acid moieties. Comparing the polar surface areas derived from the electrostatic surfaces of these two different structures (COSMO-3D-PSA)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> as well as visual inspection of these surfaces revealed that the salt bridge in <b>15</b> dramatically reduces the polarity of both charged moieties. Even taking into account that the permeating species may or may not correspond to the minimum-energy conformer in water, the reduction of the polar surface area observed here seems causative in allowing for better permeation.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Minimum-energy conformation in water at the TZVPD-FINE19 level for (a) <b>14</b> and (b) <b>15</b> (first row) and associated σ-surfaces (second row). The (<i>R</i>)-enantiomer was modeled for <b>15</b>. The folded conformation observed for <b>15</b> with the intramolecular salt bridge leads to a drastic reduction in the overall polar surface area as quantified by COSMO-3D-PSA.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After the successful identification of a suitable substituent forming the internal salt bridge in the zwitterionic amide scaffold, the stereochemistry of chiral 3-oxopiperidine was investigated for potency and physicochemical properties. Surprisingly, both enantiomers were found to be equally potent, even with similar properties, except for PPB. For unknown reasons, PPB was measured to be lower for the <i>R</i>-enantiomer as exemplified by <b>16</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) showing human PPB of 96.0% and mouse PPB of 97.4%, while the binding of its (<i>S</i>)<i>-</i>enantiomer (not shown) to human plasma was 98.6% and mouse plasma 99.7%. Therefore, the (<i>R</i>)-enantiomer was preferred for further exploration (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Adding a fluorine atom into the B-ring (<b>16</b>) or C-ring (<b>17</b>) led to slightly improved potency compared to <b>15</b>. Both compounds displayed good bioavailability and oral exposure in mice, which supported our internal salt bridge hypothesis. The addition of a second fluorine atom into the A-ring (<i>para</i> to the anilide-NH) of <b>17</b> resulted in a metabolically more stable derivative <b>18</b>, which led to a further significant (10-fold) improvement in oral exposure compared to <b>17</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Moving the fluoro-substituent in the C-ring from the <i>ortho</i>- to the <i>para</i>-position to the alkoxy substituent (<b>19</b>) caused an increase in clearance, leading to diminished oral exposure despite reaching full bioavailability. The addition of another fluorine atom into the B-ring resulted in compound <b>20</b> with very low clearance while keeping good permeability and oral bioavailability. As a consequence, <b>20</b> reached a very high oral exposure of 37 000 nmol·h/L (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Interestingly, the SUCNR1 potency was not much influenced by these modifications.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of Piperidine-Based Intramolecular Zwitterion</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0016.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as a mean (<i>n</i> ≥ 3) in the [<sup>35</sup>S]GTPγS assay run with membranes prepared from stably transfected SUCNR1 in human CHEM-1 cells.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Permeability determined by high-throughput PAMPA.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Oral bioavailability ± SD calculated as the dose-normalized ratio of extravascular AUCextrap to IV AUCextrap; both parameters were determined as a mean of three animals (male C57BL/6 mice).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Exposure (AUC; dn = dose-normalized to 1 mg/kg) ± SD reported in nM·h and measured as a mean of three animals (male C57BL/6 mice) after po dosing (3 mg/kg) using an MC:water:Tween80 (0.5:99:0.5) formulation.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Clearance measured as a mean ± SD of three animals (male C57BL/6 mice) after iv dosing (1 mg/kg) using an NMP:plasma (10:90) formulation.</p></div></div><div></div></div><div class="NLM_p">To confirm the presence of the intramolecular salt bridge, a low molecular weight X-ray structure of compound <b>20</b> was generated (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). This structure confirmed our hypothesis, i.e., 3-piperidyl is capable of participating in an internal salt bridge with the carboxylate since the piperidine nitrogen was within a favorable distance of 3.1 Å to the carboxylate oxygen. In addition, compared to the X-ray structure of the analog <b>10</b>, the structure of <b>20</b> seemed closer to the expected minimum conformation with ring A twisted by 42° toward the amide bond, the biaryl group not being bent anymore, and the two phenyl rings displaying a rather normal torsion angle of 54°.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of the hydrochloride of compound <b>20</b> in the crystal. Hydrogen bonds are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Unfortunately, a poor species cross-reactivity was observed for this scaffold, as the advanced inhibitors displayed virtually no inhibition of rat and mouse SUCNR1. For example, compound <b>20</b> showed only 23% inhibition of mouse and 56% of rat SUCNR1 activity at 100 μM concentration, whereas IC<sub>50</sub> on human SUCNR1 was 88 nM. Due to this drawback, these compounds could not be tested in any of the rodent models of arthritis or any other diseases. To understand the species difference, an X-ray structure of <b>20</b> bound to SUCNR1 was solved (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a), using a humanized rat construct recently disclosed by our group.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As already described,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> the rat SUCNR1 proved to be more suitable for crystallization due to the lack of glycosylation sites as well as higher biochemical stability than human SUCNR1. Mutagenesis studies identified a rat SUCNR1 double mutant (K18E, K269N) that allowed for binding of human selective SUCNR1 inhibitor <b>7</b>, thus indicating the key residues responsible for the species selectivity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Strikingly, the residues of the required two mutations are of a very different polarity, especially the mutation of K18 in rats into an oppositely charged glutamate found in human SUCNR1. While the inhibitor <b>20</b> does not make any direct interaction with E18 or N269 in the X-ray structure (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a, in gray), in the case of E18, this may actually happen in solution since the highest-scoring predicted pose from docking (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a, in green) forecasts a salt bridge interaction between the piperidine moiety of the ligand and E18 by virtue of a simple rotation around the biaryl axis. Even more strikingly, the two amino acid mutations (K18E and K269N), i.e. away from lysines, decreased the positive formal charge present in the binding site of the rat receptor. This is clearly reflected in a marked change in electrostatics in the binding site (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b,c), allowing the positively charged piperidine moiety to be accommodated in the humanized receptor.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) X-ray crystal structure of <b>20</b> (grey carbons) bound to humanized rat SUCNR1 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10">6Z10</a>) overlaid onto the top-scoring binding pose from docking (green carbons) forming salt bridge interaction with Glu18. (b) Electrostatic potential mapped onto the molecular surface for humanized rat SUCNR1 and (c) for wild-type rat SUCNR1 (model based on PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10">6Z10</a>) showing a large concentration of positively charged amino acid residues flanking the binding site. Calculations were done using the APBS plugin in PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Remarkably, this class of inhibitors embodied by <b>20</b> displays a chameleonic nature,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with the extended conformation binding to the receptor (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), while the closed conformation with an intramolecular salt bridge seems to be favorable in aqueous solution (quantum chemical studies, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) as well as in the solid state for the isolated compound (low-molecular-weight crystal structure, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The coexistence of the two classes of conformations that are decidedly different in polarity<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> in structures like <b>20</b> likely allows transport across membranes during absorption in the closed conformation, while these groups may be released when binding to the target. We believe that this intriguing characteristic of the zwitterions described in this publication will find wider application in medicinal chemistry, especially in the design of new bioactive molecules containing basic or acidic groups and lacking good permeability and/or oral absorption properties.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The majority of compounds described in this publication were prepared by a convergent route using a coupling of amide building blocks with simple or complex C-rings (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Whereas the amide building blocks <b>21</b> and <b>22</b> were made by a direct acylation of the commercially available methyl 2-(2-aminophenyl)acetate with corresponding benzoic acid chlorides, their analogs <b>25</b> and <b>26</b> required an access to 2-(2-amino-5-fluorophenyl)acetic acid (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). This intermediate could be reached from 5-fluorooxindole by opening the lactam upon its heating with 10% aqueous NaOH<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and was subsequently acylated with benzoic acid chlorides to provide the corresponding amide acids <b>23</b> and <b>24</b> in good yields (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). These acids were then converted into corresponding methyl esters <b>25</b> and <b>26</b>, and all bromine intermediates were then transformed into boronates (<b>27</b>–<b>30</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Amide Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><i>Reagents and conditions:</i> (a) Et<sub>3</sub>N or <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 1 h (89–97%); (b) 10% NaOH (aq.), 100 °C, 16 h; (c) THF/H<sub>2</sub>O, 23 °C, 16 h (76–92% over 2 steps); (d) MeOH, HCl, 23 °C, 16 h (86–98%); (e) (PinB)<sub>2</sub>, PdCl<sub>2</sub>dppf, KOAc, dioxane, 110 °C, 2 h (62–94%).</p></p></figure><div class="NLM_p">The C-ring building blocks were rather diverse (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Whereas intermediate <b>31</b> could be made by Boc-introduction into corresponding commercial benzylamine, the alkyloxy derivatives (<b>32</b>–<i><b>rac</b></i>-<b>36</b>) were prepared by alkylation of 5-bromo-2-chlorophenol. For acyclic alkoxy intermediate <b>32</b>, Boc-2-bromoethylamine was used, while for the cyclic substituents, the appropriate mesylates were employed (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). In contrast, the enantiomerically pure (<i>R</i>)-3-piperidyloxy building blocks (<b>36</b>–<b>38</b>) were accessed by the Mitsunobu reaction<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> of the (<i>S</i>)-<i>N</i>-Boc-3-piperidinol and various phenols (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of C-Ring Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><i>Reagents and conditions:</i> (a) Boc<sub>2</sub>O, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 16 h (83%); (b) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 6 h (91%); (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 16 h (16–72%); (d) Ph<sub>3</sub>P, diisopropyl azodicarboxylate (DIAD), THF, 60 °C, 16 h (42–77%).</p></p></figure><div class="NLM_p">The assembly of different final products is summarized in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Compound <b>4</b> was made by saponification of compound <b>39</b>, which was prepared from 4′-chloro-[1,1′-biphenyl]-3-carboxylic acid by its activation into acyl chloride and reaction with methyl 2-aminobenzoate. Derivative <b>6</b> was synthesized by Suzuki coupling of <b>22</b> with <i>p</i>-chlorophenyl boronate, whereas compound <b>10</b> was accessed from the boron ester <b>27</b> and bromo-building block <b>31</b> followed by ester hydrolysis and Boc-cleavage in <b>40</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Derivatives possessing diverse alkoxy-substituents (<b>11</b>–<b>15</b>) were made by Suzuki coupling of boronate <b>27</b> and alkoxy-phenyl bromides <b>32</b>–<i><b>rac</b></i><b>-36</b> followed by Boc-cleavage of the resulting acids <b>41</b>–<b>45</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). In analogy, the enantiomerically pure piperidyloxy analogs <b>16</b>–<b>20</b> were prepared via the corresponding acid intermediates <b>46</b>–<b>50</b>.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Final Products<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><i>Reagents and conditions:</i> (a) (COCl)<sub>2</sub>, DMF (cat.), CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 2 h, then methyl 2-aminobenzoate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 20 h (86%); (b) LiOH, H<sub>2</sub>O, MeOH, 50 °C, 3–18 h (45–89%); (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, 80 °C, 16 h (50–92%); (d) PdCl<sub>2</sub>dppf, Na<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O, 80 °C, 0.5 h (87%); (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 4 h (57% over 2 steps); (f) HCl, dioxane/CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 16 h (53–95%).</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00684" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00684" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this paper, we described the discovery and optimization of a new SUCNR1 antagonist scaffold. Starting from an HTS hit <b>2</b> (32 μM), the scaffold could be optimized to SUCNR1 antagonists with high potency such as, e.g. <b>7</b> (25 nM). However, the new inhibitors displayed poor permeability and oral absorption, possibly as a result of their zwitterionic nature due to the presence of the essential acid group and amine required for potency and favorable properties. As demonstrated by the pair of two closely related zwitterions <b>8</b> and <b>9</b> with very different absorption properties, the issue for poor permeability and absorption could be caused by the separation of the two adjacent, inversely charged groups as hypothesized from the X-ray structures of <b>8</b> and <b>9</b>. Whereas the flexible methyleneoxy linker in the well-absorbed compound <b>9</b> allowed for a salt bridge formation, its poorly permeable and bioavailable analog <b>8</b> contained a rigid amide linker that prevented the salt bridge formation. Since the amide makes key interactions with SUCNR1, a search for suitable amines was performed that would allow for the formation of the salt bridge also in the amide subseries. This effort led to the identification of the 3-piperidyloxy substituent in the C-ring that favored the salt bridge formation as confirmed by the X-ray structure of <b>20</b>. According to our hypothesis, the formation of the internal salt bridge provided derivatives with much improved oral absorption. For example, the optimized analog <b>20</b> displayed nearly full bioavailability and a very high oral exposure in mice (37 μmol·h/L), also achieved thanks to its very low clearance (0.6 mL/min/kg). Finally, the X-ray structure of <b>20</b> bound to SUCNR1 demonstrated an excellent property of such zwitterions, namely, their coexistence in two different conformations. While the closed conformation is forced by the salt bridge and may play an important role during permeation, it allows for the breaking of the salt bridge, leading to the stretched conformation required by the receptor. We believe that this work allows for the further development of SUCNR1 inhibitors, thanks to the presented SAR and disclosure of the second X-ray structure of an antagonist bound to SUCNR1. In addition, this work might also find a wide interest in the medicinal chemistry community as it describes the design of zwitterions with an internal salt bridge that can be highly useful for the improvement of permeability and/or oral absorption of new bioactive compounds containing basic or acidic groups.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p">All reagents and solvents were purchased from commercial suppliers and used without further purification. All reactions were performed under inert conditions (argon) unless otherwise stated. NMR spectra were recorded on a Bruker 400 MHz NMR spectrometer. Chemical shifts are reported in parts per million (ppm) relative to an internal solvent reference. Significant peaks are tabulated in the order of multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; quintet; m, multiplet; br, broad), coupling constants, and the number of protons. Final compounds were purified to ≥95% purity as assessed by analytical liquid chromatography:</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> LCMS method a</h4><div class="NLM_p last">Waters UPLC Acquity; column: CORTECS C18 + 2.7 μm, 2.1 mm × 50 mm at 80 °C, eluent A: water + 4.76% isopropanol + 0.05% HCOOH + 3.75 mM NH<sub>4</sub>OAc, B: isopropanol + 0.05% HCOOH, gradient: 1–50% B in 1.4 min, 50–98% in 0.3 min. Flow: 1.0 mL/min.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> LCMS method b</h4><div class="NLM_p">Waters UPLC Acquity; column: BEH C18 1.7 μm, 2.1 mm × 100 mm at 80 °C, eluent A: water + 4.76% isopropanol + 0.05% HCOOH + 3.75 mM NH<sub>4</sub>OAc, B: isopropanol + 0.05% HCOOH, gradient: 1–60% B in 8.4 min, 60–98% in 1.0 min. Flow: 0.4 mL/min.</div><div class="NLM_p last">The preparation of compounds <b>2</b>, <b>5</b>, <b>7</b>, <b>8</b>, and <b>9</b> has been previously described.<a onclick="showRef(event, 'ref20 ref28'); return false;" href="javascript:void(0);" class="ref ref20 ref28">(20,28)</a> Compound <b>3</b> was prepared according to the procedure described for compound <b>2</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> using the commercially available (<i>S</i>)-3-amino-3-(pyridin-3-yl)propanoic acid (Chem-Impex).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Preparation of Boronic Esters</h3><div class="NLM_p last">A mixture of bromo-compound (1 equiv), bis(pinacolato)diboron (1.1 equiv), and KOAc (2 equiv) in dioxane (0.2 M concentration) was degassed with argon. After the addition of PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> (0.1 equiv), the reaction mixture was heated at 110 °C for 2 h. After being cooled to 23 °C, the reaction mixture was filtered through Celite and washed with EtOAc. The reaction mixture was then treated with water, the aqueous layer was extracted with EtOAc, and the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The residue was purified by column chromatography to provide the boronates.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Phenol Alkylation by Mesylates</h3><div class="NLM_p last">A mixture of 5-bromo-2-chlorophenol (1 equiv), mesylate (1 equiv), and Cs<sub>2</sub>CO<sub>3</sub> (1.1 equiv) in DMF (0.05 M concentration) was stirred at 80 °C for 16 h. After being cooled to 23 °C, the reaction mixture was diluted with ether and washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The crude product was purified by column chromatography to provide the phenylalkyl ethers.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Phenol Alkylation by the Mitsunobu Reaction</h3><div class="NLM_p last">(<i>S</i>)-1-<i>N</i>-Boc-3-hydroxypiperidine (1 equiv) was added at 23 °C to a mixture of phenol (1 equiv), DIAD (1.5 equiv) and PPh<sub>3</sub> (1.5 equiv), in THF (0.1 M concentration), and the resulting solution was stirred at 23 °C for 16 h. The reaction mixture was concentrated and purified by column chromatography to provide phenylalkyl ethers.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Suzuki Coupling</h3><div class="NLM_p last">A mixture of the bromo intermediate (1 equiv), boronate (1 equiv), and saturated NaHCO<sub>3</sub> (5 equiv) in DME/water (4:1, 0.04 M concentration) was degassed with argon. Pd(PPh<sub>3</sub>)<sub>4</sub> (0.03 equiv) was then added, and the mixture was heated at 80 °C for 16 h. After being cooled to 23 °C, the beige suspension was diluted with 0.2 M HCl and extracted with ethyl acetate. The organic layers were washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude material was purified by column chromatography to provide the coupling products.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Boc-Cleavage with HCl</h3><div class="NLM_p">HCl (4 M) in dioxane (10 equiv) was added at 0 °C to a solution of Boc-intermediate (1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (0.05 M concentration). After being stirred at 23 °C for 16 h, the formed suspension was diluted with ether and the solid was filtered off, washed with ether, and dried in high vacuum to provide the amine products as HCl salts.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl 2-(2-(3-Bromobenzamido)phenyl)acetate (<b>21</b>)</h4><div class="NLM_p last">A solution of 3-brombenzoylchlorid (18.0 g, 82 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added dropwise at 23 °C to a solution of methyl 2-(2-aminophenyl)acetate (15.2 g, 82 mmol) and Et<sub>3</sub>N (13.7 mL, 98 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (400 mL). After being stirred at 23 °C for 1 h, the reaction mixture was concentrated and the residue was treated with <i>t</i>-BuOMe and stirred at 23 °C for 16 h. The mixture was then cooled to 0 °C, and the solid was filtered off and washed with <i>n</i>-hexane. The filtrate was concentrated to 25% of the volume, and the suspension was filtered off again and washed with <i>n</i>-hexane. Collected solids were dried in high vacuum to provide the title product as a colorless solid in 25.6 g (89%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.09 (s, 1H), 8.09 (t, <i>J</i> = 1.8 Hz, 1H), 7.92 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.80 (ddd, <i>J</i> = 8.0, 2.1, 1.0 Hz, 1H), 7.51 (t, <i>J</i> = 7.9 Hz, 1H), 7.40–7.29 (m, 3H), 7.25 (td, <i>J</i> = 7.3, 1.7 Hz, 1H), 3.74 (s, 2H), 3.52 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.4, 164.0, 136.6, 136.3, 134.3, 131.0, 130.9, 130.7, 130.3, 127.5, 126.9, 126.7, 126.3, 121.6, 51.6, 37.2. LCMS (method a) <i>m</i>/<i>z</i>: 349.9 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.98 min.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl 2-(2-(3-Bromo-2-fluorobenzamido)phenyl)acetate (<b>22</b>)</h4><div class="NLM_p last">A solution of 3-bromo-2-fluorobenzoyl chloride (3.0 g, 12.65 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise at 23 °C to a solution of methyl 2-(2-aminophenyl)acetate (1.9 g, 11.5 mmol) and DIPEA (4.1 mL, 23 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL). After being stirred at 23 °C for 1 h, the reaction mixture was treated with CH<sub>2</sub>Cl<sub>2</sub> and 10% NaHCO<sub>3</sub> (aq.). The water phase was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the organic layers were washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude product was purified by column chromatography (0–25% ethyl acetate in cyclohexane) to provide the title product as a yellowish solid in 4.1 g (97%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.06 (s, 1H), 7.88 (ddd, <i>J</i> = 8.2, 6.7, 1.8 Hz, 1H), 7.66 (ddd, <i>J</i> = 7.9, 6.3, 1.7 Hz, 1H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 7.38–7.19 (m, 4H), 3.77 (s, 2H), 3.59 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.2, 161.9, 155.2 (d, <i>J</i> = 249.3 Hz), 135.9, 135.5, 131.1, 123.0, 129.4 (d, <i>J</i> = 2.0 Hz), 127.5, 126.3, 126.2, 125.99, 125.97 (d, <i>J</i> = 13.1 Hz), 108.9 (d, <i>J</i> = 21.5 Hz), 51.6, 36.8. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −108.9. LCMS (method a) <i>m</i>/<i>z</i>: 366.0 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.99 min.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(2-(3-Bromobenzamido)-5-fluorophenyl)acetic Acid (<b>23</b>)</h4><div class="NLM_p last">5-Fluoroindolin-2-one (5.0 g, 33.1 mmol) was dissolved in 10% NaOH (aq.) (45 mL) and the mixture was stirred at 100 °C for 16 h. After being cooled to 23 °C, concentrated HCl (8.5 mL) was added and a half of the volume of this mixture was treated at 23 °C with the solution of 3-bromobenzoyl chloride (2.92 g, 13.3 mmol) in THF (10 mL) and the reaction mixture was stirred at 23 °C for 16 h. The solid was filtered off, washed with water, and dried in high vacuum to provide the title product as a brown solid in 4.25 g (76%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.33 (s, 1H), 10.14 (s, 1H), 8.10 (t, <i>J</i> = 1.9 Hz, 1H), 7.92 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.80 (ddd, <i>J</i> = 8.0, 2.1, 1.0 Hz, 1H), 7.50 (t, <i>J</i> = 7.9 Hz, 1H), 7.40 (dd, <i>J</i> = 8.8, 5.6 Hz, 1H), 7.21 (dd, <i>J</i> = 9.6, 3.0 Hz, 1H), 7.15 (td, <i>J</i> = 8.6, 3.1 Hz, 1H), 3.65 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.0, 164.1, 159.8 (d, <i>J</i> = 242.3 Hz), 136.6, 134.3, 133.9 (d, <i>J</i> = 8.6 Hz), 132.7 (d, <i>J</i> = 2.7 Hz), 130.7, 130.3, 128.5 (d, <i>J</i> = 8.6 Hz), 126.8, 121.7, 117.5 (d, <i>J</i> = 22.8 Hz), 113.8 (d, <i>J</i> = 21.8 Hz), 37.3. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.8. LCMS (method a) <i>m</i>/<i>z</i>: 352.0 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.84 min.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl 2-(2-(3-Bromobenzamido)-5-fluorophenyl)acetate (<b>25</b>)</h4><div class="NLM_p last">HCl (4 M) in dioxane (9.5 mL, 38 mmol) was added at 23 °C to a solution of 2-(2-(3-bromobenzamido)-5-fluorophenyl)acetic acid (<b>23</b>, 3.4 g, 9.54 mmol) in MeOH (100 mL). The formed suspension was stirred at 23 °C for 16 h. The reaction mixture was concentrated and the crude product was purified by column chromatography (100% CH<sub>2</sub>Cl<sub>2</sub>) to provide the title product as a yellowish solid in 3.0 g (86%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.09 (s, 1H), 8.08 (t, <i>J</i> = 1.8 Hz, 1H), 7.91 (dt, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.80 (ddd, <i>J</i> = 8.0, 2.1, 1.0 Hz, 1H), 7.50 (t, <i>J</i> = 7.9 Hz, 1H), 7.37 (dd, <i>J</i> = 8.7, 5.5 Hz, 1H), 7.24 (dd, <i>J</i> = 9.6, 3.0 Hz, 1H), 7.17 (td, <i>J</i> = 8.5, 3.0 Hz, 1H), 3.74 (s, 2H), 3.52 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 170.8, 164.2, 159.9 (d, <i>J</i> = 242.5 Hz), 136.4, 134.3, 133.6 (d, <i>J</i> = 8.6 Hz), 132.6 (d, <i>J</i> = 2.9 Hz), 130.7, 130.3, 128.9 (d, <i>J</i> = 8.7 Hz), 126.7, 121.6, 117.5 (d, <i>J</i> = 22.9 Hz), 114.2 (d, <i>J</i> = 22.1 Hz), 51.7, 36.8. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.4. LCMS (method a) <i>m</i>/<i>z</i>: 366.0 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.99 min.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(2-(3-Bromo-2-fluorobenzamido)-5-fluorophenyl)acetic Acid (<b>24</b>)</h4><div class="NLM_p last">5-Fluoroindolin-2-one (5.0 g, 33.1 mmol) was dissolved in a 10% solution of NaOH (aq.) (45.3 mL, 125 mmol) and the mixture was stirred at 100 °C for 16 h. After being cooled to 23 °C, concentrated HCl (8.5 mL) was added and a half of the volume of this mixture was treated at 23 °C with the solution of 3-bromo-2-fluorobenzoyl chloride (3.16 g, 13.3 mmol) in THF (10 mL) and the reaction mixture was stirred at 23 °C for 16 h. The solid was filtered off, washed with water, and dried in high vacuum to provide the title product as a brown solid in 4.7 g (92%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.43 (s, 1H), 10.04 (s, 1H), 7.88 (t, <i>J</i> = 7.3 Hz, 1H), 7.67 (t, <i>J</i> = 7.0 Hz, 1H), 7.51–7.42 (m, 1H), 7.29 (t, <i>J</i> = 7.7 Hz, 1H), 7.25–7.10 (m, 2H), 3.68 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.8, 162.0, 159.7 (d, <i>J</i> = 242.4 Hz), 155.2 (d, <i>J</i> = 250.0 Hz), 135.5, 133.1 (d, <i>J</i> = 8.5 Hz), 132.2 (d, <i>J</i> = 2.8 Hz), 129.5 (d, <i>J</i> = 2.4 Hz), 128.1 (d, <i>J</i> = 8.4 Hz), 126.0 (d, <i>J</i> = 4.3 Hz), 125.8 (d, <i>J</i> = 3.1 Hz), 117.5 (d, <i>J</i> = 22.9 Hz), 113.9 (d, <i>J</i> = 22.0 Hz), 109.0, 36.9. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −108.7, −116.7. LCMS (method a) <i>m</i>/<i>z</i>: 372.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.82 min.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 2-(2-(3-Bromo-2-fluorobenzamido)-5-fluorophenyl)acetate (<b>26</b>)</h4><div class="NLM_p last">HCl (4 M) in dioxane (11.7 mL, 46.7 mmol) was added at 23 °C to a solution of 2-(2-(3-bromo-2-fluorobenzamido)-5-fluorophenyl)acetic acid (<b>24</b>, 4.5 g, 11.7 mmol) in MeOH (100 mL), and the formed suspension was stirred at 23 °C for 16 h. After concentration, the crude product was purified by column chromatography (100% CH<sub>2</sub>Cl<sub>2</sub>) to provide the title product as a pale yellow solid in 4.4 g (98%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.06 (s, 1H), 7.88 (ddd, <i>J</i> = 8.2, 6.7, 1.8 Hz, 1H), 7.65 (ddd, <i>J</i> = 7.8, 6.3, 1.7 Hz, 1H), 7.44 (dd, <i>J</i> = 8.8, 5.6 Hz, 1H), 7.30 (t, <i>J</i> = 7.9 Hz, 1H), 7.23 (dd, <i>J</i> = 9.6, 3.0 Hz, 1H), 7.18 (td, <i>J</i> = 8.5, 3.0 Hz, 1H), 3.78 (s, 2H), 3.59 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 170.7, 162.1, 159.8 (d, <i>J</i> = 242.6 Hz), 155.2 (d, <i>J</i> = 249.4 Hz), 135.5, 132.7 (d, <i>J</i> = 8.5 Hz), 132.2 (d, <i>J</i> = 2.5 Hz), 129.4 (d, <i>J</i> = 2.1 Hz), 128.3 (d, <i>J</i> = 8.7 Hz), 126.0 (d, <i>J</i> = 4.3 Hz), 125.8 (d, <i>J</i> = 16.5 Hz), 117.6 (d, <i>J</i> = 22.9 Hz), 114.2 (d, <i>J</i> = 22.2 Hz), 108.9 (d, <i>J</i> = 21.4 Hz), 51.7, 36.5. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −108.9, −116.4. LCMS (method a) <i>m</i>/<i>z</i>: 384.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.99 min.</div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 2-(2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>)</h4><div class="NLM_p last">According to the general procedure for the preparation of boronesters, the reaction of methyl 2-(2-(3-bromobenzamido)phenyl)acetate (<b>21</b>, 7.5 g, 21.5 mmol) and bis(pinacolato)diboron (5.5 g, 21.5 mmol) provided the title product after column chromatography (0–30% ethyl acetate in cyclohexane) as a yellow sticky oil in 8.3 g (94%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.07 (s, 1H), 8.22 (s, 1H), 8.06–7.99 (m, 1H), 7.86 (dt, <i>J</i> = 7.4, 1.2 Hz, 1H), 7.54 (t, <i>J</i> = 7.6 Hz, 1H), 7.38–7.29 (m, 3H), 7.24 (td, <i>J</i> = 7.3, 1.7 Hz, 1H), 3.73 (s, 2H), 3.53 (s, 3H), 1.33 (s, 12H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.4, 165.5, 137.3, 136.7, 134.1, 133.6, 131.0, 130.9, 130.5, 128.0, 127.4, 126.9, 126.1, 83.9, 51.5, 37.2, 24.7 (the signal for boron α carbon not resolved). LCMS (method a) <i>m</i>/<i>z</i>: 396.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.11 min.</div></div><div id="sec5_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 2-(2-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>28</b>)</h4><div class="NLM_p last">According to the general procedure for the preparation of boronesters, the reaction of methyl 2-(2-(3-bromo-2-fluorobenzamido)phenyl)acetate (<b>22</b>, 1.0 g, 2.7 mmol) and bis(pinacolato)diboron (0.77 g, 3 mmol) provided the title product after column chromatography (0–30% ethyl acetate in cyclohexane) as a yellow sticky oil in 0.80 g (62%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 9.90 (s, 1H), 7.84–7.74 (m, 2H), 7.45 (d, <i>J</i> = 7.7 Hz, 1H), 7.38–7.27 (m, 3H), 7.26–7.20 (m, 1H), 3.77 (s, 2H), 3.61 (s, 3H), 1.33 (s, 12H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.2, 163.0 (d, <i>J</i> = 254.5 Hz), 162.8, 138.7 (d, <i>J</i> = 8.4 Hz), 136.2, 133.6 (d, <i>J</i> = 3.6 Hz), 131.0, 130.0, 127.4, 126.3, 126.0, 124.4 (d, <i>J</i> = 17.2 Hz), 124.2 (d, <i>J</i> = 3.7 Hz), 83.9, 51.5, 36.8, 24.6 (the signal for boron α carbon not resolved). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −103.8. LCMS (method a) <i>m</i>/<i>z</i>: 414.4 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.09 min.</div></div><div id="sec5_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl 2-(5-Fluoro-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>29</b>)</h4><div class="NLM_p last">According to the general procedure for the preparation of boron esters, the reaction of methyl 2-(2-(3-bromobenzamido)-5-fluorophenyl)acetate (<b>25</b>, 700 mg, 1.9 mmol) and bis(pinacolato)diboron (534 mg, 2.1 mmol) provided the title product after column chromatography (0–60% ethyl acetate in cyclohexane) as a beige solid in 612 mg (77%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.07 (s, 1H), 8.22 (s, 1H), 8.02 (d, <i>J</i> = 7.9 Hz, 1H), 7.87 (d, <i>J</i> = 7.3 Hz, 1H), 7.54 (t, <i>J</i> = 7.6 Hz, 1H), 7.36 (dd, <i>J</i> = 8.8, 5.6 Hz, 1H), 7.23 (dd, <i>J</i> = 9.6, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 3.0 Hz, 1H), 3.74 (s, 2H), 3.54 (s, 3H), 1.33 (s, 12H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 170.9, 165.7, 159.9 (d, <i>J</i> = 242.2 Hz), 137.4, 133.9, 133.6, 133.5, 133.0 (d, <i>J</i> = 2.6 Hz), 130.6, 128.9, 128.8, 128.0, 117.5 (d, <i>J</i> = 22.9 Hz), 114.1 (d, <i>J</i> = 22.1 Hz), 83.9, 51.6, 36.9, 24.7. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.8. LCMS (method a) <i>m</i>/<i>z</i>: 414.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.15 min.</div></div><div id="sec5_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 2-(5-Fluoro-2-(2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>30</b>)</h4><div class="NLM_p last">According to the general procedure for the preparation of boron esters, the reaction of methyl 2-(2-(3-bromo-2-fluorobenzamido)-5-fluorophenyl)acetate (<b>26</b>, 1.76 g, 4.6 mmol) and bis(pinacolato)diboron (1.28 g, 5.0 mmol) provided the title product after column chromatography (0–40% ethyl acetate in cyclohexane) as a beige solid in 2.1 g (86%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 9.91 (s, 1H), 7.83–7.74 (m, 2H), 7.43 (dd, <i>J</i> = 8.8, 5.6 Hz, 1H), 7.34 (t, <i>J</i> = 7.4 Hz, 1H), 7.22 (dd, <i>J</i> = 9.6, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 3.1 Hz, 1H), 3.77 (s, 2H), 3.61 (s, 3H), 1.32 (s, 12H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 170.7, 163.0, 162.9 (d, <i>J</i> = 254.6 Hz), 159.8 (d, <i>J</i> = 242.3 Hz), 138.7 (d, <i>J</i> = 8.4 Hz), 133.6 (d, <i>J</i> = 3.7 Hz), 132.7 (d, <i>J</i> = 8.5 Hz), 132.5 (d, <i>J</i> = 2.9 Hz), 128.3 (d, <i>J</i> = 8.7 Hz), 124.30, 124.19 (d, <i>J</i> = 3.7 Hz), 124.12, 117.5 (d, <i>J</i> = 22.9 Hz), 114.1 (d, <i>J</i> = 22.1 Hz), 83.9, 51.6, 36.5, 24.6. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −103.8, −116.7. LCMS (method a) <i>m</i>/<i>z</i>: 432.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.16 min.</div></div><div id="sec5_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>tert</i>-Butyl 5-Bromo-2-chlorobenzylcarbamate (<b>31</b>)</h4><div class="NLM_p last">DIPEA (1.25 mL, 7.14 mmol) and Boc<sub>2</sub>O (1.26 mL, 5.40 mmol) were added at 23 °C to a solution of 5-bromo-2-chlorobenzyl amine (750 mg, 3.40 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (34 mL). After being stirred at 23 °C for 16 h, the mixture was treated with saturated NaHCO<sub>3</sub> (aq.) and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude product was purified by column chromatography (0–20% ethyl acetate in cyclohexane) to provide the title product as a pale yellow solid in 905 mg (83%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.50–7.44 (m, 2H), 7.44–7.42 (m, 1H), 7.40 (d, <i>J</i> = 8.5 Hz, 1H), 4.18 (d, <i>J</i> = 6.2 Hz, 2H), 1.41 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 155.7, 139.5, 131.2, 131.1, 131.0, 130.8, 120.0, 78.3, 41.0, 28.1. LCMS (method a) <i>m</i>/<i>z</i>: 220.1 [M + H-Boc]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.29 min.</div></div><div id="sec5_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>tert</i>-Butyl (2-(5-Bromo-2-chlorophenoxy)ethyl)carbamate (<b>32</b>)</h4><div class="NLM_p last">A mixture of 5-bromo-2-chlorophenol (0.50 g, 2.34 mmol), <i>tert</i>-butyl (2-bromoethyl)carbamate (1.35 g, 5.84 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.92 g, 5.84 mmol) in DMF (4.7 mL) was stirred at 120 °C for 6 h. After being cooled to 23 °C, the reaction mixture was diluted with ether and washed with water. The organic phases were washed with 2 M NaOH, water, and brine; dried (Na<sub>2</sub>SO<sub>4</sub>); and concentrated. The crude product was purified by column chromatography (0–77% ethyl acetate in <i>n</i>-heptane) to provide the title product as a colorless oil in 768 mg (91%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.40–7.33 (m, 2H), 7.15 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 6.94 (t, <i>J</i> = 5.8 Hz, 1H), 4.08 (t, <i>J</i> = 5.8 Hz, 2H), 3.34–3.30 (m, 2H), 1.38 (s, 9H). LCMS (method a) <i>m</i>/<i>z</i>: 249.9 [M + H-Boc]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.36 min.</div></div><div id="sec5_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>tert</i>-Butyl 3-(5-Bromo-2-chlorophenoxy)azetidine-1-carboxylate (<b>33</b>)</h4><div class="NLM_p last">According to the general procedure for phenol alkylation by mesylates, the reaction of 5-bromo-2-chlorophenol (300 mg, 1.45 mmol) and 1-(<i>tert</i>-butoxycarbonyl)-3-(methansulfonyloxy)azetidine (363 mg, 1.45 mmol) provided the title product after column chromatography (0–20% ethyl acetate in cyclohexane) as a colorless solid in 259 mg (45%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.43 (d, <i>J</i> = 8.4 Hz, 1H), 7.21 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.09 (d, <i>J</i> = 2.2 Hz, 1H), 5.19–5.04 (m, 1H), 4.33 (dd, <i>J</i> = 9.2, 7.2 Hz, 2H), 3.81 (dd, <i>J</i> = 9.7, 3.6 Hz, 2H), 1.39 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 155.5, 152.6, 131.7, 125.2, 121.0, 120.6, 116.8, 79.0, 67.0, 55.3, 28.0. LCMS (method a) <i>m</i>/<i>z</i>: 262.1 [M + H-Boc]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.44 min.</div></div><div id="sec5_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>tert</i>-Butyl 3-(5-Bromo-2-chlorophenoxy)pyrrolidine-1-carboxylate (<b>34</b>)</h4><div class="NLM_p last">According to the general procedure for phenol alkylation by mesylates, the reaction of 5-bromo-2-chlorophenol (100 mg, 0.48 mmol) and <i>tert</i>-butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate (128 mg, 0.48 mmol) provided the title product after column chromatography (0–10% ethyl acetate in cyclohexane) as a colorless resin in 136 mg (72%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.45 (d, <i>J</i> = 2.2 Hz, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.19 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 5.29–5.06 (m, 1H), 3.60–3.47 (m, 1H), 3.46–3.31 (m, 3H), 2.21–1.96 (m, 2H), 1.40 + 1.39 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 153.7, 153.1, 131.5, 124.9, 122.1, 120.4, 118.6, 78.5, (78.3 + 77.4), (51.2 + 51.0), (43.9 + 43.7), (30.8 + 30.0), 28.1. LCMS (method a) <i>m</i>/<i>z</i>: 276.1 [M + H-Boc]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.44 min.</div></div><div id="sec5_6_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>tert</i>-Butyl 4-(5-Bromo-2-chlorophenoxy)piperidine-1-carboxylate (<b>35</b>)</h4><div class="NLM_p last">According to the general procedure for phenol alkylation by mesylates, the reaction of 5-bromo-2-chlorophenol (300 mg, 1.45 mmol) and <i>tert</i>-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate (404 mg, 1.45 mmol) provided the title product after column chromatography (0–10% ethyl acetate in cyclohexane) as a colorless resin in 321 mg (57%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.48 (d, <i>J</i> = 2.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.5 Hz, 1H), 7.16 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 4.83–4.69 (m, 1H), 3.69–3.49 (m, 2H), 3.30–3.22 (m, 2H), 1.92–1.80 (m, 2H), 1.63–1.51 (m, 2H), 1.41 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 153.9, 153.2, 131.5, 124.7, 122.1, 120.5, 118.8, 78.8, 73.5, 40.2, 30.0, 28.0. LCMS (method a) <i>m</i>/<i>z</i>: 290.0 [M + H-Boc]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.56 min.</div></div><div id="sec5_6_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>tert</i>-Butyl 3-(5-Bromo-2-chlorophenoxy)piperidine-1-carboxylate (<i>rac</i>-36)</h4><div class="NLM_p last">According to the general procedure for phenol alkylation by mesylates, the reaction of 5-bromo-2-chlorophenol (300 mg, 1.45 mmol) and <i>tert</i>-butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate (404 mg, 1.45 mmol) provided the title product after column chromatography (0–20% ethyl acetate in cyclohexane) as a colorless solid in 91 mg (16%) yield. For analytical data, see <b>36</b>.</div></div><div id="sec5_6_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-<i>tert</i>-Butyl 3-(5-Bromo-2-chlorophenoxy)piperidine-1-carboxylate (<b>36</b>)</h4><div class="NLM_p last">According to the general procedure for phenol alkylation by the Mitsunobu reaction, the reaction of (<i>S</i>)-1-<i>N</i>-Boc-3-hydroxypiperidine (485 mg, 2.4 mmol) and 5-bromo-2-chlorophenol (500 mg, 2.4 mmol) provided the title product after column chromatography (0–60% ethyl acetate in cyclohexane) as a colorless oil in 458 mg (43%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.43 (d, <i>J</i> = 2.1 Hz, 1H), 7.38 (d, <i>J</i> = 8.5 Hz, 1H), 7.15 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 4.71–4.53 (m, 1H), 3.97–3.65 (m, 1H), 3.61–3.33 (m, 1H), 3.30–3.17 (m, 1H), 3.08–2.90 (m, 1H), 1.94–1.69 (m, 3H), 1.53–1.43 (m, 1H), 1.16 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 153.7, 153.3, 131.4, 124.6, 124.2, 120.3, 117.8, 78.3, 70.9, 45.3, 42.6, 28.7, 27.6, 20.4. LCMS (method a) <i>m</i>/<i>z</i>: 290.1 [M + H-Boc]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.48 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 39.4 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_6_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-<i>tert</i>-Butyl 3-(5-Bromo-2-chloro-4-fluorophenoxy)piperidine-1-carboxylate (<b>37</b>)</h4><div class="NLM_p last">According to the general procedure for phenol alkylation by the Mitsunobu reaction, the reaction of (<i>S</i>)-<i>N</i>-Boc-3-hydroxy piperidine (1.8 g, 8.9 mmol) and 5-bromo-2-chloro-4-fluorophenol (2.0 g, 8.9 mmol) provided the title product as a colorless oil in 1.53 g (42%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.73–7.50 (m, 2H), 4.69–4.45 (m, 1H), 3.96–3.39 (m, 2H), 3.27–3.15 (m, 1H), 3.11–2.88 (m, 1H), 1.97–1.63 (m, 3H), 1.52–1.42 (m, 1H), 1.16 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 151.0 (d, <i>J</i> = 256 Hz), 149.7, 122.0, 120.1, 118.8 (d, <i>J</i> = 2.3 Hz), 118.0 (d, <i>J</i> = 26.8 Hz), 106.6 (d, <i>J</i> = 22.1 Hz), 78.3, 71.5, 45.3, 42.7, 28.7, 27.7, 20.4.<sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.8. LCMS (method a) <i>m</i>/<i>z</i>: 408.4 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.51 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 30.7 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_6_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-<i>tert</i>-Butyl 3-(3-Bromo-6-chloro-2-fluorophenoxy)piperidine-1-carboxylate (<b>38</b>)</h4><div class="NLM_p last">According to the general procedure for phenol alkylation by the Mitsunobu reaction, the reaction of (<i>S</i>)-1-<i>N</i>-Boc-3-hydroxypiperidine (0.75 g, 3.7 mmol) and 3-bromo-6-chloro-2-fluorophenol (0.60 g, 2.7 mmol) provided the title product after column chromatography (0–5% ethyl acetate in cyclohexane) in 877 mg (77%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.48 (dd, <i>J</i> = 8.8, 6.9 Hz, 1H), 7.33 (dd, <i>J</i> = 8.8, 1.9 Hz, 1H), 4.45–4.19 (m, 1H), 3.74–3.33 (m, 3H), 3.28–3.08 (m, 1H), 1.99–1.86 (m, 1H), 1.85–1.66 (m, 2H), 1.52–1.41 (m, 1H), 1.32 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 153.8, 152.7 (d, <i>J</i> = 242 Hz), 142.1 (d, <i>J</i> = 15 Hz), 127.8 (d, <i>J</i> = 9.1 Hz), 127.6 (d, <i>J</i> = 18 Hz), 126.5 (d, <i>J</i> = 3.4 Hz), 107.9 (d, <i>J</i> = 20 Hz), 78.7, 77.4, 47.1, 42.5, 29.3, 27.9, 20.9. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −119.6. LCMS (method a) <i>m</i>/<i>z</i>: 408.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.53 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 10.8 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_6_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl 2-(4′-Chloro-[1,1′-biphenyl]-3-carboxamido)benzoate (<b>39</b>)</h4><div class="NLM_p last">Oxalyl chloride (1.1 mL, 12 mmol) and DMF (1 drop) were added rapidly at 23 °C to 4′-chloro-[1,1′-biphenyl]-3-carboxylic acid (0.28 g, 1.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) and the reaction mixture was stirred at 23 °C for 2 h. After concentration in high vacuum, the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) and treated at 23 °C with methyl 2-aminobenzoate (0.17 mL, 1.26 mmol) and Et<sub>3</sub>N (0.42 mL, 3.0 mmol). After being stirred at 23 °C for 20 h, the reaction mixture was quenched with saturated NaHCO<sub>3</sub> (aq.) and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude product was purified by column chromatography (0–60% EtOAc in <i>n</i>-heptane) to provide the title compound as a white solid in 0.41 g (86%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 11.57 (s, 1H), 8.51 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 8.24 (t, <i>J</i> = 1.8 Hz, 1H), 8.02 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.99–7.94 (m, 2H), 7.84–7.79 (m, 2H), 7.76−7.67 (m, 2H), 7.62–7.57 (m, 2H), 7.28 (ddd, <i>J</i> = 8.1, 7.4, 1.2 Hz, 1H), 3.89 (s, 3H). LCMS (method a) <i>m</i>/<i>z</i> 366.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.41 min.</div></div><div id="sec5_6_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(4′-Chloro-[1,1′-biphenyl]-3-carboxamido)benzoic Acid (<b>4</b>)</h4><div class="NLM_p last">LiOH·H<sub>2</sub>O (85 mg, 2.0 mmol) was added at 23 °C to a mixture of methyl 2-(4′-chloro-[1,1′-biphenyl]-3-carboxamido)benzoate (<b>39</b>, 0.40 g, 1.0 mmol) in MeOH (8 mL) and water (2 mL). After being stirred at 50 °C for 3 h, the mixture was concentrated and the crude product was treated with concentrated HCl (11 mL). After being stirred at 60 °C for 2 h and cooled to 23 °C, the suspension was filtered off, washed with water, and dried in vacuum to provide the product <b>4</b> as a white solid in 161 mg (45%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 13.83 (s, 1H), 12.24 (s, 1H), 8.71 (d, <i>J</i> = 7.9 Hz, 1H), 8.21 (s, 1H), 8.07 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 8.00–7.89 (m, 2H), 7.78 (d, <i>J</i> = 8.6 Hz, 2H), 7.74–7.63 (m, 2H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.23 (td, <i>J</i> = 7.6, 1.2 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 170.0, 164.5, 141.0, 139.5, 138.2, 135.4, 134.3, 133.0, 131.3, 130.4, 129.8, 129.1, 128.6, 126.5, 125.1, 123.1, 120.0, 116.9. LCMS (method a) <i>m</i>/<i>z</i> 352.3 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.37 min. LCMS (method b) <i>m</i>/<i>z</i>: 352.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 6.55 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>15</sub>ClNO<sub>3</sub> 352.0735; found 352.0736.</div></div><div id="sec5_6_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(2-(4′-Chloro-2-fluoro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>6</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of methyl 2-(2-(3-bromo-2-fluorobenzamido)phenyl)acetate (<b>22</b>, 150 mg, 0.41 mmol) and 2-(4-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (117 mg, 0.49 mmol) provided the title compound after column chromatography (0–50% ethyl acetate in cyclohexane) as a white powder in 130 mg (79%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.35 (s, 1H), 9.98 (d, <i>J</i> = 1.6 Hz, 1H), 7.75–7.56 (m, 6H), 7.52 (d, <i>J</i> = 7.9 Hz, 1H), 7.42 (t, <i>J</i> = 7.6 Hz, 1H), 7.31 (t, <i>J</i> = 7.4 Hz, 2H), 7.22 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 3.69 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.4, 162.7, 155.9 (d, <i>J</i> = 251.2 Hz), 136.1, 133.3 (d, <i>J</i> = 41.2 Hz), 132.8 (d, <i>J</i> = 3.2 Hz), 131.0, 130.8 (d, <i>J</i> = 3.0 Hz), 129.9 (d, <i>J</i> = 47.3 Hz), 129.6, 128.7, 127.8 (d, <i>J</i> = 14.2 Hz), 127.2, 125.9, 125.9, 125.3 (d, <i>J</i> = 16.5 Hz), 124.8 (d, <i>J</i> = 4.1 Hz), 37.2. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −119.8. LCMS (method a) <i>m</i>/<i>z</i>: 383.8 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.12 min. LCMS (method b) <i>m</i>/<i>z</i>: 384.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.41 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>16</sub>ClFNO<sub>3</sub> 384.0797; found 384.0797.</div></div><div id="sec5_6_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl 2-(2-(3′-(((<i>tert</i>-Butoxycarbonyl)amino)methyl)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetate (<b>40</b>)</h4><div class="NLM_p last">A mixture of methyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>, 0.28 g, 0.67 mmol), <i>tert</i>-butyl 5-bromo-2-chlorobenzylcarbamate (<b>31</b>, 0.24 g, 0.67 mmol) and 2 M Na<sub>2</sub>CO<sub>3</sub> (aq.) (1.0 mL, 2.0 mmol) in DMF (6.7 mL) was degassed with argon. PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> (27 mg, 0.034 mmol) was added, and the reaction mixture was heated in a microwave oven at 80 °C for 30 min. After being cooled to 23 °C, the mixture was filtered over Celite and washed with ethyl acetate and the filtrate was concentrated. The crude product was purified by column chromatography (0–80% ethyl acetate in <i>n</i>-heptane) to provide the title product as a pale yellow resin in 0.30 g (87%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.09 (s, 1H), 8.18 (t, <i>J</i> = 1.9 Hz, 1H), 7.93 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.84 (d, <i>J</i> = 7.8 Hz, 1H), 7.72–7.66 (m, 2H), 7.64 (d, <i>J</i> = 7.8 Hz, 1H), 7.57 (d, <i>J</i> = 8.7 Hz, 1H), 7.50 (t, <i>J</i> = 5.6 Hz, 1H), 7.43–7.39 (m, 1H), 7.38–7.30 (m, 2H), 7.25 (td, <i>J</i> = 7.4, 1.5 Hz, 1H), 4.28 (d, <i>J</i> = 6.1 Hz, 2H), 3.76 (s, 2H), 3.51 (s, 3H), 1.40 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.4, 165.3, 156.0, 139.2, 138.3, 137.4, 136.5, 135.3, 133.4, 132.9, 131.0, 130.9, 129.7, 129.5, 129.2, 127.5, 126.92, 126.84, 126.80, 126.2, 125.8, 78.2, 51.6, 41.4, 37.2, 28.2. LCMS (method a) <i>m</i>/<i>z</i>: 507.2 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.26 min.</div></div><div id="sec5_6_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(2-(3′-(Aminomethyl)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>10</b>)</h4><div class="NLM_p last">LiOH·H<sub>2</sub>O (48 mg, 1.1 mmol) was added rapidly at 23 °C to a mixture of methyl 2-(2-(3′-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetate (<b>40</b>, 0.29 g, 0.56 mmol) in MeOH (5 mL) and water (1.25 mL) and the mixture was stirred at 50 °C for 18 h. After being cooled to 23 °C, the mixture was concentrated and the residue was treated with CH<sub>2</sub>Cl<sub>2</sub> (5 mL) followed by TFA (0.88 mL, 11.3 mmol). The mixture was stirred at 23 °C for 4 h. After concentration, the crude product was purified by HPLC (Gilson SunFire 30 mm × 100 mm, 23 °C, eluent A: water + 0.1% TFA, B: acetonitrile + 0.1% TFA, gradient: 5–80% B in 10 min, 80–100% B in 0.5 min. Flow: 40 mL/min) to provide the title product (TFA salt) as a white powder in 165 mg (57%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.38 (s, 1H), 10.14 (s, 1H), 8.41 (s, 3H), 8.29 (s, 1H), 8.04–7.97 (m, 2H), 7.93 (d, <i>J</i> = 7.8 Hz, 1H), 7.85 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.73–7.63 (m, 2H), 7.47 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (d, <i>J</i> = 7.4 Hz, 1H), 7.32 (d, <i>J</i> = 7.7 Hz, 1H), 7.24 (t, <i>J</i> = 7.3 Hz, 1H), 4.26 (s, 2H), 3.69 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.7, 165.1, 138.6, 136.6, 135.5, 132.5, 132.2, 131.0, 130.9, 130.1, 129.6, 129.2, 129.0, 128.5, 127.3, 127.2, 126.3, 126.0, 37.6 (three carbons missing). LCMS (method a) <i>m</i>/<i>z</i>: 395.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.56 min. LCMS (method b) <i>m</i>/<i>z</i>: 395.3 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.59 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>3</sub> 395.1157; found 395.1156.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-(2-(3′-(2-((<i>tert</i>-Butoxycarbonyl)amino)ethoxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>41</b>)</h3><div class="NLM_p">A mixture of <i>tert</i>-butyl (2-(5-bromo-2-chlorophenoxy)ethyl)carbamate (<b>32</b>, 747 mg, 2.1 mmol), methyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>, 0.86 g, 2.1 mmol), and Na<sub>2</sub>CO<sub>3</sub> (3.10 mL, 6.20 mmol) in DMF (21 mL) was degassed with argon. After the addition of PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub> (84 mg, 0.10 mmol), the mixture was stirred at 80 °C for 1 h. The mixture was cooled to 23 °C, filtered over Celite, and washed with EtOAc. The filtrate was concentrated and the crude product was purified by column chromatography (0–75% ethyl acetate in <i>n</i>-heptane) to provide the intermediate methyl 2-(2-(3′-(2-((<i>tert</i>-butoxycarbonyl)amino)ethoxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetate as a yellow foam in 0.78 g (63%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.08 (s, 1H), 8.21 (s, 1H), 8.00–7.86 (m, 2H), 7.62 (t, <i>J</i> = 7.7 Hz, 1H), 7.55 (d, <i>J</i> = 8.3 Hz, 1H), 7.50 (s, 1H), 7.44 (d, <i>J</i> = 6.5 Hz, 1H), 7.39–7.31 (m, 3H), 7.25 (td, <i>J</i> = 7.4, 1.5 Hz, 1H), 6.99 (t, <i>J</i> = 5.8 Hz, 1H), 4.20 (t, <i>J</i> = 6.0 Hz, 2H), 3.78 (s, 2H), 3.50 (s, 3H), 3.37 (dt, <i>J</i> = 6.2 Hz, 2H), 1.37 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.5, 165.3, 155.7, 154.2, 139.8, 139.2, 136.5, 135.1, 131.0, 130.8, 130.4, 129.9, 129.1, 127.5, 127.2, 126.8, 126.2, 125.9, 121.3, 120.1, 112.5, 77.8, 67.7, 51.6, 37.3, 28.2, 24.9, 24.5. LCMS (method a) <i>m</i>/<i>z</i>: 537.3 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.33 min. LiOH·H<sub>2</sub>O (35 mg, 0.84 mmol) was added at 23 °C to a mixture of products from the previous step (methyl 2-(2-(3′-(2-((<i>tert</i>-butoxycarbonyl)amino)ethoxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetate, 0.25 g, 0.42 mmol) in MeOH (3.3 mL) and water (0.84 mL), and the mixture was stirred at 23 °C for 4 h. The reaction mixture was then concentrated, and the residue was treated with 0.2 M HCl. The resulting suspension was filtered, and the solid was washed with water and dried in high vacuum to provide the title product as a white solid in 158 mg (70%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.35 (s, 1H), 10.17 (s, 1H), 8.24 (s, 1H), 7.95 (d, <i>J</i> = 1.7 Hz, 1H), 7.93 (d, <i>J</i> = 1.7 Hz, 1H), 7.62 (t, <i>J</i> = 7.7 Hz, 1H), 7.54 (d, <i>J</i> = 8.2 Hz, 1H), 7.53–7.47 (m, 2H), 7.40–7.29 (m, 3H), 7.22 (td, <i>J</i> = 7.4, 1.4 Hz, 1H), 7.00 (t, <i>J</i> = 5.6 Hz, 1H), 4.20 (t, <i>J</i> = 6.0 Hz, 2H), 3.69 (s, 2H), 3.37 (td, <i>J</i> = 6.2, 5.6 Hz, 2H), 1.37 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 174.0, 164.2, 155.8, 154.3, 139.5, 138.8, 138.1, 135.9, 130.45, 130.30, 130.23, 129.27, 129.13, 127.4, 125.9, 125.6, 123.6, 122.6, 121.0, 119.3, 112.4, 77.3, 67.51, 67.45, 44.9, 28.2. LCMS (method a) <i>m</i>/<i>z</i>: 525.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.25 min.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(2-(3′-(2-Aminoethoxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>11</b>)</h4><div class="NLM_p last">TFA (0.85 mL, 10.9 mmol) was added at 23 °C to a solution of 2-(2-(3′-(2-((<i>tert</i>-butoxycarbonyl)amino)ethoxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic acid (<b>41</b>, 148 mg, 0.27 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.7 mL). After being stirred at 23 °C for 3 h, the reaction mixture was concentrated and the crude product was purified by HPLC (Gilson SunFire 30 mm × 100 mm; 23 °C, eluent A: water + 0.1% TFA, B: acetonitrile + 0.1% TFA, gradient: 5–80% B in 10 min, 80–100% B in 0.5 min. Flow: 40 mL/min) to provide the title product (TFA-salt) as a white powder in 120 mg (81%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.45 (s, 1H), 10.11 (s, 1H), 8.23 (s, 1H), 8.02 (s, 3H), 7.98–7.89 (m, 2H), 7.64 (t, <i>J</i> = 7.7 Hz, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.53 (d, <i>J</i> = 2.0 Hz, 1H), 7.49 (d, <i>J</i> = 7.8 Hz, 1H), 7.43 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.39–7.28 (m, 2H), 7.23 (td, <i>J</i> = 7.4, 1.4 Hz, 1H), 4.41 (t, <i>J</i> = 5.2 Hz, 2H), 3.70 (s, 2H), 3.36–3.27 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 165.1, 153.7, 140.0, 139.1, 136.6, 135.3, 131.1, 130.8, 130.6, 129.9, 129.2, 127.25, 127.18, 126.3, 125.99, 125.89, 121.6, 120.9, 113.1, 66.0, 48.6, 37.7. LCMS (method a) <i>m</i>/<i>z</i>: 425.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.68 min. LCMS (method b) <i>m</i>/<i>z</i>: 425.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.13 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub> 425.1263; found 425.1263.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(2-(3′-((1-(<i>tert</i>-Butoxycarbonyl)azetidin-3-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>42</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of <i>tert</i>-butyl 3-(5-bromo-2-chlorophenoxy)azetidine-1-carboxylate (<b>33</b>, 80 mg, 0.22 mmol) and methyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>, 87 mg, 0.22 mmol) provided the title product after column chromatography (0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) as a colorless solid in 114 mg (92%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.37 (s, 1H), 10.11 (s, 1H), 8.22 (s, 1H), 8.01–7.85 (m, 2H), 7.68–7.56 (m, 2H), 7.53 (d, <i>J</i> = 7.9 Hz, 1H), 7.42 (d, <i>J</i> = 8.3 Hz, 1H), 7.38–7.28 (m, 2H), 7.23 (t, <i>J</i> = 7.5 Hz, 1H), 7.18 (s, 1H), 5.35–5.20 (m, 1H), 4.50–4.30 (m, 2H), 3.97–3.83 (m, 2H), 3.72 (s, 2H), 1.40 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 165.2, 155.5, 152.2, 140.1, 139.0, 136.6, 135.3, 131.1, 130.74, 130.68, 130.0, 129.2, 127.31, 127.25, 126.2, 126.0, 125.8, 121.3, 120.9, 112.3, 79.0, 66.8, 56.0, 37.8, 28.0. LCMS (method a) <i>m</i>/<i>z</i>: 535.3 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.33 min.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(2-(3′-(Azetidin-3-yloxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>12</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, 2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)azetidin-3-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic acid (<b>42</b>, 100 mg, 0.19 mmol) provided the title product (HCl salt) as a colorless solid in 60 mg (92%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 13.44 (s, 1H), 8.72 (s, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 8.01 (d, <i>J</i> = 1.6 Hz, 1H), 7.99 (d, <i>J</i> = 1.6 Hz, 1H), 7.78 (s, 1H), 7.64 (t, <i>J</i> = 7.7 Hz, 1H), 7.58 (d, <i>J</i> = 8.3 Hz, 1H), 7.54 (dd, <i>J</i> = 8.3, 1.6 Hz, 1H), 7.27–7.19 (m, 3H), 7.04 (td, <i>J</i> = 7.4, 1.3 Hz, 1H), 6.65 (s, 2H), 5.78 (p, <i>J</i> = 6.9 Hz, 1H), 4.44 (t, <i>J</i> = 8.1 Hz, 2H), 4.12 (t, <i>J</i> = 8.6 Hz, 2H), 3.56 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.9, 165.3, 151.9, 140.3, 138.8, 136.7, 135.3, 131.1, 130.9, 130.8, 130.2, 129.2, 127.5, 127.3, 126.5, 126.3, 125.9, 121.4, 121.3, 112.9, 68.4, 52.0, 37.4. LCMS (method a) <i>m</i>/<i>z</i>: 437.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.72 min. LCMS (method b) <i>m</i>/<i>z</i>: 437.4 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.29 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub> 437.1263; found 437.1263.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(2-(3′-((1-(<i>tert</i>-Butoxycarbonyl)pyrrolidin-3-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>43</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of <i>tert</i>-butyl 3-(5-bromo-2-chlorophenoxy)pyrrolidine-1-carboxylate (<b>34</b>, 90 mg, 0.23 mmol) and methyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>, 91 mg, 0.23 mmol) provided the title product after column chromatography (0–30% ethyl acetate in cyclohexane) as a colorless solid in 71 mg (56%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.35 (s, 1H), 10.15 (s, 1H), 8.24 (s, 1H), 7.98–7.89 (m, 2H), 7.63 (t, <i>J</i> = 7.7 Hz, 1H), 7.59–7.49 (m, 3H), 7.40 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.37–7.29 (m, 2H), 7.22 (td, <i>J</i> = 7.4, 1.5 Hz, 1H), 5.32 (s, 1H), 3.71 (s, 2H), 3.63–3.51 (m, 1H), 3.51–3.36 (m, 3H), 2.26–2.03 (m, 2H), 1.41 + 1.40 + 1.39 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 165.1, 153.7, 152.7, 139.9, 139.1, 136.6, 135.3, 131.0, 130.66, 130.60, 129.9, 129.1, 127.21, 126.2, 125.94, 125.78, 122.47, 122.40, 120.7, 114.4, 78.5, (78.1 + 77.2), (51.4 + 51.1), (44.0 + 43.7), 37.8, (31.0 + 30.1), 28.1. LCMS (method a) <i>m</i>/<i>z</i>: 551.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.31 min.</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(2-(4′-Chloro-3′-(pyrrolidin-3-yloxy)-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>13</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, 2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)pyrrolidin-3-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic acid (<b>43</b>, 60 mg, 0.11 mmol) provided the title product (HCl salt) as a colorless solid in 47 mg (85%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.35 (s, 1H), 10.19 (s, 1H), 9.45 (s, 1H), 9.34 (s, 1H), 8.27 (s, 1H), 7.92–7.98 (m, 2H), 7.64 (t, <i>J</i> = 7.8 Hz, 1H), 7.61–7.57 (m, 2H), 7.52 (d, <i>J</i> = 7.7 Hz, 1H), 7.44 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.37–7.29 (m, 2H), 7.23 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 5.46–5.39 (m, 1H), 3.72 (s, 2H), 3.64–3.58 (m, 1H), 3.48–3.34 (m, 3H), 2.29–2.19 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 165.1, 152.3, 140.0, 138.9, 136.6, 135.3, 131.01, 130.72, 130.67, 130.0, 129.1, 127.3, 127.2, 126.2, 126.0, 125.8, 122.3, 121.2, 114.5, 77.3, 49.8, 43.7, 37.8, 30.8. LCMS (method a) <i>m</i>/<i>z</i>: 451.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.72 min. LCMS (method b) <i>m</i>/<i>z</i>: 451.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.26 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>4</sub> 451.1419; found 451.1419.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(2-(3′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-4-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>44</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of methyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>, 81 mg, 0.21 mmol) and <i>tert</i>-butyl 4-(5-bromo-2-chlorophenoxy)piperidine-1-carboxylate (<b>35</b>, 80 mg, 0.21 mmol) provided the title product after column chromatography (0–50% ethyl acetate in cyclohexane) as a colorless solid in 80 mg (69%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.36 (s, 1H), 10.27 (s, 1H), 8.25 (s, 1H), 7.97–7.89 (m, 2H), 7.62 (t, <i>J</i> = 7.8 Hz, 1H), 7.59–7.51 (m, 3H), 7.37 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.35–7.29 (m, 2H), 7.21 (td, <i>J</i> = 7.4, 1.4 Hz, 1H), 4.96–4.82 (m, 1H), 3.70 (s, 2H), 3.61 (ddd, <i>J</i> = 10.8, 8.9, 5.1 Hz, 2H), 3.29–3.25 (m, 2H), 2.01–1.85 (m, 2H), 1.72–1.58 (m, 2H), 1.41 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 165.1, 153.9, 152.7, 139.9, 139.1, 136.7, 135.3, 131.0, 130.62, 130.55, 129.9, 129.1, 127.22, 127.15, 126.03, 125.91, 125.67, 122.6, 120.5, 114.8, 78.7, 73.2, 69.2, 30.2, 28.1, 24.9. LCMS (method a) <i>m</i>/<i>z</i>: 565.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.38 min.</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(2-(4′-Chloro-3′-(piperidin-4-yloxy)-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>14</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, 2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)piperidin-4-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic acid (<b>44</b>, 70 mg, 0.12 mmol) provided the title product (HCl-salt) as a colorless solid in 52 mg (84%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.36 (s, 1H), 10.18 (s, 1H), 8.80 (s, 2H), 8.25 (s, 1H), 7.95 (d, <i>J</i> = 7.8 Hz, 1H), 7.92 (d, <i>J</i> = 8.3 Hz, 1H), 7.67–7.61 (m, 2H), 7.58 (d, <i>J</i> = 8.3 Hz, 1H), 7.52 (d, <i>J</i> = 6.7 Hz, 1H), 7.40 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.37–7.29 (m, 2H), 7.23 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 5.06–4.91 (m, 1H), 3.72 (s, 2H), 3.28–3.19 (m, 2H), 3.18–3.06 (m, 2H), 2.22–2.07 (m, 2H), 2.02–1.87 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 165.1, 152.3, 140.1, 139.1, 138.6, 136.6, 135.3, 131.0, 130.7, 130.0, 129.1, 127.3, 127.2, 126.3, 126.0, 125.8, 122.5, 120.9, 114.8, 70.6, 40.4, 37.7, 27.0. LCMS (method a) <i>m</i>/<i>z</i>: 465.3 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.65 min. LCMS (method a) <i>m</i>/<i>z</i>: 465.3 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.65 min. LCMS (method b) <i>m</i>/<i>z</i>: 465.3 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.17 min. HRMS <i>m</i>/<i>z</i>: [M – H]<sup>−</sup> calcd for C<sub>26</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>4</sub> 463.1430; found 463.1431.</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(2-(3′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>45</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of methyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>, 86 mg, 0.22 mmol) and <i>tert</i>-butyl 3-(5-bromo-2-chlorophenoxy)piperidine-1-carboxylate (<i><b>rac</b></i><b>-36</b>, 85 mg, 0.22 mmol) provided the title product after column chromatography (0–50% ethyl acetate in cyclohexane) as a colorless solid in 117 mg (90%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.42 (s, 1H), 10.22 (s, 1H), 8.23 (s, 1H), 7.94 (d, <i>J</i> = 7.8 Hz, 1H), 7.92–7.84 (m, 1H), 7.62 (t, <i>J</i> = 7.7 Hz, 1H), 7.57–7.47 (m, 3H), 7.39–7.28 (m, 3H), 7.22 (td, <i>J</i> = 7.4, 1.4 Hz, 1H), 4.77 (s, 1H), 4.00–3.87 (m, 1H), 3.69 (s, 2H), 3.61–3.40 (m, 3H), 1.85 (s, 3H), 1.54–1.45 (m, 1H), 1.40 (s, 9H). LCMS (method a) <i>m</i>/<i>z</i>: 563.4 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.32 min.</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-(2-(4′-Chloro-3′-(piperidin-3-yloxy)-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>15</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, 2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic acid (<b>45</b>, 105 mg, 0.19 mmol) provided the title product (HCl salt) as a colorless solid in 50 mg (53%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.32 (s, 1H), 10.26 (s, 1H), 9.34 (s, 1H), 8.84 (s, 1H), 8.31 (s, 1H), 7.98–7.91 (m, 2H), 7.75 (d, <i>J</i> = 2.2 Hz, 1H), 7.63 (t, <i>J</i> = 7.7 Hz, 1H), 7.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.51 (d, <i>J</i> = 7.8 Hz, 1H), 7.44 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 7.34 (dd, <i>J</i> = 7.3, 1.7 Hz, 1H), 7.31 (dd, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.22 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 5.03–4.92 (m, 1H), 3.72 (s, 2H), 3.44 (d, <i>J</i> = 11.9 Hz, 1H), 3.24–3.10 (m, 2H), 3.09–2.97 (m, 1H), 2.11–1.92 (m, 2H), 1.92–1.70 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 165.1, 152.6, 140.1, 138.9, 136.6, 135.2, 131.0, 130.79, 130.72, 130.0, 129.1, 127.4, 127.1, 126.4, 126.1, 125.8, 122.6, 121.3, 115.2, 70.9, 45.3, 42.7, 37.8, 27.2, 19.0. LCMS (method a) <i>m</i>/<i>z</i>: 465.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.86 min. LCMS (method b) <i>m</i>/<i>z</i>: 465.0 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.02 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>4</sub> 465.1576; found 465.1578.</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>R</i>)-2-(2-(3′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2-fluoro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>46</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of (<i>R</i>)-<i>tert</i>-butyl 3-(5-bromo-2-chlorophenoxy)piperidine-1-carboxylate (<b>36</b>, 95 mg, 0.24 mmol) and methyl 2-(2-(2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>28</b>, 100 mg, 0.24 mmol) provided the title product after column chromatography (0–60% ethyl acetate in cyclohexane) as a colorless solid in 129 mg (86%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.15 (s, 1H), 10.05 (s, 1H), 7.77–7.67 (m, 2H), 7.65 (d, <i>J</i> = 9.1 Hz, 1H), 7.58–7.51 (m, 2H), 7.42 (t, <i>J</i> = 7.6 Hz, 1H), 7.32 (d, <i>J</i> = 7.6 Hz, 1H), 7.28–7.13 (m, 3H), 4.77–4.52 (m, 1H), 3.81–3.71 (m, 1H), 3.68 (s, 2H), 3.46–3.38 (m, 3H), 1.95–1.77 (m, 3H), 1.51–1.45 (m, 1H), 1.12 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.5, 162.7, 155.9 (d, <i>J</i> = 251.5 Hz), 153.7, 152.4, 151.7 (d, <i>J</i> = 4.6 Hz), 136.1, 134.7, 132.9, 131.0, 130.8 (d, <i>J</i> = 7.4 Hz), 130.2, 130.0, 129.6, 127.2, 125.8 (d, <i>J</i> = 4.8 Hz), 125.3 (d, <i>J</i> = 16.3 Hz), 124.7 (d, <i>J</i> = 4.1 Hz), 124.4, 122.0, 115.5 (d, <i>J</i> = 4.3 Hz), 78.2, 70.6, 45.4, 42.7, 37.4, 28.8, 27.6, 20.5. <sup>19</sup>H NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −119.5. LCMS (method a) <i>m</i>/<i>z</i>: 581.3 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.30 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 26.2 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>R</i>)-2-(2-(4′-Chloro-2-fluoro-3′-(piperidin-3-yloxy)-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>16</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, (<i>R</i>)-2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2-fluoro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic acid (<b>46</b>, 120 mg, 0.2 mmol) provided the title product (HCl-salt) as a colorless solid in 70 mg (65%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.36 (s, 1H), 10.03 (s, 1H), 9.37 (s, 1H), 8.87 (s, 1H), 7.80–7.66 (m, 2H), 7.61 (d, <i>J</i> = 8.2 Hz, 1H), 7.57–7.47 (m, 2H), 7.43 (t, <i>J</i> = 7.6 Hz, 1H), 7.36–7.15 (m, 4H), 4.90–4.77 (m, 1H), 3.70 (s, 2H), 3.50–3.25 (m, 3H), 3.13–2.96 (m, 2H), 2.10–1.91 (m, 2H), 1.90–1.68 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.5, 162.7, 155.9 (d, <i>J</i> = 251.7 Hz), 152.2, 136.1, 135.0, 133.0 (d, <i>J</i> = 2.9 Hz), 131.1, 130.5, 130.1, 129.8 (d, <i>J</i> = 2.6 Hz), 127.9 (d, <i>J</i> = 13.8 Hz), 127.2, 125.9, 125.3 (d, <i>J</i> = 16.1 Hz), 124.73, 124.70, 123.5 (d, <i>J</i> = 2.2 Hz), 123.0, 117.4 (d, <i>J</i> = 2.6 Hz), 71.0, 45.3, 42.6, 37.3, 27.0, 18.8. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −119.0. LCMS (method a) <i>m</i>/<i>z</i>: 483.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.72 min. LCMS (method b) <i>m</i>/<i>z</i>: 483.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.28 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>25</sub>ClFN<sub>2</sub>O<sub>4</sub> 483.1481; found 483.1482. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 1.4 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-2-(2-(3′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2′-fluoro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>47</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of (<i>R</i>)-<i>tert</i>-butyl 3-(3-bromo-6-chloro-2-fluorophenoxy)piperidine-1-carboxylate (<b>38</b>, 103 mg, 0.25 mmol) and methyl 2-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>27</b>, 100 mg, 0.25 mmol) provided the title product after column chromatography (0–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) as a colorless resin in 108 mg (70%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.34 (s, 1H), 10.11 (s, 1H), 8.10 (s, 1H), 8.00 (d, <i>J</i> = 7.7 Hz, 1H), 7.78 (d, <i>J</i> = 7.7 Hz, 1H), 7.65 (t, <i>J =</i> 7.7 Hz, 1H), 7.50–7.43 (m, 2H), 7.42–7.28 (m, 3H), 7.23 (td, <i>J =</i> 7.5, 1.4 Hz, 1H), 4.44–4.18 (m, 1H), 3.85–3.68 (m, 1H), 3.67 (s, 2H), 3.64–3.52 (m, 1H), 3.49–3.35 (m, 1H), 3.29–3.10 (m, 1H), 2.12–1.70 (m, 3H), 1.52–1.41 (m, 1H), 1.30 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.8, 164.9, 153.9, 153.0 (d, <i>J</i> = 252.1 Hz), 141.8 (d, <i>J</i> = 14.5 Hz), 136.6, 135.1, 134.2, 131.9 (d, <i>J</i> = 3.4 Hz), 131.0, 130.8, 128.8, 128.2 (d, <i>J</i> = 12.2 Hz), 127.9, 127.5, 127.2, 126.2, 125.78, 125.70 (d, <i>J</i> = 3.8 Hz), 125.30, 125.22, 78.7, (77.55 + 77.46), (47.4 + 46.6), (43.5 + 42.7), 38.0, 29.5, 27.9, (22.1 + 21.2). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −131.2. LCMS (method a) <i>m</i>/<i>z</i>: 583.3 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.33 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 13.3 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>R</i>)-2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2′-fluoro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>17</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, (<i>R</i>)-2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2′-fluoro-[1,1′-biphenyl]-3-carboxamido)phenyl)acetic acid (<b>47</b>, 97 mg, 0.17 mmol) provided the title product (HCl salt) as a colorless solid in 76 mg (88%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.33 (s, 1H), 10.12 (s, 1H), 9.10 (s, 1H), 8.84 (s, 1H), 8.12 (s, 1H), 8.02 (d, <i>J</i> = 7.8 Hz, 1H), 7.79 (d, <i>J</i> = 7.0 Hz, 1H), 7.66 (t, <i>J</i> = 7.8 Hz, 1H), 7.53 (d, <i>J</i> = 9.5 Hz, 1H), 7.49–7.42 (m, 2H), 7.37–7.28 (m, 2H), 7.23 (td, <i>J</i> = 7.4, 1.5 Hz, 1H), 4.48 (tt, <i>J</i> = 7.0, 3.3 Hz, 1H), 3.68 (s, 2H), 3.48–3.37 (m, 2H), 3.16–2.97 (m, 2H), 2.11–1.96 (m, 2H), 1.96–1.82 (m, 1H), 1.79–1.65 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.7, 164.9, 153.1 (d, <i>J</i> = 249.6 Hz), 141.9 (d, <i>J</i> = 13.4 Hz), 136.5, 135.1, 134.0, 131.9, 131.0, 130.8, 128.9, 128.3, 128.0, 127.5 (d, <i>J</i> = 9.0 Hz), 127.4, 127.2, 126.4, 126.2 (d, <i>J</i> = 2.7 Hz), 125.93, 125.79 (d, <i>J</i> = 3.1 Hz), 76.3, 46.2, 42.8, 37.6, 27.4, 18.7. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −130.8. LCMS (method a) <i>m</i>/<i>z</i>: 483.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.73 min. LCMS (method b) <i>m</i>/<i>z</i>: 483.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.18 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>25</sub>ClFN<sub>2</sub>O<sub>4</sub> 483.1481; found 483.1484. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 2.2 (<i>c</i> 0.5, MeOH).</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>R</i>)-2-(2-(3′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2′-fluoro-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic Acid (<b>48</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of (<i>R</i>)-<i>tert</i>-butyl 3-(3-bromo-6-chloro-2-fluorophenoxy)piperidine-1-carboxylate (<b>38</b>, 99 mg, 0.24 mmol) and methyl 2-(5-fluoro-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>29</b>, 100 mg, 0.24 mmol) provided the title product after column chromatography (0–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) as a colorless resin in 113 mg (70%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.39 (s, 1H), 10.16 (s, 1H), 8.09 (s, 1H), 7.99 (d, <i>J</i> = 7.7 Hz, 1H), 7.77 (d, <i>J</i> = 7.7 Hz, 1H), 7.64 (t, <i>J</i> = 7.7 Hz, 1H), 7.50–7.35 (m, 3H), 7.22 (dd, <i>J</i> = 9.7, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 3.0 Hz, 1H), 4.47–4.17 (m, 1H), 3.67 (s, 2H), 3.63–3.49 (m, 1H), 3.43–3.19 (m, 3H), 2.07–1.66 (m, 3H), 1.47–1.41 (m, 1H), 1.33 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.0, 165.1, 159.7 (d, <i>J</i> = 242.0 Hz), 153.9, 152.9 (d, <i>J</i> = 251.3 Hz), 141.8 (d, <i>J</i> = 14.5 Hz), 134.9, 134.2, 133.8 (d, <i>J</i> = 8.5 Hz), 132.9 (d, <i>J</i> = 2.8 Hz), 131.9, 128.8, 128.4 (d, <i>J</i> = 8.7 Hz), 128.2 (d, <i>J</i> = 12.3 Hz), 127.9 (d, <i>J</i> = 2.2 Hz), 127.50, 127.45, 125.7 (d, <i>J</i> = 3.8 Hz), 125.3, 117.4 (d, <i>J</i> = 22.8 Hz), 113.8 (d, <i>J</i> = 22.1 Hz), 78.7, (77.6 + 77.4), (47.4 + 46.6), (43.4 + 42.6), 37.3, 29.5, 27.9, (22.0 + 21.2). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −117.0, −131.2. LCMS (method a) <i>m</i>/<i>z</i>: 601.5 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.33 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 12.6 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>R</i>)-2-(2-(4′-Chloro-2′-fluoro-3′-(piperidin-3-yloxy)-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic Acid (<b>18</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, (<i>R</i>)-2-(2-(3′-((1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2′-fluoro-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic acid (<b>48</b>, 113 mg, 0.17 mmol) provided the title product (HCl salt) as a colorless solid in 73 mg (80%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.39 (s, 1H), 10.16 (s, 1H), 9.45 (s, 1H), 9.01 (s, 1H), 8.12 (s, 1H), 8.01 (d, <i>J</i> = 7.8 Hz, 1H), 7.79 (d, <i>J</i> = 7.6 Hz, 1H), 7.66 (t, <i>J</i> = 7.8 Hz, 1H), 7.52 (d, <i>J</i> = 9.3 Hz, 1H), 7.49–7.38 (m, 2H), 7.23 (dd, <i>J</i> = 9.7, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 3.1 Hz, 1H), 4.57–4.39 (m, 1H), 3.69 (s, 2H), 3.50–3.30 (m, 1H), 3.23 (dd, <i>J</i> = 12.4, 7.2 Hz, 1H), 3.16–2.93 (m, 2H), 2.11–1.97 (m, 2H), 1.94–1.82 (m, 1H), 1.80–1.65 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.0, 165.1, 159.8 (d, <i>J</i> = 242.1 Hz), 153.1 (d, <i>J</i> = 249.8 Hz), 141.8 (d, <i>J</i> = 14.8 Hz), 134.9, 133.9, 133.8 (d, <i>J</i> = 8.5 Hz), 132.8 (d, <i>J</i> = 2.9 Hz), 131.9 (d, <i>J</i> = 3.2 Hz), 128.8, 128.5 (d, <i>J</i> = 8.6 Hz), 128.3 (d, <i>J</i> = 12.2 Hz), 128.0, 127.6, 127.5 (d, <i>J</i> = 2.4 Hz), 126.2 (d, <i>J</i> = 3.4 Hz), 125.8 (d, <i>J</i> = 4.1 Hz), 117.4 (d, <i>J</i> = 22.8 Hz), 113.8 (d, <i>J</i> = 22.1 Hz), 76.3, 46.1, 42.7, 37.2, 27.6, 18.8. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.9, −130.7. LCMS (method a) <i>m</i>/<i>z</i>: 501.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.73 min. LCMS (method b) <i>m</i>/<i>z</i>: 501.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.35 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>24</sub>ClF<sub>2</sub>N<sub>2</sub>O<sub>4</sub> 501.1387; found 501.1392. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 1.5 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>R</i>)-2-(2-(5′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2′-fluoro-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic Acid (<b>49</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of (<i>R</i>)-<i>tert</i>-butyl 3-(5-bromo-2-chloro-4-fluorophenoxy)piperidine-1-carboxylate (<b>37</b>, 99 mg, 0.24 mmol) and methyl 2-(5-fluoro-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>29</b>, 100 mg, 0.24 mmol) provided the title product after column chromatography (0–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) as a colorless resin in 81 mg (50%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.38 (s, 1H), 10.06 (s, 1H), 8.09 (s, 1H), 7.99 (d, <i>J</i> = 7.7 Hz, 1H), 7.85–7.69 (m, 1H), 7.65 (t, <i>J</i> = 7.7 Hz, 1H), 7.60 (d, <i>J</i> = 10.0 Hz, 1H), 7.45 (dd, <i>J</i> = 8.8, 5.5 Hz, 1H), 7.43–7.29 (m, 1H), 7.22 (dd, <i>J</i> = 9.7, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 3.0 Hz, 1H), 4.78–4.44 (m, 1H), 3.96–3.70 (m, 1H), 3.69 (s, 2H), 3.53–3.32 (m, 3H), 2.01–1.70 (m, 3H), 1.57–1.43 (m, 1H), 1.15 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 172.1, 165.2, 159.7 (d, <i>J</i> = 242.0 Hz), 153.8, 152.6 (d, <i>J</i> = 252.2 Hz), 149.3 (d, <i>J</i> = 2.6 Hz), 134.8, 134.5, 133.6 (d, <i>J</i> = 8.4 Hz), 132.8 (d, <i>J</i> = 2.7 Hz), 132.0 (d, <i>J</i> = 3.2 Hz), 128.8, 128.4 (d, <i>J</i> = 8.6 Hz), 128.1 (d, <i>J</i> = 2.5 Hz), 127.4, 127.1 (d, <i>J</i> = 14.5 Hz), 122.8, 117.9 (d, <i>J</i> = 27.5 Hz), 117.5 (d, <i>J</i> = 22.8 Hz), 116.4, 113.8 (d, <i>J</i> = 22.0 Hz), 78.3, 71.3, 45.6, 42.7, 37.2, 28.8, 27.6, 20.6. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.9, −126.3. LCMS (method a) <i>m</i>/<i>z</i>: 599.4 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.36 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 34.9 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>R</i>)-2-(2-(4′-Chloro-2′-fluoro-5′-(piperidin-3-yloxy)-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic Acid (<b>19</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, (<i>R</i>)-2-(2-(5′-((1-(<i>tert</i>-butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2′-fluoro-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic acid (<b>49</b>, 81 mg, 0.12 mmol) provided the title product (HCl-salt) as a colorless solid in 52 mg (81%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.37 (s, 1H), 10.18 (s, 1H), 9.00 (s, 1H), 8.67 (s, 1H), 8.14 (s, 1H), 8.00 (d, <i>J</i> = 7.8 Hz, 1H), 7.80 (d, <i>J</i> = 7.5 Hz, 1H), 7.70–7.62 (m, 2H), 7.59 (d, <i>J</i> = 7.1 Hz, 1H), 7.52–7.41 (m, 1H), 7.22 (dd, <i>J</i> = 9.6, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 3.0 Hz, 1H), 4.89–4.72 (m, 1H), 3.70 (s, 2H), 3.44–3.38 (m, 1H), 3.29–3.19 (m, 1H), 3.16–2.99 (m, 2H), 2.08–1.94 (m, 2H), 1.92–1.80 (m, 1H), 1.79–1.65 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.1, 165.1, 159.7 (d, <i>J</i> = 240.8 Hz), 153.4 (d, <i>J</i> = 244.5 Hz), 149.2 (d, <i>J</i> = 2.8 Hz), 134.9, 134.1, 133.6, 132.8 (d, <i>J</i> = 7.8 Hz), 132.0 (d, <i>J</i> = 3.5 Hz), 130.8 (d, <i>J</i> = 31.8 Hz), 128.8, 128.1, 127.52, 127.35 (d, <i>J</i> = 14.5 Hz), 123.3, 118.8 (d, <i>J</i> = 3.5 Hz), 118.1 (d, <i>J</i> = 27.5 Hz), 117.4 (d, <i>J</i> = 22.6 Hz), 113.8 (d, <i>J</i> = 21.6 Hz), 71.9, 45.4, 42.7, 37.4, 27.0, 18.7. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −117.0, −124.1. LCMS (method a) <i>m</i>/<i>z</i>: 501.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.97 min. LCMS (method b) <i>m</i>/<i>z</i>: 501.2 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.53 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>24</sub>ClF<sub>2</sub>N<sub>2</sub>O<sub>4</sub> 501.1387; found 501.1389. [α]<sub class="stack">D</sub><sup class="stack">23</sup> – 2.1 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>R</i>)-2-(2-(5′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2,2′-difluoro-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic Acid (<b>50</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, the reaction of (<i>R</i>)-<i>tert</i>-butyl 3-(5-bromo-2-chloro-4-fluorophenoxy)piperidine-1-carboxylate (<b>37</b>, 489 mg, 1.2 mmol) and methyl 2-(5-fluoro-2-(2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamido)phenyl)acetate (<b>30</b>, 600 mg, 1.2 mmol) provided the title product as a white foam in 486 mg (62%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.45 (s, 1H), 10.05 (s, 1H), 7.77 (t, <i>J</i> = 6.4 Hz, 1H), 7.69–7.56 (m, 2H), 7.50 (dd, <i>J</i> = 8.8, 5.6 Hz, 1H), 7.45 (t, <i>J</i> = 7.7 Hz, 1H), 7.40–7.26 (m, 1H), 7.21 (dd, <i>J</i> = 9.7, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 2.9 Hz, 1H), 4.70–4.49 (m, 1H), 4.17–4.05 (m, 1H), 3.96–3.72 (m, 1H), 3.68 (s, 2H), 3.27–3.20 (m, 1H), 3.08–2.86 (m, 1H), 1.97–1.69 (m, 3H), 1.52–1.42 (m, 1H), 1.21 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.9, 162.7, 159.3 (d, <i>J</i> = 242.5 Hz), 156.1 (d, <i>J</i> = 252.5 Hz), 153.8, 150.3 (d, <i>J</i> = 234 Hz), 149.1, 133.8, 133.1 (d, <i>J</i> = 8.4 Hz), 132.4 (d, <i>J</i> = 2.6 Hz), 130.3, 128.0 (d, <i>J</i> = 8.8 Hz), 124.8 (d, <i>J</i> = 16.0 Hz), 124.5 (d, <i>J</i> = 3.9 Hz), 122.8 (d, <i>J</i> = 16.9 Hz), 121.6 (d, <i>J</i> = 17.2 Hz), 117.7 (d, <i>J</i> = 12.2 Hz), 117.4 (d, <i>J</i> = 7.8 Hz), 117.04, 114.0, 113.8, 78.3, 71.1, 45.4, 42.7, 37.0, 28.8, 27.7, 20.5.<sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.84, −116.90, −123.1. LCMS (method a) <i>m</i>/<i>z</i>: 617.2 [M – H]<sup>−</sup>, <i>t</i><sub>R</sub> = 1.33 min. [α]<sub class="stack">D</sub><sup class="stack">23</sup> + 29.0 (<i>c</i> 1.0, MeOH).</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>R</i>)-2-(2-(5′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2,2′-difluoro-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic Acid (<b>20</b>)</h4><div class="NLM_p last">Following the general procedure for Boc-cleavage with HCl, (<i>R</i>)-2-(2-(5′-((1-(<i>tert</i>-Butoxycarbonyl)piperidin-3-yl)oxy)-4′-chloro-2,2′-difluoro-[1,1′-biphenyl]-3-carboxamido)-5-fluorophenyl)acetic acid (<b>50</b>, 423 mg, 0.65 mmol) provided the title product (HCl salt) as a colorless solid in 341 mg (95%) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 12.42 (s, 1H), 10.05 (s, 1H), 9.17 (s, 1H), 8.75 (s, 1H), 7.78 (t, <i>J</i> = 6.3 Hz, 1H), 7.72–7.62 (m, 2H), 7.54–7.41 (m, 3H), 7.21 (dd, <i>J</i> = 9.7, 3.0 Hz, 1H), 7.16 (td, <i>J</i> = 8.5, 3.1 Hz, 1H), 4.78–4.64 (m, 1H), 3.69 (s, 2H), 3.42–3.28 (m, 1H), 3.20 (dd, <i>J</i> = 12.3, 6.2 Hz, 1H), 3.14–2.99 (m, 2H), 2.05–1.90 (m, 2H), 1.89–1.79 (m, 1H), 1.77–1.67 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 171.9, 162.7, 159.7 (d, <i>J</i> = 242.1 Hz), 156.0 (d, <i>J</i> = 253.3 Hz), 152.3 (d, <i>J</i> = 245.3 Hz), 148.92 (d, <i>J</i> = 2.5 Hz) 133.9, 133.1 (d, <i>J</i> = 8.4 Hz), 130.4 (d, <i>J</i> = 3.0 Hz), 128.0 (d, <i>J</i> = 8.5 Hz), 124.8 (d, <i>J</i> = 15.7 Hz), 124.5 (d, <i>J</i> = 3.7 Hz), 124.2 (d, <i>J</i> = 10.5 Hz), 122.5 (d, <i>J</i> = 16.3 Hz), 121.9 (d, <i>J</i> = 17.1 Hz), 120.0, 117.9, 117.6 (d, <i>J</i> = 6.1 Hz), 117.4, 113.9 (d, <i>J</i> = 22.3 Hz), 71.9, 45.2, 42.7, 37.0, 26.9, 18.6. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>, δ) −116.6, −116.8, −120.8. LCMS (method a) <i>m</i>/<i>z</i>: 519.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 0.81 min. LCMS (method b) <i>m</i>/<i>z</i>: 519.1 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.66 min. HRMS <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>23</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> 519.1293; found 519.1293. [α]<sub class="stack">D</sub><sup class="stack">23</sup> – 1.3 (<i>c</i> 1.0, MeOH).</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> SUCNR1 GTPγS Assay</h3><div class="NLM_p last">Assays were done as described (Haffke et al. 2019)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> using membranes from stably transfected Chem1 or CHO-K1 cells expressing human or rat SUCNR1, respectively. The final assay mixture in 96-well Optiplates (Perkin Elmer) contained 15 μg of rat or human SUCNR1 membranes, wheat germ-agglutinin-coated scintillation proximity assay beads (Perkin Elmer), 200 pM [<sup>35</sup>S]GTPγS (Perkin Elmer), 20 mM HEPES pH 7.4, 100 mM NaCl, 10 mM MgCl<sub>2</sub>, 25 μg/mL saponin, 10 μM GDP, 0.1% fat-free bovine serum albumin, 50 μM succinate, and the test compound. After incubation for 60 min at room temperature sealed plates were centrifuged for 10 min at 1200 rpm and the radioactivity was counted (TopCount NXT; Perkin Elmer). IC<sub>50</sub> values were determined from eight-point concentration–response curves using GraphPad Prism.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>In Vivo</i> Experiments</h3><div class="NLM_p last">All animals used were 5–12 weeks of age and were maintained in the specific pathogen-free facilities. All animal studies were performed in accordance with the animal experimentation guidelines and laws laid down by the Swiss Federal and Cantonal Authorities.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>In Vivo</i> Pharmacokinetic Studies in Mice</h3><div class="NLM_p last">Pharmacokinetic studies were conducted using male C57/BL6 mice. For 1 mg/kg intravenous dosing, compounds were formulated as a solution (NMP:plasma (10:90)) and mice (<i>n</i> = 3 per group) were administered compounds by bolus injection; the dose volume was 5 mL/kg. For oral dosing, compounds were formulated as a suspension (MC:water:Tween80 (0.5:99:0.5)). Mice (<i>n</i> = 3 per group) were administered by oral gavage; the dose volume was 10 mL/kg. Serial intravenous blood samples were taken at 0.083, 0.25, 0.5, 1, 2, 4, 7, and 24 h. For the oral arm blood samples were taken at 0.25, 0.5, 1, 2, 4, 7, and 24 h; precipitated with acetonitrile; and stored at −20 °C prior to liquid chromatography–mass spectrometry (LC–MS)/MS analysis. Pharmacokinetic parameters were calculated by noncompartmental analysis. Pharmacokinetic studies with compounds <b>8</b> and <b>9</b> were described previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Protein Expression, Purification, and Crystallization of Humanized Rat SUCNR1 in Complex with <b>20</b></h3><div class="NLM_p">The expression, purification, and crystallization of the humanized rat SUCNR1–Nanobody6 complex were performed as described previously with the following modifications for complex formation and crystallization:<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">Compound <b>5</b> was added to purified humanized rat SUCNR1 to a final concentration of 1 mM from a 100 mM stock solution in DMSO, giving a final DMSO concentration of 1% (v/v). The receptor was mixed with a 1.2 M excess of purified Nanobody6, incubated on ice for 30 min. The complex was further purified without any antagonist by size-exclusion chromatography on a Superose6 Increase 10/300 GL column (GE Healthcare) equilibrated in 25 mM HEPES pH 7.5, 800 mM NaCl, 10% (w/v) glycerol, 0.002% (w/v) LMNG, and 0.0004% (w/v) CHS. Peak fractions were pooled and concentrated using a 100 kDa MWCO concentrator (Millipore) to a final concentration of 30 mg/mL. The complex was flash-frozen in liquid nitrogen in small aliquots and stored at −80 °C until crystallization.</div><div class="NLM_p last">The rat SUCNR1–Nanbody6 complex was reconstituted in the lipidic cubic phase (LCP) by mixing protein at 30 mg/mL with monoolein:cholesterol (9:1) (w:w) at a 2:3 ratio (v:w) in 50 μL Hamilton syringes using the two-syringe method. Crystallization trials were performed using Innovadyne SD-2 vapor diffusion plates and dispensed using an Oryx8 crystallization robot (Douglas Instruments). Protein-laden LCP (50 nL) was covered with 2.25 μL of precipitant, containing 200 μM <b>20</b>, and incubated at 20 °C in an RI-1000 imager (Formulatrix). First crystals appeared within 24 h and grew to a maximum size of 40 μm × 40 μm × 40 μm in 10 days in 50 mM 2-[(2-amino-2-oxoethyl)-(carboxymethyl)amino]acetic acid (ADA) pH 7.0, 28% (w/v) poly(ethylene glycol) monomethyl ether (PEG MME) 550, 0.55 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 200 μM <b>20</b>, and 2% (v/v) DMSO. Crystals were directly collected from the LCP bolus with MiTeGen micromount loops and flash-frozen in liquid nitrogen.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Data Collection, Structure Solution and Refinement</h3><div class="NLM_p">Data for the humanized rat SUCNR1–Nanobody6-<b>20</b> complex were collected at PXII at the Swiss Light Source, Villigen, Switzerland, using a 10 μm diameter beam at a wavelength of 0.999 Å on a Dectris Eiger-16M detector. Crystals were exposed for 0.05 s per 0.1° oscillation per frame using an attenuated beam to reduce radiation damage. Datasets were integrated, scaled, and merged using XDS and XSCALE in autoPROC and aP_Scale (Global Phasing). Data collection and refinement statistics are reported in Extended Data <a href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_001.pdf" class="ext-link">Table S1</a> (Supporting Information). The structure was solved by molecular replacement in Phaser using the structure of the humanized rat SUCNR1–Nanobody6–NF-56-EJ40 (<b>7</b>) complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RNK">6RNK</a>) as a search model. The structural model was adjusted by repetitive rounds of manual model building in Coot and refinement against the anisotropic-scaled data in Buster (Global Phasing). Structure factors and coordinates of the humanized rat GRP91–Nanobody6–<b>20</b> complex were deposited in the Protein Data Bank (PDB) under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10">6Z10</a>.</div><div class="NLM_p last">Following high-throughput assays were performed according to the described procedures: <b>PAMPA</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><b>LogD</b><sub><b>7.4</b></sub>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and <b>UV-metric</b> p<i>K</i><sub>a</sub>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Plasma Protein Binding (PPB)</h3><div class="NLM_p last">Compounds, dissolved in DMSO, were added to the plasma to achieve a concentration of 5 μM and 0.5% DMSO. Plasma samples were placed in one chamber of the rapid equilibrium dialysis (RED) device. Phosphate-buffered saline (100 mM) containing 0.5% DMSO was placed in the other chamber. The RED device was shaken at 250 rpm at 37 °C with 5% CO<sub>2</sub> for 4 h to reach equilibrium. After the incubation, 0.45 μL of the sample was removed from each side of the membrane. An equal volume of 100 mM phosphate buffer containing 0.5% DMSO was added to the plasma sample. An equal volume of plasma containing 0.5% DMSO was also added to the buffer sample. Samples were protein-precipitated with 180 μL of chilled methanol (containing the internal standard 0.55 μM metoprolol). After being shaken, the samples were centrifuged at 2000<i>g</i> for 30 min, and 20 μL of the supernatant was removed and diluted with 20 μL of water prior to LC–MS/MS analysis. The fraction unbound in plasma (fu) was calculated by dividing the concentration in the buffer chamber by the concentration in the plasma chamber.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Docking Studies</h3><div class="NLM_p last">Docking studies were carried out using Glide SP at standard settings (cite: Schrödinger Release 2019-2: Glide, Schrödinger, LLC, New York, NY, 2019). Figures were prepared using PyMOL (cite: The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01020" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01020?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01020</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC and NMR charts and X-ray crystallographic data for compounds <b>9</b>, <b>10</b>, and <b>20</b> as well as SUCNR1-bound <b>20</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_001.pdf">jm0c01020_si_001.pdf (0.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_002.csv">jm0c01020_si_002.csv (1.92 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the crystal structures of compounds <b>9</b>, <b>10</b>, and <b>20</b> can be accessed using the following codes: CCDC 2009710 (<b>9</b>), CCDC 2009711 (<b>10</b>), and CCDC 2009712 (<b>20</b>). For compound <b>20</b> bound to humanized rat SUCNR1, the PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10">6Z10</a>. The authors will release the atomic coordinates upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01020" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juraj Velcicky</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6564-1448" title="Orcid link">http://orcid.org/0000-0001-6564-1448</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b3d9c6c1d2d99dc5d6dfd0dad0d8caf3dddcc5d2c1c7dac09dd0dcde"><span class="__cf_email__" data-cfemail="dbb1aea9bab1f5adbeb7b8b2b8b0a29bb5b4adbaa9afb2a8f5b8b4b6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer Wilcken</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6159-1460" title="Orcid link">http://orcid.org/0000-0002-6159-1460</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simona Cotesta</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philipp Janser</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Achim Schlapbach</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trixie Wagner</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Piechon</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederic Villard</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rochdi Bouhelal</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabian Piller</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span>Present Address:
                        F.P.: F. Hoffmann-La Roche, 4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie Harlfinger</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span>Present Address:
                        S.H.: Astra Zeneca, Hodgkin Building (B900), Chesterford Research Park, Little Chesterford, Saffron Walden, CB10 1XL, U.K</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rowan Stringer</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominique Fehlmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klemens Kaupmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amanda Littlewood-Evans</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Haffke</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nina Gommermann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for
BioMedical Research, CH-4002 Basel, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>The authors declare no competing financial interest, and all work described was funded by Novartis Institutes for BioMedical Research Inc.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6465-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Daniel Pflieger, Günter Schwalm, Bernard Faller, Gaelle Chenal, and Harald Schroeder for their assistance during the preparation of this manuscript. We would also like to thank Stephane Rodde and Damien Hubert for the physicochemical measurements and Corinne Marx for HRMS measurements.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CHO-K1</td><td class="NLM_def"><p class="first last">Chinese hamster ovary cells</p></td></tr><tr><td class="NLM_term">CHS</td><td class="NLM_def"><p class="first last">cholesteryl hemisuccinate</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">dn</td><td class="NLM_def"><p class="first last">dose-normalized</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-ferrocenediyl-bis(diphenylphosphine)</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HIF1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor 1α</p></td></tr><tr><td class="NLM_term">extrap</td><td class="NLM_def"><p class="first last">extrapolated</p></td></tr><tr><td class="NLM_term">LMNG</td><td class="NLM_def"><p class="first last">lauryl maltose neopentyl glycol</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methyl cellulose</p></td></tr><tr><td class="NLM_term">MWCO</td><td class="NLM_def"><p class="first last">molecular weight cut-off</p></td></tr><tr><td class="NLM_term">Pin</td><td class="NLM_def"><p class="first last">pinacol</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, F. J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwandner, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L.</span></span> <span> </span><span class="NLM_article-title">Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>429</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1038/nature02488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fnature02488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=15141213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVKgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2004&pages=188-193&author=W.+Heauthor=F.+J.-P.+Miaoauthor=D.+C.-H.+Linauthor=R.+T.+Schwandnerauthor=Z.+Wangauthor=J.+Gaoauthor=J.-L.+Chenauthor=H.+Tianauthor=L.+Ling&title=Citric+acid+cycle+intermediates+as+ligands+for+orphan+G-protein-coupled+receptors&doi=10.1038%2Fnature02488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors</span></div><div class="casAuthors">He, Weihai; Miao, Frederick J.-P.; Lin, Daniel C.-H.; Schwandner, Ralf T.; Wang, Zhulun; Gao, Jinhai; Chen, Jin-Long; Tian, Hui; Ling, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">6988</span>),
    <span class="NLM_cas:pages">188-193</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The citric acid cycle is central to the regulation of energy homeostasis and cell metab.  Mutations in enzymes that catalyze steps in the citric acid cycle result in human diseases with various clin. presentations.  The intermediates of the citric acid cycle are present at micromolar concn. in blood and are regulated by respiration, metab. and renal resorption/extrusion.  Here we show that GPR91, a previously orphan G-protein-coupled receptor (GPCR), functions as a receptor for the citric acid cycle intermediate succinate.  We also report that GPR99, a close relative of GPR91, responds to α-ketoglutarate, another intermediate in the citric acid cycle.  Thus by acting as ligands for GPCRs, succinate and α-ketoglutarate are found to have unexpected signaling functions beyond their traditional roles.  Furthermore, we show that succinate increases blood pressure in animals.  The succinate-induced hypertensive effect involves the renin-angiotensin system and is abolished in GPR91-deficient mice.  Our results indicate a possible role for GPR91 in renovascular hypertension, a disease closely linked to atherosclerosis, diabetes and renal failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqik8IPAYY4BrVg90H21EOLACvtfcHk0ljuPgPxAMZHvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVKgsLs%253D&md5=9b0fe4e5744f968d2999dccf591125a9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature02488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02488%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DF.%2BJ.-P.%26aulast%3DLin%26aufirst%3DD.%2BC.-H.%26aulast%3DSchwandner%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.-L.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DL.%26atitle%3DCitric%2520acid%2520cycle%2520intermediates%2520as%2520ligands%2520for%2520orphan%2520G-protein-coupled%2520receptors%26jtitle%3DNature%26date%3D2004%26volume%3D429%26spage%3D188%26epage%3D193%26doi%3D10.1038%2Fnature02488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Castro Fonseca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguiar, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Rocha Franco, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingold, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leite, M. F.</span></span> <span> </span><span class="NLM_article-title">GPR91: expanding the frontiers of Krebs cycle intermediates</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">3</span> <span class="refDoi"> DOI: 10.1186/s12964-016-0126-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1186%2Fs12964-016-0126-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=26759054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A280%3ADC%252BC28rpvVehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&author=M.+de%0ACastro+Fonsecaauthor=C.+J.+Aguiarauthor=J.+A.+da+Rocha+Francoauthor=R.+N.+Gingoldauthor=M.+F.+Leite&title=GPR91%3A+expanding+the+frontiers+of+Krebs+cycle+intermediates&doi=10.1186%2Fs12964-016-0126-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">GPR91: expanding the frontiers of Krebs cycle intermediates</span></div><div class="casAuthors">de Castro Fonseca Matheus; da Rocha Franco Joao Antonio; Gingold Rafael N; Leite M Fatima; Aguiar Carla J</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since it was discovered, the citric acid cycle has been known to be central to cell metabolism and energy homeostasis.  Mainly found in the mitochondrial matrix, some of the intermediates of the Krebs cycle are also present in the blood stream.  Currently, there are several reports that indicate functional roles for Krebs intermediates out of its cycle.  Succinate, for instance, acts as an extracellular ligand by binding to a G-protein coupled receptor, known as GPR91, expressed in kidney, liver, heart, retinal cells and possibly many other tissues, leading to a wide array of physiological and pathological effects.  Through GPR91, succinate is involved in functions such as regulation of blood pressure, inhibition of lipolysis in white adipose tissue, development of retinal vascularization, cardiac hypertrophy and activation of stellate hepatic cells by ischemic hepatocytes.  Along the current review, these new effects of succinate through GPR91 will be explored and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeyAmELi8DJq__Jf7-eMvJfW6udTcc2eaMNYwka7ptUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rpvVehsA%253D%253D&md5=8bac2375e234a08e2495036dde6101a7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Fs12964-016-0126-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12964-016-0126-1%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastro%2BFonseca%26aufirst%3DM.%26aulast%3DAguiar%26aufirst%3DC.%2BJ.%26aulast%3Dda%2BRocha%2BFranco%26aufirst%3DJ.%2BA.%26aulast%3DGingold%26aufirst%3DR.%2BN.%26aulast%3DLeite%26aufirst%3DM.%2BF.%26atitle%3DGPR91%253A%2520expanding%2520the%2520frontiers%2520of%2520Krebs%2520cycle%2520intermediates%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2016%26volume%3D14%26doi%3D10.1186%2Fs12964-016-0126-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauro, C.</span></span> <span> </span><span class="NLM_article-title">Intermediates of metabolism: from bystanders to signalling molecules</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2016.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.tibs.2016.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=26935843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=460-471&author=R.+Haasauthor=D.+Cucchiauthor=J.+Smithauthor=V.+Pucinoauthor=C.+E.+Macdougallauthor=C.+Mauro&title=Intermediates+of+metabolism%3A+from+bystanders+to+signalling+molecules&doi=10.1016%2Fj.tibs.2016.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Intermediates of Metabolism: From Bystanders to Signalling Molecules</span></div><div class="casAuthors">Haas, Robert; Cucchi, Danilo; Smith, Joanne; Pucino, Valentina; MacDougall, Claire Elizabeth; Mauro, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-471</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The integration of biochem. into immune cell biol. has contributed immensely to our understanding of immune cell function and the assocd. pathologies.  So far, most studies have focused on the regulation of metabolic pathways during an immune response and their contribution to its success.  More recently, novel signalling functions of metabolic intermediates are being discovered that might play important roles in the regulation of immunity.  Here we describe the three long-known small metabolites lactate, acetyl-CoA, and succinate in the context of immunometabolic signalling.  Functions of these ubiquitous mols. are largely dependent on their intra- and extracellular concns. as well as their subcompartmental localisation.  Importantly, the signalling functions of these metabolic intermediates extend beyond self-regulatory roles and include cell-to-cell communication and sensing of microenvironmental conditions to elicit stress responses and cellular adaptation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdlTSqJS77KbVg90H21EOLACvtfcHk0liI6d3TXBJUJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCht7c%253D&md5=261e006174495a131197e0e18f5ae18f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2016.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2016.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DHaas%26aufirst%3DR.%26aulast%3DCucchi%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DPucino%26aufirst%3DV.%26aulast%3DMacdougall%26aufirst%3DC.%2BE.%26aulast%3DMauro%26aufirst%3DC.%26atitle%3DIntermediates%2520of%2520metabolism%253A%2520from%2520bystanders%2520to%2520signalling%2520molecules%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2016%26volume%3D41%26spage%3D460%26epage%3D471%26doi%3D10.1016%2Fj.tibs.2016.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palsson-McDermott, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGettrick, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jany, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corr, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haneklaus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beasley, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clish, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auron, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span> <span> </span><span class="NLM_article-title">Succinate is an inflammatory signal that induces IL-1β through HIF-1α</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1038/nature11986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fnature11986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=23535595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=238-242&author=G.+M.+Tannahillauthor=A.+M.+Curtisauthor=J.+Adamikauthor=E.+M.+Palsson-McDermottauthor=A.+F.+McGettrickauthor=G.+Goelauthor=C.+Frezzaauthor=N.+J.+Bernardauthor=B.+Kellyauthor=N.+H.+Foleyauthor=L.+Zhengauthor=A.+Gardetauthor=Z.+Tongauthor=S.+S.+Janyauthor=S.+C.+Corrauthor=M.+Haneklausauthor=B.+E.+Caffreyauthor=K.+Pierceauthor=S.+Walmsleyauthor=F.+C.+Beasleyauthor=E.+Cumminsauthor=V.+Nizetauthor=M.+Whyteauthor=C.+T.+Taylorauthor=H.+Linauthor=S.+L.+Mastersauthor=E.+Gottliebauthor=V.+P.+Kellyauthor=C.+Clishauthor=P.+E.+Auronauthor=R.+J.+Xavierauthor=L.+A.+J.+O%E2%80%99Neill&title=Succinate+is+an+inflammatory+signal+that+induces+IL-1%CE%B2+through+HIF-1%CE%B1&doi=10.1038%2Fnature11986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate is an inflammatory signal that induces IL-1β through HIF-1α</span></div><div class="casAuthors">Tannahill, G. M.; Curtis, A. M.; Adamik, J.; Palsson-McDermott, E. M.; McGettrick, A. F.; Goel, G.; Frezza, C.; Bernard, N. J.; Kelly, B.; Foley, N. H.; Zheng, L.; Gardet, A.; Tong, Z.; Jany, S. S.; Corr, S. C.; Haneklaus, M.; Caffrey, B. E.; Pierce, K.; Walmsley, S.; Beasley, F. C.; Cummins, E.; Nizet, V.; Whyte, M.; Taylor, C. T.; Lin, H.; Masters, S. L.; Gottlieb, E.; Kelly, V. P.; Clish, C.; Auron, P. E.; Xavier, R. J.; O'Neill, L. A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7444</span>),
    <span class="NLM_cas:pages">238-242</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages activated by the Gram-neg. bacterial product lipopolysaccharide switch their core metab. from oxidative phosphorylation to glycolysis.  Here the authors show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1β but not tumor-necrosis factor-α in mouse macrophages.  A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows up-regulation of glycolytic and down-regulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites.  Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate.  Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (γ-aminobutyric acid) shunt' pathway also has a role.  Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1α, an effect that is inhibited by 2-deoxyglucose, with interleukin-1β as an important target.  Lipopolysaccharide also increases succinylation of several proteins.  The authors therefore identify succinate as a metabolite in innate immune signaling, which enhances interleukin-1β prodn. during inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppb1rAXukXlbVg90H21EOLACvtfcHk0liI6d3TXBJUJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrk%253D&md5=e3da1ebd7b2b48cab60fc940de31a224</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature11986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11986%26sid%3Dliteratum%253Aachs%26aulast%3DTannahill%26aufirst%3DG.%2BM.%26aulast%3DCurtis%26aufirst%3DA.%2BM.%26aulast%3DAdamik%26aufirst%3DJ.%26aulast%3DPalsson-McDermott%26aufirst%3DE.%2BM.%26aulast%3DMcGettrick%26aufirst%3DA.%2BF.%26aulast%3DGoel%26aufirst%3DG.%26aulast%3DFrezza%26aufirst%3DC.%26aulast%3DBernard%26aufirst%3DN.%2BJ.%26aulast%3DKelly%26aufirst%3DB.%26aulast%3DFoley%26aufirst%3DN.%2BH.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DGardet%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DJany%26aufirst%3DS.%2BS.%26aulast%3DCorr%26aufirst%3DS.%2BC.%26aulast%3DHaneklaus%26aufirst%3DM.%26aulast%3DCaffrey%26aufirst%3DB.%2BE.%26aulast%3DPierce%26aufirst%3DK.%26aulast%3DWalmsley%26aufirst%3DS.%26aulast%3DBeasley%26aufirst%3DF.%2BC.%26aulast%3DCummins%26aufirst%3DE.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DWhyte%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DC.%2BT.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DKelly%26aufirst%3DV.%2BP.%26aulast%3DClish%26aufirst%3DC.%26aulast%3DAuron%26aufirst%3DP.%2BE.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DSuccinate%2520is%2520an%2520inflammatory%2520signal%2520that%2520induces%2520IL-1%25CE%25B2%2520through%2520HIF-1%25CE%25B1%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D238%26epage%3D242%26doi%3D10.1038%2Fnature11986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ariza, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deen, P. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robben, J. H.</span></span> <span> </span><span class="NLM_article-title">The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.3389/fendo.2012.00022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.3389%2Ffendo.2012.00022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=22649402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1-8&author=A.+C.+Arizaauthor=P.+M.+T.+Deenauthor=J.+H.+Robben&title=The+succinate+receptor+as+a+novel+therapeutic+target+for+oxidative+and+metabolic+stress-related+conditions&doi=10.3389%2Ffendo.2012.00022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2012.00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2012.00022%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DA.%2BC.%26aulast%3DDeen%26aufirst%3DP.%2BM.%2BT.%26aulast%3DRobben%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520succinate%2520receptor%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520oxidative%2520and%2520metabolic%2520stress-related%2520conditions%26jtitle%3DFront.%2520Endocrinol.%26date%3D2012%26volume%3D3%26spage%3D1%26epage%3D8%26doi%3D10.3389%2Ffendo.2012.00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E.-H.</span></span> <span> </span><span class="NLM_article-title">Succinate as a regulator of hepatic stellate cells in liver fibrosis</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">455</span>, <span class="refDoi"> DOI: 10.3389/fendo.2018.00455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.3389%2Ffendo.2018.00455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=30186230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A280%3ADC%252BB3c3lvFagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=455&author=E.-H.+Cho&title=Succinate+as+a+regulator+of+hepatic+stellate+cells+in+liver+fibrosis&doi=10.3389%2Ffendo.2018.00455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis</span></div><div class="casAuthors">Cho Eun-Hee</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">455</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">The rapid increase of obesity rates worldwide is associated with chronic liver injury due to non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.  Chronic liver inflammation drives hepatic fibrosis, which is a highly conserved and coordinated protective response to tissue injury, and is a reversible process.  Hepatocytes, immune cells, and hepatic stellate cells (HSCs) have been identified as key players in the mechanisms of hepatic fibrosis and inflammation.  During the last decade, succinate, an intermediate of the tricarboxylic acid cycle in mitochondrial ATP production, has emerged as an important signaling molecule in various diseases.  Succinate acts as an extracellular ligand for G-protein coupled receptor 91, also known as succinate receptor 1, which is mainly expressed in the kidney, heart, liver, immune cells, and retinal cells, suggesting a widespread function in cellular metabolism.  Furthermore, succinate stabilizes hypoxia-inducible factor-1α in immune cells and tumors as a signaling molecule, and has been shown to post-translationally modify proteins.  This review summarizes the recent evidence pointing to an additional role of succinate in profibrotic signaling, along with its downstream signaling pathways, and updates the current state of knowledge on the role of succinate in liver fibrosis through its action on HSCs.  Further focus on this link can help identify succinate, its receptor, and its downstream signaling molecules as new targets for the treatment of liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1yNpWn_zQMIkFb3mqPUYDfW6udTcc2easMG9IhuVi5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3lvFagtw%253D%253D&md5=3bbff83efa9c5eafdf090fe4d6545170</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2018.00455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2018.00455%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DE.-H.%26atitle%3DSuccinate%2520as%2520a%2520regulator%2520of%2520hepatic%2520stellate%2520cells%2520in%2520liver%2520fibrosis%26jtitle%3DFront.%2520Endocrinol.%26date%3D2018%26volume%3D9%26spage%3D455%26doi%3D10.3389%2Ffendo.2018.00455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macaulay, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijssen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thijssen-Timmer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusnanto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langford, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudbridge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwaginga, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Schoot, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouwehand, W. H.</span></span> <span> </span><span class="NLM_article-title">Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3260</span>– <span class="NLM_lpage">3269</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-07-036269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1182%2Fblood-2006-07-036269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=17192395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=3260-3269&author=I.+C.+Macaulayauthor=M.+R.+Tijssenauthor=D.+C.+Thijssen-Timmerauthor=A.+Gusnantoauthor=M.+Stewardauthor=P.+Burnsauthor=C.+F.+Langfordauthor=P.+D.+Ellisauthor=F.+Dudbridgeauthor=J.+J.+Zwagingaauthor=N.+A.+Watkinsauthor=C.+E.+van+der+Schootauthor=W.+H.+Ouwehand&title=Comparative+gene+expression+profiling+of+in+vitro+differentiated+megakaryocytes+and+erythroblasts+identifies+novel+activatory+and+inhibitory+platelet+membrane+proteins&doi=10.1182%2Fblood-2006-07-036269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins</span></div><div class="casAuthors">Macaulay, Iain C.; Tijssen, Marloes R.; Thijssen-Timmer, Daphne C.; Gusnanto, Arief; Steward, Michael; Burns, Philippa; Langford, Cordelia F.; Ellis, Peter D.; Dudbridge, Frank; Zwaginga, Jaap-Jan; Watkins, Nicholas A.; van der Schoot, C. Ellen; Ouwehand, Willem H.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3260-3269</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">To identify previously unknown platelet receptors we compared the transcriptomes of in vitro differentiated megakaryocytes (MKs) and erythroblasts (EBs).  RNA was obtained from purified, biol. paired MK and EB cultures and compared using cDNA microarrays.  Bioinformatical anal. of MK-up-regulated genes identified 151 transcripts encoding transmembrane domain-contg. proteins.  Although many of these were known platelet genes, a no. of previously unidentified or poorly characterized transcripts were also detected.  Many of these transcripts, including G6b, G6f, LRRC32, LAT2, and the G protein-coupled receptor SUCNR1, encode proteins with structural features or functions that suggest they may be involved in the modulation of platelet function.  Immunoblotting on platelets confirmed the presence of the encoded proteins, and flow cytometric anal. confirmed the expression of G6b, G6f, and LRRC32 on the surface of platelets.  Through comparative anal. of expression in platelets and other blood cells we demonstrated that G6b, G6f, and LRRC32 are restricted to the platelet lineage, whereas LAT2 and SUCNR1 were also detected in other blood cells.  The identification of the succinate receptor SUCNR1 in platelets is of particular interest, because physiol. relevant concns. of succinate were shown to potentiate the effect of low doses of a variety of platelet agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKB0LzfekFebVg90H21EOLACvtfcHk0lhpxzLITpMYrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWitbc%253D&md5=1309bbe914fcd74290b9d2a8e325772a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-036269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-036269%26sid%3Dliteratum%253Aachs%26aulast%3DMacaulay%26aufirst%3DI.%2BC.%26aulast%3DTijssen%26aufirst%3DM.%2BR.%26aulast%3DThijssen-Timmer%26aufirst%3DD.%2BC.%26aulast%3DGusnanto%26aufirst%3DA.%26aulast%3DSteward%26aufirst%3DM.%26aulast%3DBurns%26aufirst%3DP.%26aulast%3DLangford%26aufirst%3DC.%2BF.%26aulast%3DEllis%26aufirst%3DP.%2BD.%26aulast%3DDudbridge%26aufirst%3DF.%26aulast%3DZwaginga%26aufirst%3DJ.%2BJ.%26aulast%3DWatkins%26aufirst%3DN.%2BA.%26aulast%3Dvan%2Bder%2BSchoot%26aufirst%3DC.%2BE.%26aulast%3DOuwehand%26aufirst%3DW.%2BH.%26atitle%3DComparative%2520gene%2520expression%2520profiling%2520of%2520in%2520vitro%2520differentiated%2520megakaryocytes%2520and%2520erythroblasts%2520identifies%2520novel%2520activatory%2520and%2520inhibitory%2520platelet%2520membrane%2520proteins%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D3260%26epage%3D3269%26doi%3D10.1182%2Fblood-2006-07-036269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti-Peterdi, J.</span></span> <span> </span><span class="NLM_article-title">Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">2526</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1172/JCI33293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1172%2FJCI33293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=18535668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1OntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=2526-2534&author=I.+Tomaauthor=J.+J.+Kangauthor=A.+Siposauthor=S.+Vargasauthor=E.+Bansalauthor=F.+Hannerauthor=E.+Meerauthor=J.+Peti-Peterdi&title=Succinate+receptor+GPR91+provides+a+direct+link+between+high+glucose+levels+and+renin+release+in+murine+and+rabbit+kidney&doi=10.1172%2FJCI33293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney</span></div><div class="casAuthors">Toma, Ildiko; Kang, Jung Julie; Sipos, Arnold; Vargas, Sarah; Bansal, Eric; Hanner, Fiona; Meer, Elliott; Peti-Peterdi, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2526-2534</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Diabetes mellitus is the most common and rapidly growing cause of end-stage renal disease in developed countries.  A classic hallmark of early diabetes mellitus includes activation of the renin-angiotensin system (RAS), which may lead to hypertension and renal tissue injury, but the mechanism of RAS activation is elusive.  Here we identified a paracrine signaling pathway in the kidney in which high levels of glucose directly triggered the release of the prohypertensive hormone renin.  The signaling cascade involved the local accumulation of succinate and activation of the kidney-specific G protein-coupled metabolic receptor, GPR91, in the glomerular endothelium as obsd. in rat, mouse, and rabbit kidney sections.  Elements of signal transduction included endothelial Ca2+, the prodn. of NO and prostaglandin (PGE2), and their paracrine actions on adjacent renin-producing cells.  This GPR91 signaling cascade may serve to modulate kidney function and help remove metabolic waste products through renal hyperfiltration, and it could also link metabolic diseases, such as diabetes, or metabolic syndrome with RAS overactivation, systemic hypertension, and organ injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYiuLKXSyM67Vg90H21EOLACvtfcHk0lgsuvxDRNu6mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1OntLY%253D&md5=e46fdc0ede06f7a4f1d6064a2c014d27</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI33293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI33293%26sid%3Dliteratum%253Aachs%26aulast%3DToma%26aufirst%3DI.%26aulast%3DKang%26aufirst%3DJ.%2BJ.%26aulast%3DSipos%26aufirst%3DA.%26aulast%3DVargas%26aufirst%3DS.%26aulast%3DBansal%26aufirst%3DE.%26aulast%3DHanner%26aufirst%3DF.%26aulast%3DMeer%26aufirst%3DE.%26aulast%3DPeti-Peterdi%26aufirst%3DJ.%26atitle%3DSuccinate%2520receptor%2520GPR91%2520provides%2520a%2520direct%2520link%2520between%2520high%2520glucose%2520levels%2520and%2520renin%2520release%2520in%2520murine%2520and%2520rabbit%2520kidney%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D2526%26epage%3D2534%26doi%3D10.1172%2FJCI33293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meer, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti-Peterdi, J.</span></span> <span> </span><span class="NLM_article-title">Activation of the succinate receptor GPR91 in macula densa cells causes renin release</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1002</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1681/ASN.2008070740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1681%2FASN.2008070740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=19389848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFKqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1002-1011&author=S.+L.+Vargasauthor=I.+Tomaauthor=J.+J.+Kangauthor=E.+J.+Meerauthor=J.+Peti-Peterdi&title=Activation+of+the+succinate+receptor+GPR91+in+macula+densa+cells+causes+renin+release&doi=10.1681%2FASN.2008070740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the succinate receptor GPR91 in macula densa cells causes renin release</span></div><div class="casAuthors">Vargas, Sarah Laurin; Toma, Ildiko; Kang, Jung Julie; Meer, Elliott James; Peti-Peterdi, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1002-1011</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Macula densa (MD) cells of the juxtaglomerular app. (JGA) are salt sensors and generate paracrine signals that control renal blood flow, glomerular filtration, and release of the prohypertensive hormone renin.  We hypothesized that the recently identified succinate receptor GPR91 is present in MD cells and regulates renin release.  Using immunohistochem., we identified GPR91 in the apical plasma membrane of MD cells.  Treatment of MD cells with succinate activated mitogen-activated protein kinases (MAPKs; p38 and extracellular signal-regulated kinases 1/2) and cyclooxygenase 2 (COX-2) and induced the synthesis and release of prostaglandin E2, a potent vasodilator and classic paracrine mediator of renin release.  Using microperfused JGA and real-time confocal fluorescence imaging of quinacrinelabeled renin granules, we detected significant renin release in response to tubular succinate (EC50 350 μM).  Genetic deletion of GPR91 (GPR91-/- mice) or pharmacol. inhibition of MAPK or COX-2 blocked succinate-induced renin release.  Streptozotocin-induced diabetes caused GPR91-dependent upregulation of renal cortical phospho-p38, extracellular signal-regulated kinases 1/2, COX-2, and renin content.  Salt depletion for 1 wk increased plasma renin activity seven-fold in wild-type mice but only 3.4-fold in GPR91-/- mice.  In summary, MD cells can sense alterations in local tissue metab. via accumulation of tubular succinate and GPR91 signaling, which involves the activation of MAPKs, COX-2, and the release of prostaglandin E2.  This mechanism may be integral in the regulation of renin release and activation of the renin-angiotensin system in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DQZnZmyIgrVg90H21EOLACvtfcHk0lgsuvxDRNu6mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFKqtr0%253D&md5=ce2d38b2f9299865bff97b69c8017e1c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1681%2FASN.2008070740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2008070740%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DS.%2BL.%26aulast%3DToma%26aufirst%3DI.%26aulast%3DKang%26aufirst%3DJ.%2BJ.%26aulast%3DMeer%26aufirst%3DE.%2BJ.%26aulast%3DPeti-Peterdi%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520succinate%2520receptor%2520GPR91%2520in%2520macula%2520densa%2520cells%2520causes%2520renin%2520release%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2009%26volume%3D20%26spage%3D1002%26epage%3D1011%26doi%3D10.1681%2FASN.2008070740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCreath, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gálvez, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepúlveda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervera, A. M.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.2337/db14-0346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.2337%2Fdb14-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=25352636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslCjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=1154-1167&author=K.+J.+McCreathauthor=S.+Espadaauthor=B.+G.+G%C3%A1lvezauthor=M.+Benitoauthor=A.+de+Molinaauthor=P.+Sep%C3%BAlvedaauthor=A.+M.+Cervera&title=Targeted+disruption+of+the+SUCNR1+metabolic+receptor+leads+to+dichotomous+effects+on+obesity&doi=10.2337%2Fdb14-0346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity</span></div><div class="casAuthors">McCreath, Kenneth J.; Espada, Sandra; Galvez, Beatriz G.; Benito, Marina; de Molina, Antonio; Sepulveda, Pilar; Cervera, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1154-1167</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">A no. of metabolites have signaling properties by acting through G-protein-coupled receptors.  Succinate, a Krebs cycle intermediate, increases after dysregulated energy metab. and can bind to its cognate receptor succinate receptor 1 (Sucnr1, or GPR91) to activate downstream signaling pathways.  We show that Sucnr1 is highly expressed in the white adipose tissue (WAT) compartment of mice and regulates adipose mass and glucose homeostasis.  Sucnr1-/- mice were generated, and wt. gain was monitored under basal and nutritional stress (high-fat diet [HFD]) conditions.  On chow diet, Sucnr1-/- mice had increased energy expenditure, were lean with a smaller WAT compartment, and had improved glucose buffering.  Lipolysis measurements revealed that Sucnr1-/- mice were released from succinate-induced inhibition of lipolysis, demonstrating a function of Sucnr1 in adipose tissue.  Sucnr1 deletion also protected mice from obesity on HFD, but only during the initial period; at later stages, body wt. of HFD-fed Sucnr1-/- mice was almost comparable with wild-type (WT) mice, but WAT content was greater.  Also, these mice became progressively hyperglycemic and failed to secrete insulin, although pancreas architecture was similar to WT mice.  These findings suggest that Sucnr1 is a sensor for dietary energy and raise the interesting possibility that protocols to modulate Sucnr1 might have therapeutic utility in the setting of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2DcEVGYi717Vg90H21EOLACvtfcHk0lgsuvxDRNu6mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslCjsLk%253D&md5=cd985279ea90837a66eb37b087ae2045</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2337%2Fdb14-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb14-0346%26sid%3Dliteratum%253Aachs%26aulast%3DMcCreath%26aufirst%3DK.%2BJ.%26aulast%3DEspada%26aufirst%3DS.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DB.%2BG.%26aulast%3DBenito%26aufirst%3DM.%26aulast%3Dde%2BMolina%26aufirst%3DA.%26aulast%3DSep%25C3%25BAlveda%26aufirst%3DP.%26aulast%3DCervera%26aufirst%3DA.%2BM.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520SUCNR1%2520metabolic%2520receptor%2520leads%2520to%2520dichotomous%2520effects%2520on%2520obesity%26jtitle%3DDiabetes%26date%3D2015%26volume%3D64%26spage%3D1154%26epage%3D1167%26doi%3D10.2337%2Fdb14-0346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapieha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirinyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaniolo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyal, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kermorvant-Duchemin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihakova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Polo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauséjour, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andelfinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sennlaub, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chemtob, S.</span></span> <span> </span><span class="NLM_article-title">The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1076</span>, <span class="refDoi"> DOI: 10.1038/nm.1873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fnm.1873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=18836459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1067-1076&author=P.+Sapiehaauthor=M.+Sirinyanauthor=D.+Hamelauthor=K.+Zanioloauthor=J.+S.+Joyalauthor=J.-H.+Choauthor=J.+C.+Honor%C3%A9author=E.+Kermorvant-Ducheminauthor=D.+R.+Varmaauthor=S.+Tremblayauthor=M.+Leducauthor=L.+Rihakovaauthor=P.+Hardyauthor=W.+H.+Kleinauthor=X.+Muauthor=O.+Mamerauthor=P.+Lachapelleauthor=A.+Di+Poloauthor=C.+Beaus%C3%A9jourauthor=G.+Andelfingerauthor=G.+Mitchellauthor=F.+Sennlaubauthor=S.+Chemtob&title=The+succinate+receptor+GPR91+in+neurons+has+a+major+role+in+retinal+angiogenesis&doi=10.1038%2Fnm.1873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis</span></div><div class="casAuthors">Sapieha, Przemyslaw; Sirinyan, Mirna; Hamel, David; Zaniolo, Karine; Joyal, Jean-Sebastien; Cho, Jang-Hyeon; Honore, Jean-Claude; Kermorvant-Duchemin, Elsa; Varma, Daya R.; Tremblay, Sophie; Leduc, Martin; Rihakova, Lenka; Hardy, Pierre; Klein, William H.; Mu, Xiuqian; Mamer, Orval; Lachapelle, Pierre; Di Polo, Adriana; Beausejour, Christian; Andelfinger, Gregor; Mitchell, Grant; Sennlaub, Florian; Chemtob, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1067-1076</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Vascularization is essential for tissue development and in restoration of tissue integrity after an ischemic injury.  In studies of vascularization, the focus has largely been placed on vascular endothelial growth factor (VEGF), yet other factors may also orchestrate this process.  Here we show that succinate accumulates in the hypoxic retina of rodents and, via its cognate receptor G protein-coupled receptor-91 (GPR91), is a potent mediator of vessel growth in the settings of both normal retinal development and proliferative ischemic retinopathy.  The effects of GPR91 are mediated by retinal ganglion neurons (RGCs), which, in response to increased succinate levels, regulate the prodn. of numerous angiogenic factors including VEGF.  Accordingly, succinate did not have proangiogenic effects in RGC-deficient rats.  Our observations show a pathway of metabolite signaling where succinate, acting through GPR91, governs retinal angiogenesis and show the propensity of RGCs to act as sensors of ischemic stress.  These findings provide a new therapeutic target for modulating revascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo836psMwLyH7Vg90H21EOLACvtfcHk0lihks7Xfngn4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7rI&md5=234c8591c5c6036e126bc40198a9e518</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.1873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1873%26sid%3Dliteratum%253Aachs%26aulast%3DSapieha%26aufirst%3DP.%26aulast%3DSirinyan%26aufirst%3DM.%26aulast%3DHamel%26aufirst%3DD.%26aulast%3DZaniolo%26aufirst%3DK.%26aulast%3DJoyal%26aufirst%3DJ.%2BS.%26aulast%3DCho%26aufirst%3DJ.-H.%26aulast%3DHonor%25C3%25A9%26aufirst%3DJ.%2BC.%26aulast%3DKermorvant-Duchemin%26aufirst%3DE.%26aulast%3DVarma%26aufirst%3DD.%2BR.%26aulast%3DTremblay%26aufirst%3DS.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DRihakova%26aufirst%3DL.%26aulast%3DHardy%26aufirst%3DP.%26aulast%3DKlein%26aufirst%3DW.%2BH.%26aulast%3DMu%26aufirst%3DX.%26aulast%3DMamer%26aufirst%3DO.%26aulast%3DLachapelle%26aufirst%3DP.%26aulast%3DDi%2BPolo%26aufirst%3DA.%26aulast%3DBeaus%25C3%25A9jour%26aufirst%3DC.%26aulast%3DAndelfinger%26aufirst%3DG.%26aulast%3DMitchell%26aufirst%3DG.%26aulast%3DSennlaub%26aufirst%3DF.%26aulast%3DChemtob%26aufirst%3DS.%26atitle%3DThe%2520succinate%2520receptor%2520GPR91%2520in%2520neurons%2520has%2520a%2520major%2520role%2520in%2520retinal%2520angiogenesis%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1067%26epage%3D1076%26doi%3D10.1038%2Fnm.1873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lametschwandtner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinteregger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido-Perrig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwärzler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voshol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meingassner, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span> <span> </span><span class="NLM_article-title">Triggering the succinate receptor GPR91 on dendritic cells enhances immunity</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1038/ni.1657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fni.1657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=18820681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1261-1269&author=T.+Rubicauthor=G.+Lametschwandtnerauthor=S.+Jostauthor=S.+Hintereggerauthor=J.+Kundauthor=N.+Carballido-Perrigauthor=C.+Schw%C3%A4rzlerauthor=T.+Juntauthor=H.+Vosholauthor=J.+G.+Meingassnerauthor=X.+Maoauthor=G.+Wernerauthor=A.+Rotauthor=J.+M.+Carballido&title=Triggering+the+succinate+receptor+GPR91+on+dendritic+cells+enhances+immunity&doi=10.1038%2Fni.1657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Triggering the succinate receptor GPR91 on dendritic cells enhances immunity</span></div><div class="casAuthors">Rubic, Tina; Lametschwandtner, Guenther; Jost, Sandra; Hinteregger, Sonja; Kund, Julia; Carballido-Perrig, Nicole; Schwaerzler, Christoph; Junt, Tobias; Voshol, Hans; Meingassner, Josef G.; Mao, Xiaohong; Werner, Gudrun; Rot, Antal; Carballido, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1261-1269</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Succinate acts as an extracellular mediator signaling through the G protein-coupled receptor GPR91.  Here the authors show that dendritic cells had high expression of GPR91.  In these cells, succinate triggered intracellular calcium mobilization, induced migratory responses and acted in synergy with Toll-like receptor ligands for the prodn. of proinflammatory cytokines.  Succinate also enhanced antigen-specific activation of human and mouse helper T cells.  GPR91-deficient mice had less migration of Langerhans cells to draining lymph nodes and impaired tetanus toxoid-specific recall T cell responses.  Furthermore, GPR91-deficient allografts elicited weaker transplant rejection than did the corresponding grafts from wild-type mice.  The results suggest that the succinate receptor GPR91 is involved in sensing immunol. danger, which establishes a link between immunity and a metabolite of cellular respiration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-oJPPLkVcp7Vg90H21EOLACvtfcHk0lihks7Xfngn4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrF&md5=56e7f2eb72deae72041d67bb196bcf1e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fni.1657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1657%26sid%3Dliteratum%253Aachs%26aulast%3DRubic%26aufirst%3DT.%26aulast%3DLametschwandtner%26aufirst%3DG.%26aulast%3DJost%26aufirst%3DS.%26aulast%3DHinteregger%26aufirst%3DS.%26aulast%3DKund%26aufirst%3DJ.%26aulast%3DCarballido-Perrig%26aufirst%3DN.%26aulast%3DSchw%25C3%25A4rzler%26aufirst%3DC.%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DVoshol%26aufirst%3DH.%26aulast%3DMeingassner%26aufirst%3DJ.%2BG.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DWerner%26aufirst%3DG.%26aulast%3DRot%26aufirst%3DA.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26atitle%3DTriggering%2520the%2520succinate%2520receptor%2520GPR91%2520on%2520dendritic%2520cells%2520enhances%2520immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1261%26epage%3D1269%26doi%3D10.1038%2Fni.1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veras, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peres, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luiz, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, F. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryffel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves-Filho, J. C.</span></span> <span> </span><span class="NLM_article-title">Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">6550</span>– <span class="NLM_lpage">6558</span>, <span class="refDoi"> DOI: 10.1096/fj.201800285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1096%2Ffj.201800285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjslSitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=6550-6558&author=A.+L.+Saraivaauthor=F.+P.+Verasauthor=R.+S.+Peresauthor=J.+Talbotauthor=K.+A.+de+Limaauthor=J.+P.+Luizauthor=J.+M.+Carballidoauthor=T.+M.+Cunhaauthor=F.+Q.+Cunhaauthor=B.+Ryffelauthor=J.+C.+Alves-Filho&title=Succinate+receptor+deficiency+attenuates+arthritis+by+reducing+dendritic+cell+traffic+and+expansion+of+Th17+cells+in+the+lymph+nodes&doi=10.1096%2Ffj.201800285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes</span></div><div class="casAuthors">Saraiva, Andre L.; Veras, Flavio P.; Peres, Raphael S.; Talbot, Jhimmy; de Lima, Kalil A.; Luiz, Joao P.; Carballido, Jose M.; Cunha, Thiago M.; Cunha, Fernando Q.; Ryffel, Bernhard; Alves-Filho, Jose C.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6550-6558</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Rheumatoid arthritis is a chronic inflammatory disease that leads to significant changes in metabolic activity.  Succinate, an intermediate of the tricarboxylic acid cycle, has emerged as ametabolicmediator of the innate immune response.  However, the involvement of succinate in the generation of the adaptive immune response and establishment of autoimmune response has not been addressed thus far.Here we demonstrated that the succinatesensing receptor (Sucnr1/GPR91) plays a crit. role in the development of immune-mediated arthritis.  We found that Sucnr1 acts as a chemotacticgradient sensor that guides dendritic cells (DCs) intothe lymphnodes,orchestrating the expansionof theThelper (Th)17-cellpopulation and thedevelopment of exptl. antigen-induced arthritis.Sucnr1-/- mice show reduced articul arhyperalgesia, neutrophil infiltration andinflammatory cytokines inthe joint, and reduced frequency of Th17 cells in draining lymph nodes.  Adoptive transfer of wild-type (WT) DCs into Sucnr1-/- mice restored the development of arthritis.  Moreover, DC-depletedmice transferredwith Sucnr1-/- DCs developed less arthritis than mice transferred with WT DCs.  In contrast, succinate given together with the immunization boosted the recruitment of DCs and the frequency of Th17 cells in draining lymph nodes, increasing arthritis severity.  Therefore, the blockade of Sucnr1may represent a novel therapeutic target of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy86VaIXji0rVg90H21EOLACvtfcHk0lihks7Xfngn4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjslSitLs%253D&md5=457898569316d2912169082a9316d92a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1096%2Ffj.201800285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201800285%26sid%3Dliteratum%253Aachs%26aulast%3DSaraiva%26aufirst%3DA.%2BL.%26aulast%3DVeras%26aufirst%3DF.%2BP.%26aulast%3DPeres%26aufirst%3DR.%2BS.%26aulast%3DTalbot%26aufirst%3DJ.%26aulast%3Dde%2BLima%26aufirst%3DK.%2BA.%26aulast%3DLuiz%26aufirst%3DJ.%2BP.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26aulast%3DCunha%26aufirst%3DT.%2BM.%26aulast%3DCunha%26aufirst%3DF.%2BQ.%26aulast%3DRyffel%26aufirst%3DB.%26aulast%3DAlves-Filho%26aufirst%3DJ.%2BC.%26atitle%3DSuccinate%2520receptor%2520deficiency%2520attenuates%2520arthritis%2520by%2520reducing%2520dendritic%2520cell%2520traffic%2520and%2520expansion%2520of%2520Th17%2520cells%2520in%2520the%2520lymph%2520nodes%26jtitle%3DFASEB%2520J.%26date%3D2018%26volume%3D32%26spage%3D6550%26epage%3D6558%26doi%3D10.1096%2Ffj.201800285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span> <span> </span><span class="NLM_article-title">Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e97501</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0097501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1371%2Fjournal.pone.0097501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=24887281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKiu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=S.+Kimauthor=J.+Hwangauthor=J.+Xuanauthor=Y.+H.+Jungauthor=H.-S.+Chaauthor=K.+H.+Kim&title=Global+metabolite+profiling+of+synovial+fluid+for+the+specific+diagnosis+of+rheumatoid+arthritis+from+other+inflammatory+arthritis&doi=10.1371%2Fjournal.pone.0097501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis</span></div><div class="casAuthors">Kim, Sooah; Hwang, Jiwon; Xuan, Jinhua; Jung, Young Hoon; Cha, Hoon-Suk; Kim, Kyoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e97501/1-e97501/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Currently, reliable biomarkers that can be used to distinguish rheumatoid arthritis (RA) from other inflammatory diseases are unavailable.  To find possible distinctive metabolic patterns and biomarker candidates for RA, we performed global metabolite profiling of synovial fluid samples.  Synovial fluid samples from 38 patients with RA, ankylosing spondylitis, Behcet's disease, and gout were analyzed by gas chromatog./time-of-flight mass spectrometry (GC/TOF MS).  Orthogonal partial least-squares discriminant and hierarchical clustering analyses were performed for the discrimination of RA and non-RA groups.  Variable importance for projection values were detd., and the Wilcoxon-Mann-Whitney test and the breakdown and one-way anal. of variance were conducted to identify potential biomarkers for RA.  A total of 105 metabolites were identified from synovial fluid samples.  The score plot of orthogonal partial least squares discriminant anal. showed significant discrimination between the RA and non-RA groups.  The 20 metabolites, including citrulline, succinate, glutamine, octadecanol, isopalmitic acid, and glycerol, were identified as potential biomarkers for RA.  These metabolites were found to be assocd. with the urea and TCA cycles as well as fatty acid and amino acid metab.  The metabolomic anal. results demonstrated that global metabolite profiling by GC/TOF MS might be a useful tool for the effective diagnosis and further understanding of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNQ5-IluY1bVg90H21EOLACvtfcHk0lhN32sMejAsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKiu7bP&md5=2b44186884ca717dccf690501bd18c6b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0097501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0097501%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DXuan%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DY.%2BH.%26aulast%3DCha%26aufirst%3DH.-S.%26aulast%3DKim%26aufirst%3DK.%2BH.%26atitle%3DGlobal%2520metabolite%2520profiling%2520of%2520synovial%2520fluid%2520for%2520the%2520specific%2520diagnosis%2520of%2520rheumatoid%2520arthritis%2520from%2520other%2520inflammatory%2520arthritis%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0097501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apfel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loesle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tigani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kneuer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valeaux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubic-Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span> <span> </span><span class="NLM_article-title">GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1662</span>, <span class="refDoi"> DOI: 10.1084/jem.20160061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1084%2Fjem.20160061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=27481132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVyksr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2016&pages=1655-1662&author=A.+Littlewood-Evansauthor=S.+Sarretauthor=V.+Apfelauthor=P.+Loesleauthor=J.+Dawsonauthor=J.+Zhangauthor=A.+Mullerauthor=B.+Tiganiauthor=R.+Kneuerauthor=S.+Patelauthor=S.+Valeauxauthor=N.+Gommermannauthor=T.+Rubic-Schneiderauthor=T.+Juntauthor=J.+M.+Carballido&title=GPR91+senses+extracellular+succinate+released+from+inflammatory+macrophages+and+exacerbates+rheumatoid+arthritis&doi=10.1084%2Fjem.20160061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis</span></div><div class="casAuthors">Littlewood-Evans, Amanda; Sarret, Sophie; Apfel, Verena; Loesle, Perrine; Dawson, Janet; Zhang, Juan; Muller, Alban; Tigani, Bruno; Kneuer, Rainer; Patel, Saijel; Valeaux, Stephanie; Gommermann, Nina; Rubic-Schneider, Tina; Junt, Tobias; Carballido, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1655-1662</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">1540-9538</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">When SUCNR1/GPR91-expressing macrophages are activated by inflammatory signals, they change their metab. and accumulate succinate.  In this study, we show that during this activation, macrophages release succinate into the extracellular milieu.  They simultaneously up-regulate GPR91, which functions as an autocrine and paracrine sensor for extracellular succinate to enhance IL-1β prodn.  GPR91-deficient mice lack this metabolic sensor and show reduced macrophage activation and prodn. of IL-1β during antigen-induced arthritis.  Succinate is abundant in synovial fluids from rheumatoid arthritis (RA) patients, and these fluids elicit IL-1β release from macrophages in a GPR91-dependent manner.  Together, we reveal a GPR91/succinate-dependent feed-forward loop of macrophage activation and propose GPR91 antagonists as novel therapeutic principles to treat RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp51mM1dfvbeLVg90H21EOLACvtfcHk0lhN32sMejAsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVyksr3M&md5=65237378a1e94906ee0d486c1211b5fb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20160061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20160061%26sid%3Dliteratum%253Aachs%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DSarret%26aufirst%3DS.%26aulast%3DApfel%26aufirst%3DV.%26aulast%3DLoesle%26aufirst%3DP.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DTigani%26aufirst%3DB.%26aulast%3DKneuer%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DValeaux%26aufirst%3DS.%26aulast%3DGommermann%26aufirst%3DN.%26aulast%3DRubic-Schneider%26aufirst%3DT.%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26atitle%3DGPR91%2520senses%2520extracellular%2520succinate%2520released%2520from%2520inflammatory%2520macrophages%2520and%2520exacerbates%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2016%26volume%3D213%26spage%3D1655%26epage%3D1662%26doi%3D10.1084%2Fjem.20160061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umrani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salunke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukreja, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naykodi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitole, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurhade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shejul, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T.-Q.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective small molecule hGPR91 antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3596</span>– <span class="NLM_lpage">3602</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.bmcl.2011.04.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=21571530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3596-3602&author=D.+Bhuniyaauthor=D.+Umraniauthor=B.+Daveauthor=D.+Salunkeauthor=G.+Kukrejaauthor=J.+Gunduauthor=M.+Naykodiauthor=N.+S.+Shaikhauthor=P.+Shitoleauthor=S.+Kurhadeauthor=S.+Deauthor=S.+Majumdarauthor=S.+B.+Reddyauthor=S.+Tambeauthor=Y.+Shejulauthor=A.+Chughauthor=V.+P.+Palleauthor=K.+A.+Mookhtiarauthor=D.+Cullyauthor=J.+Vaccaauthor=P.+K.+Chakravartyauthor=R.+P.+Nargundauthor=S.+D.+Wrightauthor=M.+P.+Grazianoauthor=S.+B.+Singhauthor=S.+Royauthor=T.-Q.+Cai&title=Discovery+of+a+potent+and+selective+small+molecule+hGPR91+antagonist&doi=10.1016%2Fj.bmcl.2011.04.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and selective small molecule hGPR91 antagonist</span></div><div class="casAuthors">Bhuniya, Debnath; Umrani, Dhananjay; Dave, Bhavesh; Salunke, Deepak; Kukreja, Gagan; Gundu, Jayasagar; Naykodi, Minakshi; Shaikh, Nadim S.; Shitole, Prasad; Kurhade, Santosh; De, Siddhartha; Majumdar, Sreemita; Reddy, Srinivasa B.; Tambe, Suhas; Shejul, Yogesh; Chugh, Anita; Palle, Venkata P.; Mookhtiar, Kasim A.; Cully, Doris; Vacca, Joseph; Chakravarty, Prasun K.; Nargund, Ravi P.; Wright, Samuel D.; Graziano, Michael P.; Singh, Sheo B.; Roy, Sophie; Cai, Tian-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3596-3602</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR91, a 7TM G-Protein-Coupled Receptor, has been recently deorphanized with succinic acid as its endogenous ligand.  Current literature indicates that GPR91 plays role in various pathophysiol. including renal hypertension, autoimmune disease and retinal angiogenesis.  Starting from naphthyridine-contg. small mol. high-throughput screening hit I (hGPR91 IC50: 0.8 μM)-originally synthesized at Merck for a Bradykinin B1 Receptor (BK1R) program, a systematic structure-activity relationship study led to the discovery of potent and selective hGPR91 antagonists e.g. II, III, and IV (IC50: 7-35 nM; >1000 fold selective against hGPR99, a closest related GPCR; >100 fold selective in Drug Matrix screening).  This initial work also led to identification of two structurally distinct and orally bio-available lead compds.: IV (%F: 26) and V (IC50: 180 nM; >100 fold selective against hGPR99; %F: 87).  A rat pharmacodynamic assay was developed to characterize the antagonists in vivo using succinate induced increase in blood pressure.  Using two representative antagonists, II and III, the GPR91 target engagement was subsequently demonstrated using the designed pharmacodynamic assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-All39--H7Vg90H21EOLACvtfcHk0liRpumHprJlbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhsrk%253D&md5=39579730e461de19ec78ecae37581c64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.091%26sid%3Dliteratum%253Aachs%26aulast%3DBhuniya%26aufirst%3DD.%26aulast%3DUmrani%26aufirst%3DD.%26aulast%3DDave%26aufirst%3DB.%26aulast%3DSalunke%26aufirst%3DD.%26aulast%3DKukreja%26aufirst%3DG.%26aulast%3DGundu%26aufirst%3DJ.%26aulast%3DNaykodi%26aufirst%3DM.%26aulast%3DShaikh%26aufirst%3DN.%2BS.%26aulast%3DShitole%26aufirst%3DP.%26aulast%3DKurhade%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DS.%2BB.%26aulast%3DTambe%26aufirst%3DS.%26aulast%3DShejul%26aufirst%3DY.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26aulast%3DCully%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DGraziano%26aufirst%3DM.%2BP.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DT.-Q.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520small%2520molecule%2520hGPR91%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3596%26epage%3D3602%26doi%3D10.1016%2Fj.bmcl.2011.04.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trauelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjorth, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brvar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1585</span>– <span class="NLM_lpage">1596</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2017.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.molmet.2017.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=29157600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1ars7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=1585-1596&author=M.+Trauelsenauthor=E.+R.+Ulvenauthor=S.+A.+Hjorthauthor=M.+Brvarauthor=C.+Monacoauthor=T.+M.+Frimurerauthor=T.+W.+Schwartz&title=Receptor+structure-based+discovery+of+non-metabolite+agonists+for+the+succinate+receptor+GPR91&doi=10.1016%2Fj.molmet.2017.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor structure-based discovery of non-metabolite agonists for the succinate receptor gpr91</span></div><div class="casAuthors">Trauelsen, Mette; Rexen Ulven, Elisabeth; Hjorth, Siv A.; Brvar, Matjaz; Monaco, Claudia; Frimurer, Thomas M.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1585-1596</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Besides functioning as an intracellular metabolite, succinate acts as a stress-induced extracellular signal through activation of GPR91 (SUCNR1) for which we lack suitable pharmacol. tools.  Here we first detd. that the cis conformation of the succinate backbone is preferred and that certain backbone modifications are allowed for GPR91 activation.  Through receptor modeling over the X-ray structure of the closely related P2Y1 receptor, we discovered that the binding pocket is partly occupied by a segment of an extracellular loop and that succinate therefore binds in a very different mode than generally believed.  Importantly, an empty side-pocket is identified next to the succinate binding site.  All this information formed the basis for a substructure-based search query, which, combined with mol. docking, was used in virtual screening of the ZINC database to pick two serial mini-libraries of a total of only 245 compds. from which sub-micromolar, selective GPR91 agonists of unique structures were identified.  The best compds. were backbone-modified succinate analogs in which an amide-linked hydrophobic moiety docked into the side-pocket next to succinate as shown by both loss- and gain-of-function mutagenesis.  These compds. displayed GPR91-dependent activity in altering cytokine expression in human M2 macrophages similar to succinate, and importantly were devoid of any effect on the major intracellular target, succinate dehydrogenase.  These novel, synthetic non-metabolite GPR91 agonists will be valuable both as pharmacol. tools to delineate the GPR91-mediated functions of succinate and as leads for the development of GPR91-targeted drugs to potentially treat low grade metabolic inflammation and diabetic complications such as retinopathy and nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4X9H6LZ_ah7Vg90H21EOLACvtfcHk0liRpumHprJlbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1ars7vE&md5=0cd72477f109c9ee657e3d719ae4dfa6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2017.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2017.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DTrauelsen%26aufirst%3DM.%26aulast%3DUlven%26aufirst%3DE.%2BR.%26aulast%3DHjorth%26aufirst%3DS.%2BA.%26aulast%3DBrvar%26aufirst%3DM.%26aulast%3DMonaco%26aufirst%3DC.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DReceptor%2520structure-based%2520discovery%2520of%2520non-metabolite%2520agonists%2520for%2520the%2520succinate%2520receptor%2520GPR91%26jtitle%3DMol.%2520Metab.%26date%3D2017%26volume%3D6%26spage%3D1585%26epage%3D1596%26doi%3D10.1016%2Fj.molmet.2017.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brvar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lückmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielefeldt, LØ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity investigations and optimisations of nonmetabolite agonists for the Succinate Receptor 1</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="NLM_elocation-id">10010</span> <span class="refDoi"> DOI: 10.1038/s41598-018-28263-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fs41598-018-28263-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=29968758" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=E.+R.+Ulvenauthor=M.+Trauelsenauthor=M.+Brvarauthor=M.+L%C3%BCckmannauthor=L%C3%98.+Bielefeldtauthor=L.+K.+I.+Jensenauthor=T.+W.+Schwartzauthor=T.+M.+Frimurer&title=Structure-activity+investigations+and+optimisations+of+nonmetabolite+agonists+for+the+Succinate+Receptor+1&doi=10.1038%2Fs41598-018-28263-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-28263-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-28263-7%26sid%3Dliteratum%253Aachs%26aulast%3DUlven%26aufirst%3DE.%2BR.%26aulast%3DTrauelsen%26aufirst%3DM.%26aulast%3DBrvar%26aufirst%3DM.%26aulast%3DL%25C3%25BCckmann%26aufirst%3DM.%26aulast%3DBielefeldt%26aufirst%3DL%25C3%2598.%26aulast%3DJensen%26aufirst%3DL.%2BK.%2BI.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26atitle%3DStructure-activity%2520investigations%2520and%2520optimisations%2520of%2520nonmetabolite%2520agonists%2520for%2520the%2520Succinate%2520Receptor%25201%26jtitle%3DSci.%2520Rep.%26date%3D2018%26doi%3D10.1038%2Fs41598-018-28263-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geubelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilissen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laschet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouret, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span> <span> </span><span class="NLM_article-title">Identification and pharmacological characterization of succinate receptor agonists</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.1111/bph.13738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1111%2Fbph.13738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=28160606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVKns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=796-808&author=P.+Geubelleauthor=J.+Gilissenauthor=S.+Dillyauthor=L.+Pomaauthor=N.+Dupuisauthor=C.+Laschetauthor=D.+Abboudauthor=A.+Inoueauthor=F.+Jouretauthor=B.+Pirotteauthor=J.+Hanson&title=Identification+and+pharmacological+characterization+of+succinate+receptor+agonists&doi=10.1111%2Fbph.13738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and pharmacological characterization of succinate receptor agonists</span></div><div class="casAuthors">Geubelle, Pierre; Gilissen, Julie; Dilly, Sebastien; Poma, Laurence; Dupuis, Nadine; Laschet, Celine; Abboud, Dayana; Inoue, Asuka; Jouret, Francois; Pirotte, Bernard; Hanson, Julien</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">796-808</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The succinate receptor (formerly GPR91 or SUCNR1) is described as a metabolic sensor that may be involved in homeostasis.  Notwithstanding its implication in important (patho)physiol. processes, the function of succinate receptors has remained ill-defined because no pharmacol. tools were available.  We report on the discovery of the first family of potent synthetic agonists.  Exptl. Approach : We screened a library of succinate analogs and analyzed their activity on succinate receptors.  Also, we modelled a pharmacophore and a binding site for this receptor.  New agonists were identified based on the information provided by these two approaches.  Their activity was studied in various bioassays, including measurement of cAMP levels, [Ca2+]i mobilization, TGF-α shedding and recruitment of arrestin 3.  The in vivo effects of activating succinate receptors with these new agonists was evaluated on rat BP.  Key Results : We identified cis-epoxysuccinic acid and cis-1,2-cyclopropanedicarboxylic acid as agonists with an efficacy similar to that of succinic acid.  Interestingly, cis-epoxysuccinic acid was 10- to 20-fold more potent than succinic acid on succinate receptors.  For example, cis-epoxysuccinic acid reduced cAMP levels with a pEC50 = 5.57 ± 0.02 (EC50 = 2.7 μM), compared with succinate pEC50 = 4.54 ± 0.08 (EC50 = 29 μM).  The rank order of potency of the three agonists was the same in all in vitro assays.  Both cis-epoxysuccinic and cis-1,2-cyclopropanedicarboxylic acid were as potent as succinate in increasing rat BP.  Conclusions and Implications : We describe new agonists at succinate receptors that should facilitate further research on this understudied receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaDo2EIERJSbVg90H21EOLACvtfcHk0lhm6Sb3cTE6dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVKns7c%253D&md5=5c5836e816fbbbd6a8f094e4ce63b715</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fbph.13738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13738%26sid%3Dliteratum%253Aachs%26aulast%3DGeubelle%26aufirst%3DP.%26aulast%3DGilissen%26aufirst%3DJ.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DPoma%26aufirst%3DL.%26aulast%3DDupuis%26aufirst%3DN.%26aulast%3DLaschet%26aufirst%3DC.%26aulast%3DAbboud%26aufirst%3DD.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DJouret%26aufirst%3DF.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DHanson%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520pharmacological%2520characterization%2520of%2520succinate%2520receptor%2520agonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D796%26epage%3D808%26doi%3D10.1111%2Fbph.13738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haffke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehlmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivineau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckely, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirockin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V.-P.</span></span> <span> </span><span class="NLM_article-title">Structural basis of species-selective antagonist binding to the succinate receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>574</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1663-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fs41586-019-1663-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=31645725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVagsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=574&publication_year=2019&pages=581-585&author=M.+Haffkeauthor=D.+Fehlmannauthor=G.+Rummelauthor=J.+Boivineauauthor=M.+Duckelyauthor=N.+Gommermannauthor=S.+Cotestaauthor=F.+Sirockinauthor=F.+Freulerauthor=A.+Littlewood-Evansauthor=K.+Kaupmannauthor=V.-P.+Jaakola&title=Structural+basis+of+species-selective+antagonist+binding+to+the+succinate+receptor&doi=10.1038%2Fs41586-019-1663-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of species-selective antagonist binding to the succinate receptor</span></div><div class="casAuthors">Haffke, Matthias; Fehlmann, Dominique; Rummel, Gabriele; Boivineau, Jacques; Duckely, Myriam; Gommermann, Nina; Cotesta, Simona; Sirockin, Finton; Freuler, Felix; Littlewood-Evans, Amanda; Kaupmann, Klemens; Jaakola, Veli-Pekka</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">574</span>
        (<span class="NLM_cas:issue">7779</span>),
    <span class="NLM_cas:pages">581-585</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The tricarboxylic acid cycle intermediate succinate is involved in metabolic processes and plays a crucial role in the homeostasis of mitochondrial reactive oxygen species1.  The receptor responsible for succinate signalling, SUCNR1 (also known as GPR91), is a member of the G-protein-coupled-receptor family2 and links succinate signalling to renin-induced hypertension, retinal angiogenesis and inflammation3-5.  Because SUCNR1 senses succinate as an immunol. danger signal6-which has relevance for diseases including ulcerative colitis, liver fibrosis7, diabetes and rheumatoid arthritis3,8-it is of interest as a therapeutic target.  Here we report the high-resoln. crystal structure of rat SUCNR1 in complex with an intracellular binding nanobody in the inactive conformation.  Structure-based mutagenesis and radioligand-binding studies, in conjunction with mol. modeling, identified key residues for species-selective antagonist binding and enabled the detn. of the high-resoln. crystal structure of a humanized rat SUCNR1 in complex with a high-affinity, human-selective antagonist denoted NF-56-EJ40.  We anticipate that these structural insights into the architecture of the succinate receptor and its antagonist selectivity will enable structure-based drug discovery and will further help to elucidate the function of SUCNR1 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9By42eRbVnrVg90H21EOLACvtfcHk0lhm6Sb3cTE6dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVagsbzL&md5=7a76c0a8fef43a8ccb968f8e5c3334ac</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1663-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1663-8%26sid%3Dliteratum%253Aachs%26aulast%3DHaffke%26aufirst%3DM.%26aulast%3DFehlmann%26aufirst%3DD.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DBoivineau%26aufirst%3DJ.%26aulast%3DDuckely%26aufirst%3DM.%26aulast%3DGommermann%26aufirst%3DN.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DSirockin%26aufirst%3DF.%26aulast%3DFreuler%26aufirst%3DF.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DJaakola%26aufirst%3DV.-P.%26atitle%3DStructural%2520basis%2520of%2520species-selective%2520antagonist%2520binding%2520to%2520the%2520succinate%2520receptor%26jtitle%3DNature%26date%3D2019%26volume%3D574%26spage%3D581%26epage%3D585%26doi%3D10.1038%2Fs41586-019-1663-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span> <i>Drug-like Properties: Concepts, Structure Design
and Methods from
ADME to Toxicity Optimization</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E.</span></span>, Eds.; <span class="NLM_publisher-name">Academic press</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.+Kerns&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design%0Aand+Methods+from%0AADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%250Aand%2520Methods%2520from%250AADME%2520to%2520Toxicity%2520Optimization%26aulast%3DDi%26aufirst%3DL.%26pub%3DAcademic%2520press%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohnsland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span> <span> </span><span class="NLM_article-title">High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/jm001020e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&author=F.+Wohnslandauthor=B.+Faller&title=High-throughput+permeability+pH+profile+and+high-throughput+alkane%2Fwater+log+P+with+artificial+membranes&doi=10.1021%2Fjm001020e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Permeability pH Profile and High-Throughput Alkane/Water log P with Artificial Membranes</span></div><div class="casAuthors">Wohnsland, Frank; Faller, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-930</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study reports on a novel, high-throughput assay, designed to predict passive, transcellular permeability in early drug discovery.  The assay is carried out in 96-well microtiterplates and measures the ability of compds. to diffuse from a donor to an acceptor compartment which are sepd. by a 9-10 μm hexadecane liq. layer.  A set of 32 well-characterized, chem. diverse drugs was used to validate the method.  The permeability values derived from the flux factors between donor and acceptor compartments show a good correlation with gastrointestinal absorption in humans.  For comparison, correlations based on exptl. or calcd. octanol/water distribution coeffs. (log Do/w,6.8) were significantly lower.  In addn., this simple and robust assay allows detn. of pH permeability profiles, crit. information to predict gastrointestinal absorption of ionizable drugs and difficult to obtain from cell culture expts.  Correction for the unstirred water layer effect allows to differentiate between effective and intrinsic membrane permeability and opens up the dynamic range of the method.  In addn., alkane/water partition coeffs. can be derived from intrinsic membrane permeabilities, making this assay the first high-throughput method able to measure alkane/water log P in the microtiterplate format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXoYADWFOUn7Vg90H21EOLACvtfcHk0lhNmacS98gOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D&md5=de19e881e03d62d48a8acfea729790b4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh-throughput%2520permeability%2520pH%2520profile%2520and%2520high-throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D923%26epage%3D930%26doi%3D10.1021%2Fjm001020e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Low, Y. W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span> <span> </span><span class="NLM_article-title">Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2016.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.ejps.2016.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=27373604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKrsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=110-116&author=Y.+W.+I.+Lowauthor=F.+Blascoauthor=P.+Vachaspati&title=Optimised+method+to+estimate+octanol+water+distribution+coefficient+%28logD%29+in+a+high+throughput+format&doi=10.1016%2Fj.ejps.2016.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format</span></div><div class="casAuthors">Low, Ying Wei; Blasco, Francesca; Vachaspati, Prakash</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lipophilicity is one of the mol. properties assessed in early drug discovery.  Direct measurement of the octanol-water distribution coeff. (logD) requires an anal. method with a large dynamic range or multistep dilns., as the analyte's concns. span across several orders of magnitude.  In addn., water/buffer and octanol phases which have very different polarity could lead to matrix effects and affect the LC-MS response, leading to erroneous logD values.  Most compd. libraries use DMSO stocks as it greatly reduces the sample requirement but the presence of DMSO has been shown to underestimate the lipophilicity of the analyte.  The present work describes the development of an optimized shake flask logD method using deepwell 96 well plate that addresses the issues related to matrix effects, DMSO concn. and incubation conditions and is also amenable to high throughput.  Our results indicate that the equil. can be achieved within 30 min by flipping the plate on its side while even 0.5% of DMSO is not tolerated in the assay.  This study uses the matched matrix concept to minimise the errors in analyzing the two phases namely buffer and octanol in LC-MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQW7-Y-gkR7Vg90H21EOLACvtfcHk0lhNmacS98gOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKrsr%252FI&md5=97b8c5312efc8b7f535332af1c0d9cab</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DY.%2BW.%2BI.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DVachaspati%26aufirst%3DP.%26atitle%3DOptimised%2520method%2520to%2520estimate%2520octanol%2520water%2520distribution%2520coefficient%2520%2528logD%2529%2520in%2520a%2520high%2520throughput%2520format%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D92%26spage%3D110%26epage%3D116%26doi%3D10.1016%2Fj.ejps.2016.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lhNmacS98gOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velcicky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflieger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawtin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppertz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feifel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersperger, R.</span></span> <span> </span><span class="NLM_article-title">Modulating ADME properties by fluorination: MK2 inhibitors with improved oral exposure</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltV2jsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=392-396&author=J.+Velcickyauthor=A.+Schlapbachauthor=R.+Hengauthor=L.+Reveszauthor=D.+Pfliegerauthor=E.+Blumauthor=S.+Hawtinauthor=C.+Huppertzauthor=R.+Feifelauthor=R.+Hersperger&title=Modulating+ADME+properties+by+fluorination%3A+MK2+inhibitors+with+improved+oral+exposure&doi=10.1021%2Facsmedchemlett.8b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral Exposure</span></div><div class="casAuthors">Velcicky, Juraj; Schlapbach, Achim; Heng, Richard; Revesz, Laszlo; Pflieger, Daniel; Blum, Ernst; Hawtin, Stuart; Huppertz, Christine; Feifel, Roland; Hersperger, Rene</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-396</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MAP-activated protein kinase 2 (MK2) plays an important role in the regulation of innate immune response as well as in cell survival upon DNA damage.  Despite its potential for the treatment of inflammation and cancer, to date no MK2 low mol. wt. inhibitors have reached the clinic, mainly due to inadequate absorption, distribution, metab., and excretion (ADME) properties.  We describe here an approach based on specifically placed fluorine within a recently described pyrrole-based MK2 inhibitor scaffold for manipulation of its physicochem. and ADME properties.  While preserving target potency, the novel fluoro-derivs. showed greatly improved permeability as well as enhanced soly. and reduced in vivo clearance leading to significantly increased oral exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDrifcJh5ef7Vg90H21EOLACvtfcHk0lhNmacS98gOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltV2jsLY%253D&md5=6dca69f60838d59b87c90a936682b13a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00098%26sid%3Dliteratum%253Aachs%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DPflieger%26aufirst%3DD.%26aulast%3DBlum%26aufirst%3DE.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHersperger%26aufirst%3DR.%26atitle%3DModulating%2520ADME%2520properties%2520by%2520fluorination%253A%2520MK2%2520inhibitors%2520with%2520improved%2520oral%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D392%26epage%3D396%26doi%3D10.1021%2Facsmedchemlett.8b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, K.</span></span> <span> </span><span class="NLM_article-title">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.2533/chimia.2014.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.2533%2Fchimia.2014.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=25198745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=356-362&author=K.+M%C3%BCller&title=Simple+vector+considerations+to+assess+the+polarity+of+partially+fluorinated+alkyl+and+alkoxy+groups&doi=10.2533%2Fchimia.2014.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span></div><div class="casAuthors">Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-362</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  While H/F exchange at aryl groups or introduction of CF3 units have dominated medicinal chem. for decades, the use of partially fluorinated alkyl and alkoxy groups has come into focus more recently.  A simple bond vector anal. scheme, based on the assumption of context-independent bond polarities as well as idealized configurational and conformational geometries, is applied to small alkyl and alkoxy groups with prototypic fluorination patterns for qual. assessments of relative polarities as well as polarity modulation by conformational change.  Combined with a const. vol. increase for each hydrogen/fluorine exchange these polarity ests. can be translated into expected lipophilicity shifts (ΔlogP), using a simple parameterization scheme derived from exptl. logP values.  While terminal monofluoro- and gem-difluoromethyl groups in small aliph. units are correctly predicted to show lower lipophilicity compared to their tri- or non-fluorinated congeners, vicinal difluoro and bis-vicinal trifluoro patterns are identified to exhibit significantly lower lipophilicities than their resp. geminal di- and trifluoro substituted counterparts.  The trifluoromethoxy group is diagnosed as an intrinsically lipophilic unit compared to the parent methoxy group.  The difluoromethoxy group is of particular interest as it can easily interconvert between a highly lipophilic and a polar conformation, thus enabling this unit to adjust to polarity changes of the mol. environment.  For di- and trifluoroalkoxy groups, again the vic-difluoro and bis-vic-trifluoro substitution patterns stand out as most promising to keep lipophilicity low.  The 1,3-difluoro pattern next to an ether moiety shows an interesting conformational dependence of polarity, similar to the difluoromethoxy group.  While very qual. in nature, the simple bond vector anal. promises to be a useful tool for the identification of lipophilicity-lowering fluorinated alkyl or alkoxy groups and particularly those groups that display marked conformation-dependent lipophilicity and thus potentially serve as 'environmental adaptors'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yZ2IogEjkrVg90H21EOLACvtfcHk0ljtzE9kJELPww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI&md5=073bd4a2d1d9dcc5f1540296263dda62</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.356%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DSimple%2520vector%2520considerations%2520to%2520assess%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520alkyl%2520and%2520alkoxy%2520groups%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D356%26epage%3D362%26doi%3D10.2533%2Fchimia.2014.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecours, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillion, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keddie, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, T. B.</span></span> <span> </span><span class="NLM_article-title">Janus face aspect of all-cis 1,2,3,4,5,6-hexafluorocyclohexane dictates remarkable anion and cation interactions in the gas phase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">7460</span>– <span class="NLM_lpage">7463</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b02856</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b02856" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=7460-7463&author=B.+E.+Zieglerauthor=M.+Lecoursauthor=R.+A.+Martaauthor=J.+Featherstoneauthor=E.+Fillionauthor=W.+S.+Hopkinsauthor=V.+Steinmetzauthor=N.+S.+Keddieauthor=D.+O%E2%80%99Haganauthor=T.+B.+McMahon&title=Janus+face+aspect+of+all-cis+1%2C2%2C3%2C4%2C5%2C6-hexafluorocyclohexane+dictates+remarkable+anion+and+cation+interactions+in+the+gas+phase&doi=10.1021%2Fjacs.6b02856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Janus Face Aspect of All-cis 1,2,3,4,5,6-Hexafluorocyclohexane Dictates Remarkable Anion and Cation Interactions In the Gas Phase</span></div><div class="casAuthors">Ziegler, Blake E.; Lecours, Michael; Marta, Rick A.; Featherstone, Joshua; Fillion, Eric; Hopkins, W. Scott; Steinmetz, Vincent; Keddie, Neil S.; O'Hagan, David; McMahon, Terrance B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7460-7463</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Expts. were carried out in which electrospray ionization was used to generate ionic complexes of all-cis-1,2,3,4,5,6-hexafluorocyclohexane.  These complexes were subsequently mass isolated in a quadrupole ion trap mass spectrometer and then irradiated by the tunable IR output of a free electron laser in the 800-1600 cm-1 range.  From the frequency dependence of the fragmentation of the complexes, vibrational signatures of the complexes were obtained.  Computational work carried out in parallel reveals that the complexes formed are very strongly bound and are among the most strongly bound complexes of Na+ and Cl- ever obsd. with mol. species.  The dipole moment calcd. for the heaxafluorocyclohexane is very large (∼7 D), and apparently the bonding in each of the complexes has a significant electrostatic contribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOcxldRsWtLVg90H21EOLACvtfcHk0ljtzE9kJELPww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCmurY%253D&md5=cc190a84a0a188ba31223d86e68ebfdf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b02856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b02856%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DB.%2BE.%26aulast%3DLecours%26aufirst%3DM.%26aulast%3DMarta%26aufirst%3DR.%2BA.%26aulast%3DFeatherstone%26aufirst%3DJ.%26aulast%3DFillion%26aufirst%3DE.%26aulast%3DHopkins%26aufirst%3DW.%2BS.%26aulast%3DSteinmetz%26aufirst%3DV.%26aulast%3DKeddie%26aufirst%3DN.%2BS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%26aulast%3DMcMahon%26aufirst%3DT.%2BB.%26atitle%3DJanus%2520face%2520aspect%2520of%2520all-cis%25201%252C2%252C3%252C4%252C5%252C6-hexafluorocyclohexane%2520dictates%2520remarkable%2520anion%2520and%2520cation%2520interactions%2520in%2520the%2520gas%2520phase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D7460%26epage%3D7463%26doi%3D10.1021%2Fjacs.6b02856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainolfi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jendza, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solovay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prentiss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradoux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Erkenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogi, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and preclinical characterization of selective Factor D inhibitors targeting the alternative complement pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4656</span>– <span class="NLM_lpage">4668</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00271</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00271" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnslalsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4656-4668&author=R.+G.+Karkiauthor=J.+Powersauthor=N.+Mainolfiauthor=K.+Andersonauthor=D.+B.+Belangerauthor=D.+Liuauthor=N.+Jiauthor=K.+Jendzaauthor=C.+F.+Gelinauthor=A.+Mac+Sweeneyauthor=C.+Solovayauthor=O.+Delgadoauthor=M.+Crowleyauthor=S.+M.+Liaoauthor=U.+A.+Argikarauthor=S.+Flohrauthor=L.+R.+La+Bonteauthor=E.+L.+Lorthioisauthor=A.+Vulpettiauthor=A.+Brownauthor=D.+Longauthor=M.+Prentissauthor=N.+Gradouxauthor=A.+de+Erkenezauthor=F.+Cuminauthor=C.+Adamsauthor=B.+Jaffeeauthor=M.+Mogi&title=Design%2C+synthesis%2C+and+preclinical+characterization+of+selective+Factor+D+inhibitors+targeting+the+alternative+complement+pathway&doi=10.1021%2Facs.jmedchem.9b00271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway</span></div><div class="casAuthors">Karki, Rajeshri G.; Powers, James; Mainolfi, Nello; Anderson, Karen; Belanger, David B.; Liu, Donglei; Ji, Nan; Jendza, Keith; Gelin, Christine F.; Mac Sweeney, Aengus; Solovay, Catherine; Delgado, Omar; Crowley, Maura; Liao, Sha-Mei; Argikar, Upendra A.; Flohr, Stefanie; La Bonte, Laura R.; Lorthiois, Edwige L.; Vulpetti, Anna; Brown, Ann; Long, Debby; Prentiss, Melissa; Gradoux, Nathalie; de Erkenez, Andrea; Cumin, Frederic; Adams, Christopher; Jaffee, Bruce; Mogi, Muneto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4656-4668</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system.  Dysregulation of AP activity predisposes individuals to diverse disorders such as age-related macular degeneration, atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis type II, and paroxysmal nocturnal hemoglobinuria.  Previously, the authors have reported the screening efforts and identification of reversible benzylamine-based FD inhibitors (I and II) binding to the open active conformation of FD.  In continuation of the authors' drug discovery program, the authors designed compds. applying structure-based approaches to improve interactions with FD and gain selectivity against S1 serine proteases.  The authors report herein the design, synthesis, and medicinal chem. optimization of the benzylamine series culminating in the discovery of (S)-2-(2-((3'-(1-Amino-2-hydroxyethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic acid, an orally bioavailable and selective FD inhibitor.  (S)-2-(2-((3'-(1-Amino-2-hydroxyethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic acid demonstrated systemic suppression of AP activation in a lipopolysaccharide-induced AP activation model as well as local ocular suppression in intravitreal injection-induced AP activation model in mice expressing human FD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov5uolWfBzK7Vg90H21EOLACvtfcHk0ljtzE9kJELPww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnslalsbw%253D&md5=a4a56886a758093516952737306a5d8a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00271%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DR.%2BG.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DMainolfi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DBelanger%26aufirst%3DD.%2BB.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DN.%26aulast%3DJendza%26aufirst%3DK.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DSolovay%26aufirst%3DC.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DCrowley%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DLorthiois%26aufirst%3DE.%2BL.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DD.%26aulast%3DPrentiss%26aufirst%3DM.%26aulast%3DGradoux%26aufirst%3DN.%26aulast%3Dde%2BErkenez%26aufirst%3DA.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DMogi%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preclinical%2520characterization%2520of%2520selective%2520Factor%2520D%2520inhibitors%2520targeting%2520the%2520alternative%2520complement%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4656%26epage%3D4668%26doi%3D10.1021%2Facs.jmedchem.9b00271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roache, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes-Seeman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvadie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiering, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihofen, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perruccio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dentel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zessis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis-Symynkywicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghausen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruedisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C. M.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and pre-clinical characterization of selective and orally bioavailable Factor XIa inhibitors: Demonstrating the power of an integrated S1 protease family approach in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8113</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFymu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8088-8113&author=E.+Lorthioisauthor=J.+Roacheauthor=D.+Barnes-Seemanauthor=E.+Altmannauthor=U.+Hassiepenauthor=G.+Turnerauthor=R.+Duvadieauthor=V.+Hornakauthor=R.+G.+Karkiauthor=N.+Schieringauthor=W.+A.+Weihofenauthor=F.+Perruccioauthor=A.+Calhounauthor=T.+Fazalauthor=D.+Dedicauthor=C.+Durandauthor=S.+Dussaugeauthor=K.+Fettisauthor=F.+Tritschauthor=C.+Dentelauthor=A.+Druetauthor=D.+Liuauthor=L.+Kirmanauthor=J.+Lachalauthor=K.+Namotoauthor=D.+Bevanauthor=R.+Moauthor=G.+Monnetauthor=L.+Mullerauthor=R.+Zessisauthor=X.+Huangauthor=L.+Lindsleyauthor=T.+Currieauthor=Y.-H.+Chiuauthor=C.+Fridrichauthor=P.+Delgadoauthor=S.+Wangauthor=M.+Hollis-Symynkywiczauthor=J.+Berghausenauthor=E.+Williamsauthor=H.+Liuauthor=G.+Liangauthor=H.+Kimauthor=P.+Hoffmannauthor=A.+Heinauthor=P.+Ramageauthor=A.+D%E2%80%99Arcyauthor=S.+Harlfingerauthor=M.+Renatusauthor=S.+Ruedisserauthor=D.+Feldmanauthor=J.+Elliottauthor=R.+Sedraniauthor=J.+Maibaumauthor=C.+M.+Adams&title=Structure-based+design+and+pre-clinical+characterization+of+selective+and+orally+bioavailable+Factor+XIa+inhibitors%3A+Demonstrating+the+power+of+an+integrated+S1+protease+family+approach+in+drug+discovery&doi=10.1021%2Facs.jmedchem.0c00279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach</span></div><div class="casAuthors">Lorthiois, Edwige; Roache, James; Barnes-Seeman, David; Altmann, Eva; Hassiepen, Ulrich; Turner, Gordon; Duvadie, Rohit; Hornak, Viktor; Karki, Rajeshri G.; Schiering, Nikolaus; Weihofen, Wilhelm A.; Perruccio, Francesca; Calhoun, Amy; Fazal, Tanzina; Dedic, Darija; Durand, Corinne; Dussauge, Solene; Fettis, Kamal; Tritsch, Fabien; Dentel, Celine; Druet, Adelaide; Liu, Donglei; Kirman, Louise; Lachal, Julie; Namoto, Kenji; Bevan, Douglas; Mo, Rose; Monnet, Gabriela; Muller, Lionel; Zessis, Richard; Huang, Xueming; Lindsley, Loren; Currie, Treeve; Chiu, Yu-Hsin; Fridrich, Cary; Delgado, Peter; Wang, Shuangxi; Hollis-Symynkywicz, Micah; Berghausen, Joerg; Williams, Eric; Liu, Hong; Liang, Guiqing; Kim, Hyungchul; Hoffmann, Peter; Hein, Andreas; Ramage, Paul; D'Arcy, Allan; Harlfinger, Stefanie; Renatus, Martin; Ruedisser, Simon; Feldman, David; Elliott, Jason; Sedrani, Richard; Maibaum, Juergen; Adams, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8088-8113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The serine protease factor XI (FXI) is a prominent drug target as it holds promise to deliver efficacious anticoagulation without an enhanced risk of major bleeds.  Several efforts have been described targeting the active form of the enzyme, FXIa.  Herein, we disclose our efforts to identify potent, selective, and orally bioavailable inhibitors of FXIa.  Compd. 1, identified from a diverse library of internal serine protease inhibitors, was originally designed as a complement factor D inhibitor and exhibited submicromolar FXIa activity and an encouraging absorption, distribution, metab., and excretion (ADME) profile while being devoid of a peptidomimetic architecture.  Optimization of interactions in the S1, S1β, and S1' pockets of FXIa through a combination of structure-based drug design and traditional medicinal chem. led to the discovery of compd. 23 with subnanomolar potency on FXIa, enhanced selectivity over other coagulation proteases, and a preclin. pharmacokinetics (PK) profile consistent with bid dosing in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrysqlO_YjosbVg90H21EOLACvtfcHk0lgUQZYafsLv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFymu7%252FO&md5=e2b187ccf8c81b83acd31db1320842bc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00279%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DRoache%26aufirst%3DJ.%26aulast%3DBarnes-Seeman%26aufirst%3DD.%26aulast%3DAltmann%26aufirst%3DE.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DTurner%26aufirst%3DG.%26aulast%3DDuvadie%26aufirst%3DR.%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DKarki%26aufirst%3DR.%2BG.%26aulast%3DSchiering%26aufirst%3DN.%26aulast%3DWeihofen%26aufirst%3DW.%2BA.%26aulast%3DPerruccio%26aufirst%3DF.%26aulast%3DCalhoun%26aufirst%3DA.%26aulast%3DFazal%26aufirst%3DT.%26aulast%3DDedic%26aufirst%3DD.%26aulast%3DDurand%26aufirst%3DC.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DTritsch%26aufirst%3DF.%26aulast%3DDentel%26aufirst%3DC.%26aulast%3DDruet%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DKirman%26aufirst%3DL.%26aulast%3DLachal%26aufirst%3DJ.%26aulast%3DNamoto%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DD.%26aulast%3DMo%26aufirst%3DR.%26aulast%3DMonnet%26aufirst%3DG.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DZessis%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLindsley%26aufirst%3DL.%26aulast%3DCurrie%26aufirst%3DT.%26aulast%3DChiu%26aufirst%3DY.-H.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DDelgado%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHollis-Symynkywicz%26aufirst%3DM.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DHein%26aufirst%3DA.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DHarlfinger%26aufirst%3DS.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DRuedisser%26aufirst%3DS.%26aulast%3DFeldman%26aufirst%3DD.%26aulast%3DElliott%26aufirst%3DJ.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26atitle%3DStructure-based%2520design%2520and%2520pre-clinical%2520characterization%2520of%2520selective%2520and%2520orally%2520bioavailable%2520Factor%2520XIa%2520inhibitors%253A%2520Demonstrating%2520the%2520power%2520of%2520an%2520integrated%2520S1%2520protease%2520family%2520approach%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8088%26epage%3D8113%26doi%3D10.1021%2Facs.jmedchem.0c00279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüdisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and design of first benzylamine-based ligands binding to an unlocked conformation of the Complement Factor D</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00104</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00104" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=490-495&author=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=T.+Yoonauthor=A.+Mac+Sweeneyauthor=F.+Cuminauthor=E.+Lorthioisauthor=S.+R%C3%BCdisserauthor=P.+Erbelauthor=J.+Maibaum&title=Discovery+and+design+of+first+benzylamine-based+ligands+binding+to+an+unlocked+conformation+of+the+Complement+Factor+D&doi=10.1021%2Facsmedchemlett.8b00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D</span></div><div class="casAuthors">Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Yoon, Taeyoung; MacSweeney, Aengus; Cumin, Frederic; Lorthiois, Edwige; Rudisser, Simon; Erbel, Paul; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complement Factor D, a serine protease of the S1 family and key component of the alternative pathway amplification loop, represents a promising target for the treatment of several prevalent and rare diseases linked to the innate immune system.  Previously reported FD inhibitors have been shown to bind to the FD active site in its self-inhibited conformation characterized by the presence of a salt bridge at the bottom of the S1 pocket between Asp189 and Arg218.  We report herein a new set of small-mol. FD ligands that harbor a basic S1 binding moiety directly binding to the carboxylate of Asp189, thereby displacing the Asp189-Arg218 ionic interaction and significantly changing the conformation of the self-inhibitory loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRdpNj9LCQYrVg90H21EOLACvtfcHk0lhUBQ7fiwOO1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D&md5=c24dccac197253f882e3a38a86a597ed</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00104%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DR%25C3%25BCdisser%26aufirst%3DS.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520design%2520of%2520first%2520benzylamine-based%2520ligands%2520binding%2520to%2520an%2520unlocked%2520conformation%2520of%2520the%2520Complement%2520Factor%2520D%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D490%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.8b00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmonson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastracchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colwell, L. F.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habulihaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E. R.</span></span> <span> </span><span class="NLM_article-title">Potent and selective proline derived dipeptidyl peptidase IV inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5151</span>– <span class="NLM_lpage">5155</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.07.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.bmcl.2004.07.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=15380217" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5151-5155&author=S.+D.+Edmonsonauthor=A.+Mastracchioauthor=M.+Beconiauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=S.+Kumarauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=A.+Maoauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Potent+and+selective+proline+derived+dipeptidyl+peptidase+IV+inhibitors&doi=10.1016%2Fj.bmcl.2004.07.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.07.056%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonson%26aufirst%3DS.%2BD.%26aulast%3DMastracchio%26aufirst%3DA.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DPotent%2520and%2520selective%2520proline%2520derived%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5151%26epage%3D5155%26doi%3D10.1016%2Fj.bmcl.2004.07.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathvink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2533</span>– <span class="NLM_lpage">2536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.bmcl.2005.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=15863311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2533-2536&author=J.+Xuauthor=L.+Weiauthor=R.+Mathvinkauthor=J.+Heauthor=Y.+J.+Parkauthor=H.+Heauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Discovery+of+potent+and+selective+phenylalanine+based+dipeptidyl+peptidase+IV+inhibitors&doi=10.1016%2Fj.bmcl.2005.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Xu, Jinyou; Wei, Lan; Mathvink, Robert; He, Jiafang; Park, You-Jung; He, Huaibing; Leiting, Barbara; Lyons, Kathryn A.; Marsilio, Frank; Patel, Reshma A.; Wu, Joseph K.; Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2533-2536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anti-Substituted β-methylphenylalanine derived amides have been shown to be potent DPP-IV inhibitors exhibiting excellent selectivity over both DPP8 and DPP9.  These are among the most potent compds. reported to date lacking an electrophilic trap.  The most potent compd. among these is 5-oxo-1,2,4-oxadiazole I, which is a 3 nM DPP-IV inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRQ1sHQJH4ebVg90H21EOLACvtfcHk0lhUBQ7fiwOO1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D&md5=14bb621ee7b95eb2e00ac0bd5c8c99eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520phenylalanine%2520based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2533%26epage%3D2536%26doi%3D10.1016%2Fj.bmcl.2005.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caudana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span> <span> </span><span class="NLM_article-title">Permeability prediction for zwitterions via chromatographic indexes and classification into ‘certain’ and ‘uncertain’</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1553</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.4155/fmc-2019-0071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.4155%2Ffmc-2019-0071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=31240942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1553-1563&author=F.+Caudanaauthor=G.+Ermondiauthor=M.+Vallaroauthor=M.+Shalaevaauthor=G.+Caron&title=Permeability+prediction+for+zwitterions+via+chromatographic+indexes+and+classification+into+%E2%80%98certain%E2%80%99+and+%E2%80%98uncertain%E2%80%99&doi=10.4155%2Ffmc-2019-0071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Permeability prediction for zwitterions via chromatographic indexes and classification into 'certain' and 'uncertain'</span></div><div class="casAuthors">Caudana, Francesco; Ermondi, Giuseppe; Vallaro, Maura; Shalaeva, Marina; Caron, Giulia</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1553-1563</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: The development of zwitterions to a drug is likely to be more challenging than compds. of other charge types.  Results: Two chromatog. indexes (log k'80 PLRP-S and log KWIAM) can be successfully used as permeability classifiers of ampholytes.  Moreover, a pragmatic classification into ordinary ampholytes; zwitterions 'certain' (i.e., the zwitterionic species is dominant in the physiol. pH range); and zwitterions 'uncertain' (multiple species are present in the physiol. pH range) enables to study the permeability of ampholytic compds. in relation to species distribution.  Methodol.: Potentiometry (pKa), reversed-phase (RP)-chromatog., tri-layer parallel artificial membrane permeability assays, quant. structure-property relationships (QSPR) and block relevance (BR) anal., receiver operating characteristic (ROC) curves.  Conclusion: Structures considered as poorly permeable like zwitterions can be integrated in drug discovery programs by applying ad hoc exptl. and computational tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohpo5wES8SnrVg90H21EOLACvtfcHk0lhUBQ7fiwOO1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtrzF&md5=3da20dc0eb7f47762ec64f0fa639061b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2019-0071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2019-0071%26sid%3Dliteratum%253Aachs%26aulast%3DCaudana%26aufirst%3DF.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DVallaro%26aufirst%3DM.%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DG.%26atitle%3DPermeability%2520prediction%2520for%2520zwitterions%2520via%2520chromatographic%2520indexes%2520and%2520classification%2520into%2520%25E2%2580%2598certain%25E2%2580%2599%2520and%2520%25E2%2580%2598uncertain%25E2%2580%2599%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D1553%26epage%3D1563%26doi%3D10.4155%2Ffmc-2019-0071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.-S.</span></span> <span> </span><span class="NLM_article-title">Plasma protein binding: from discovery to development</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">2953</span>– <span class="NLM_lpage">2994</span>, <span class="refDoi"> DOI: 10.1002/jps.23614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2Fjps.23614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=23798314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=2953-2994&author=T.+Bohnertauthor=L.-S.+Gan&title=Plasma+protein+binding%3A+from+discovery+to+development&doi=10.1002%2Fjps.23614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma protein binding: From discovery to development</span></div><div class="casAuthors">Bohnert, Tonika; Gan, Liang-Shang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2953-2994</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The importance of plasma protein binding (PPB) in modulating the effective drug concn. at pharmacol. target sites has been the topic of significant discussion and debate amongst drug development groups over the past few decades.  Free drug theory, which states that in absence of energy-dependent processes, after steady state equil. has been attained, free drug concn. in plasma is equal to free drug concn. at the pharmacol. target receptor(s) in tissues, has been used to explain pharmacokinetics/pharmacodynamics relationships in a large no. of cases.  Any sudden increase in free concn. of a drug could potentially cause toxicity and may need dose adjustment.  Free drug concn. is also helpful to est. the effective concn. of drugs that potentially can ppt. metab. (or transporter)-related drug-drug interactions.  Disease models are extensively validated in animals to progress a compd. into development.  Unbound drug concn., and therefore PPB information across species is very informative in establishing safety margins and guiding selection of First in Human (FIH) dose and human efficacious dose.  The scope of this review is to give an overview of reported role of PPB in several therapeutic areas, highlight cases where PPB changes are clin. relevant, and provide drug metab. and pharmacokinetics recommendations in discovery and development settings. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqobJp8eG98XrVg90H21EOLACvtfcHk0lh6xlDq76Grbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D&md5=d676f7490c6e0f09c8acf7cce5183b17</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.23614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23614%26sid%3Dliteratum%253Aachs%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DGan%26aufirst%3DL.-S.%26atitle%3DPlasma%2520protein%2520binding%253A%2520from%2520discovery%2520to%2520development%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D2953%26epage%3D2994%26doi%3D10.1002%2Fjps.23614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span> <span> </span><span class="NLM_article-title">Zwitterionic structures: from physicochemical properties toward computer-aided drug designs</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2262</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.4155%2Ffmc-2016-0176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=27874291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCjsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=2245-2262&author=Z.+Yangauthor=Q.+Liauthor=G.+Yang&title=Zwitterionic+structures%3A+from+physicochemical+properties+toward+computer-aided+drug+designs&doi=10.4155%2Ffmc-2016-0176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Zwitterionic structures: from physicochemical properties toward computer-aided drug designs</span></div><div class="casAuthors">Yang, Zhiwei; Li, Qinyi; Yang, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2245-2262</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Zwitterions, used widely in chem., biol. and medicinal fields, show distinct physicochem. properties relative to ordinary ampholytes, which largely decide their bioavailability and biol. activities.  In the present manuscript, these properties are discussed in order to facilitate our understanding of zwitterionic structures, followed by various examples of zwitterionic drugs and the crit. role these properties play.  We specifically focus our discussions on neuraminidase inhibitors (NAIs), which are used in the treatment and prevention of influenza, covering their computer-assisted design, transformation to zwitterionic isomers and interaction mechanisms of NAIs with proteins.  The discovery and development of NAIs provide useful insights that may assist in the exploration of new zwitterionic drugs.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxfDWrce1a7Vg90H21EOLACvtfcHk0lh6xlDq76Grbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCjsLbE&md5=66a234e03eedf85e908515e9cd43b181</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0176%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%26atitle%3DZwitterionic%2520structures%253A%2520from%2520physicochemical%2520properties%2520toward%2520computer-aided%2520drug%2520designs%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D2245%26epage%3D2262%26doi%3D10.4155%2Ffmc-2016-0176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berellini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span> <span> </span><span class="NLM_article-title">Benefit of retraining pKa models studied using internally measured data</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1449-1459&author=P.+Gedeckauthor=Y.+Luauthor=S.+Skolnikauthor=S.+Roddeauthor=G.+Dollingerauthor=W.+Jiaauthor=G.+Berelliniauthor=R.+Vianelloauthor=B.+Fallerauthor=F.+Lombardo&title=Benefit+of+retraining+pKa+models+studied+using+internally+measured+data&doi=10.1021%2Facs.jcim.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of Retraining pKa Models Studied Using Internally Measured Data</span></div><div class="casAuthors">Gedeck, Peter; Lu, Yipin; Skolnik, Suzanne; Rodde, Stephane; Dollinger, Gavin; Jia, Weiping; Berellini, Giuliano; Vianello, Riccardo; Faller, Bernard; Lombardo, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ionization state of drugs influences many pharmaceutical properties such as their soly., permeability, and biol. activity.  It is therefore important to understand the structure property relation for the acid-base dissocn. const. pKa during the lead optimization process to make better-informed design decisions.  Computational approaches, such as implemented in MoKa, can help with this; however, they often predict with too large error esp. for proprietary compds.  In this contribution, the authors look at how retraining helps to greatly improve prediction error.  Using a longitudinal study with data measured over 15 years in a drug discovery environment, the authors assess the impact of model training on prediction accuracy and look at model degrdn. over time.  Using the MoKa software, regular retraining is required to address changes in chem. space leading to model degrdn. over six to nine months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCUz-ylPu6bVg90H21EOLACvtfcHk0lh6xlDq76Grbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ&md5=6a178b50d5ac0a597391cc2b19af8e32</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DDollinger%26aufirst%3DG.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DBenefit%2520of%2520retraining%2520pKa%2520models%2520studied%2520using%2520internally%2520measured%2520data%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D1449%26epage%3D1459%26doi%3D10.1021%2Facs.jcim.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsinman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, N.</span></span> <span> </span><span class="NLM_article-title">The permeation of amphoteric drugs through artificial membranes - An in combo absorption model based on paracellular and transmembrane permeability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1021/jm901421c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901421c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2hurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=392-401&author=K.+Y.+Tamauthor=A.+Avdeefauthor=O.+Tsinmanauthor=N.+Sun&title=The+permeation+of+amphoteric+drugs+through+artificial+membranes+-+An+in+combo+absorption+model+based+on+paracellular+and+transmembrane+permeability&doi=10.1021%2Fjm901421c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The Permeation of Amphoteric Drugs through Artificial Membranes - An in Combo Absorption Model Based on Paracellular and Transmembrane Permeability</span></div><div class="casAuthors">Tam, Kin Y.; Avdeef, Alex; Tsinman, Oksana; Sun, Na</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The permeability characteristics of 33 amphoteric drugs (about 64% zwitterions at physiol. pH) were studied using the parallel artificial membrane permeability assay (PAMPA) at pH 6.5.  The PAMPA data were modified to include the paracellular permeability component found in cellular monolayers based on a newly generalized version of a popular model devised for Caco-2 cells.  These "in combo" PAMPA data were used to predict the human abs. bioavailability of the ampholytes.  The anal. produced a good fit, with only five outliers whose transport properties, could be rationalized by (a) nonpassive permeability processes, (b) metabolic instability, and (c) the possible sensitivity to microclimate pH effects in the case of acidic ampholytes.  With the exception of two compds., all of the ampholytes with bioavailability <50% were predominantly transported by the paracellular route, surprisingly with several of the compds. having mol. wts. exceeding 350 Da.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAna98uyyUs7Vg90H21EOLACvtfcHk0liGDAu4Nyc-gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2hurjO&md5=93344e87f7a783144a1f57bcafbfa6ca</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901421c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901421c%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DTsinman%26aufirst%3DO.%26aulast%3DSun%26aufirst%3DN.%26atitle%3DThe%2520permeation%2520of%2520amphoteric%2520drugs%2520through%2520artificial%2520membranes%2520-%2520An%2520in%2520combo%2520absorption%2520model%2520based%2520on%2520paracellular%2520and%2520transmembrane%2520permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D392%26epage%3D401%26doi%3D10.1021%2Fjm901421c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoermer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Orally absorbed cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">8094</span>– <span class="NLM_lpage">8128</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00838</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=8094-8128&author=D.+S.+Nielsenauthor=N.+E.+Shepherdauthor=W.+Xuauthor=A.+J.+Luckeauthor=M.+J.+Stoermerauthor=D.+P.+Fairlie&title=Orally+absorbed+cyclic+peptides&doi=10.1021%2Facs.chemrev.6b00838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Absorbed Cyclic Peptides</span></div><div class="casAuthors">Nielsen, Daniel S.; Shepherd, Nicholas E.; Xu, Weijun; Lucke, Andrew J.; Stoermer, Martin J.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8094-8128</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptides and proteins are not orally bioavailable in mammals, although a few peptides are intestinally absorbed in small amts.  Polypeptides are generally too large and polar to passively diffuse through lipid membranes, while most known active transport mechanisms facilitate cell uptake of only very small peptides.  Systematic evaluations of peptides with mol. wts. above 500 Da are needed to identify parameters that influence oral bioavailability.  Here we describe 125 cyclic peptides contg. four to thirty-seven amino acids that are orally absorbed by mammals.  Cyclization minimizes degrdn. in the gut, blood and tissues by removing cleavable N- and C-termini and by shielding components from metabolic enzymes.  Cyclization also folds peptides into bioactive conformations that det. exposure of polar atoms to solvation by water and lipids, and therefore should influence oral bioavailability.  Key chem. properties thought to influence oral absorption and bioavailability are analyzed, including mol. wt., octanol-water partitioning, hydrogen bond donors/acceptors, rotatable bonds and polar surface area.  The cyclic peptides violated to different degrees all of the limits traditionally considered to be important for oral bioavailability of drug-like small mols., although fewer hydrogen bond donors and reduced flexibility generally favored oral absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHf1YVkf7ErVg90H21EOLACvtfcHk0liGDAu4Nyc-gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D&md5=38af1945471e5ddffd3ae630ebbe129b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00838%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DD.%2BS.%26aulast%3DShepherd%26aufirst%3DN.%2BE.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLucke%26aufirst%3DA.%2BJ.%26aulast%3DStoermer%26aufirst%3DM.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DOrally%2520absorbed%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D8094%26epage%3D8128%26doi%3D10.1021%2Facs.chemrev.6b00838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussinov, R.</span></span> <span> </span><span class="NLM_article-title">Close-range electrostatic interactions in proteins</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">604</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=12324994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1Kmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=604-617&author=S.+Kumarauthor=R.+Nussinov&title=Close-range+electrostatic+interactions+in+proteins&doi=10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Close-range electrostatic interactions in proteins</span></div><div class="casAuthors">Kumar, Sandeep; Nussinov, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">604-617</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review with 59 refs.  Two types of noncovalent bonding interactions are present in protein structures, specific and nonspecific.  Nonspecific interactions are mostly hydrophobic and van der Waals.  Specific interactions are largely electrostatic.  Whereas the hydrophobic effect is the major driving force in protein folding, electrostatic interactions are important in protein folding, stability, flexibility, and function.  Here, the authors review the role of close-range electrostatic interactions (salt bridges) and their networks in proteins.  Salt bridges are formed by spatially proximal pairs of oppositely charged residues in native protein structures.  Often salt-bridging residues are also close in the protein sequence and fall in the same secondary structural element, building block, autonomous folding unit, domain, or subunit, consistent with the hierarchical model for protein folding.  Recent evidence also suggests that charged and polar residues in largely hydrophobic interfaces may act as hot spots for binding.  Salt bridges are rarely found across protein parts which are joined by flexible hinges, a fact suggesting that salt bridges constrain flexibility and motion.  Whereas conventional chem. intuition expects that salt bridges contribute favorably to protein stability, recent computational and exptl. evidence shows that salt bridges can be either stabilizing or destabilizing.  Due to systemic protein flexibility, reflected in small-scale side-chain and backbone atom motions, salt bridges and their stabilities fluctuate in proteins.  At the same time, genome-wide, amino acid sequence compn., structural, and thermodn. comparisons of thermophilic and mesophilic proteins indicate that specific interactions, such as salt bridges, may contribute significantly toward the thermophilic-mesophilic protein stability differential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRHG8yeknSJLVg90H21EOLACvtfcHk0liGDAu4Nyc-gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1Kmtbw%253D&md5=ca8b51ea594b21580d716f3efe9cf92b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820020703%25293%253A7%253C604%253A%253AAID-CBIC604%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DNussinov%26aufirst%3DR.%26atitle%3DClose-range%2520electrostatic%2520interactions%2520in%2520proteins%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D604%26epage%3D617%26doi%3D10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1707</span>– <span class="NLM_lpage">1729</span>, <span class="refDoi"> DOI: 10.1002/med.21562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2Fmed.21562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=30659634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1707-1729&author=G.+Caronauthor=J.+Kihlbergauthor=G.+Ermondi&title=Intramolecular+hydrogen+bonding%3A+An+opportunity+for+improved+design+in+medicinal+chemistry&doi=10.1002%2Fmed.21562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry</span></div><div class="casAuthors">Caron, Giulia; Kihlberg, Jan; Ermondi, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1707-1729</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Recent literature shows that intramol. hydrogen bond (IMHB) formation can pos. impact upon the triad of permeability, soly., and potency of drugs and candidates.  IMHB modulation can be applied to compds. in any chem. space as a means for discovering drug candidates with both acceptable potency and absorption, distribution, metab., and excretion-Tox profiles.  Integrating IMHB formation in design of drugs is, therefore, an exciting and timely challenge for modern medicinal chem.  In this review, we first provide some background about IMHBs from the medicinal chemist's point of view and highlight some IMHB-assocd. misconceptions.  Second, we propose a classification of IMHBs for drug discovery purposes, review the most common in silico tactics to include IMHBs in lead optimization and list some exptl. physicochem. descriptors, which quantify the propensity of compds. to form IMHBs.  By focusing on the compds. size and the no. of IMHBs that can potentially be formed, we also outline the major difficulties encountered when designing compds. based on the inclusion of IMHBs.  Finally, we discuss recent case studies illustrating the application of IMHB to optimize cell permeability and physicochem. properties of small mols., cyclic peptides and macrocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUDeUtYxxbaLVg90H21EOLACvtfcHk0liGDAu4Nyc-gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnF&md5=8c0b208b54443ac2ebe6f241183e5348</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fmed.21562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21562%26sid%3Dliteratum%253Aachs%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DKihlberg%26aufirst%3DJ.%26aulast%3DErmondi%26aufirst%3DG.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%253A%2520An%2520opportunity%2520for%2520improved%2520design%2520in%2520medicinal%2520chemistry%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1707%26epage%3D1729%26doi%3D10.1002%2Fmed.21562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1021/ci7002494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.+A.+Brameldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis&doi=10.1021%2Fci7002494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule conformational preferences derived from crystal structure data. a medicinal chemistry focused analysis</span></div><div class="casAuthors">Brameld, Ken A.; Kuhn, Bernd; Reuter, Deborah C.; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Based on torsion angle distributions of frequently occurring substructures, conformation preferences of druglike mols. are presented, accompanied by a review of the relevant literature.  First, the relevance of the Cambridge Structural Database (CSD) for drug design is demonstrated by comparing substructures present in compds. entering clin. trials with those found in the CSD and protein-bound ligands in the Protein Data Bank (PDB).  Next, we briefly highlight preferred conformations of elementary acyclic systems, followed by a discussion of sulfonamide conformations.  Due to their central role in medicinal chem., we discuss properties of aryl ring substituents in depth, including biaryl systems and systems of two aryl rings connected by two acyclic bonds.  For a subset of torsion motifs, we also compare torsion angle histograms derived from CSD structures with those derived from ligands in the PDB.  Furthermore, selected properties of some six- and seven-membered ring systems are discussed.  The article closes with a section on attractive sulfur-oxygen contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBrdvMrRvKirVg90H21EOLACvtfcHk0ljh6iPkGuB00g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D&md5=289969338dcb94a145ce736d19d05cf4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24%26doi%3D10.1021%2Fci7002494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vashchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span> <span> </span><span class="NLM_article-title">Unusual structure of a biphenyl fragment: the important role of weak interactions</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1454</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.1107/S2053229619012567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1107%2FS2053229619012567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=31686653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2gtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2019&pages=1454-1458&author=A.+Vashchenkoauthor=V.+Smirnovauthor=N.+Semenovaauthor=E.+Schmidt&title=Unusual+structure+of+a+biphenyl+fragment%3A+the+important+role+of+weak+interactions&doi=10.1107%2FS2053229619012567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual structure of a biphenyl fragment: the important role of weak interactions</span></div><div class="casAuthors">Vashchenko, Alexander; Smirnov, Vladimir; Semenova, Nadezhda; Schmidt, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1454-1458</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">1,5-Bis([1,1'-biphenyl]-4-yl)-5-hydroxy-3-methylheptane-1,6-dione, C32H30O3, was investigated by X-ray anal., quantum chem. calcns. and AIM (atoms in mols.) anal.  It was shown that four intramol. C-H···π forces are established between the two biphenyl fragments.  C-H···π interactions lead to a bending of the biphenyl part.  The energy of the intramol. interactions was estd. and the exclusive role of the moment of force was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx1Y0mN6s4PrVg90H21EOLACvtfcHk0ljh6iPkGuB00g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2gtL%252FI&md5=df57c783b0699409a9cc5606f2f9ebc9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS2053229619012567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229619012567%26sid%3Dliteratum%253Aachs%26aulast%3DVashchenko%26aufirst%3DA.%26aulast%3DSmirnov%26aufirst%3DV.%26aulast%3DSemenova%26aufirst%3DN.%26aulast%3DSchmidt%26aufirst%3DE.%26atitle%3DUnusual%2520structure%2520of%2520a%2520biphenyl%2520fragment%253A%2520the%2520important%2520role%2520of%2520weak%2520interactions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2019%26volume%3D75%26spage%3D1454%26epage%3D1458%26doi%3D10.1107%2FS2053229619012567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1039/c1md00093d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space&doi=10.1039%2Fc1md00093d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674%26doi%3D10.1039%2Fc1md00093d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Udvarhelyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcken, R.</span></span> <span> </span><span class="NLM_article-title">ReSCoSS: A flexible quantum chemistry workflow identifying relevant solution conformers of drug-like molecules</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1007/s10822-020-00337-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1007%2Fs10822-020-00337-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=32803515" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=A.+Udvarhelyiauthor=S.+Roddeauthor=R.+Wilcken&title=ReSCoSS%3A+A+flexible+quantum+chemistry+workflow+identifying+relevant+solution+conformers+of+drug-like+molecules&doi=10.1007%2Fs10822-020-00337-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs10822-020-00337-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-020-00337-7%26sid%3Dliteratum%253Aachs%26aulast%3DUdvarhelyi%26aufirst%3DA.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DWilcken%26aufirst%3DR.%26atitle%3DReSCoSS%253A%2520A%2520flexible%2520quantum%2520chemistry%2520workflow%2520identifying%2520relevant%2520solution%2520conformers%2520of%2520drug-like%2520molecules%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2020%26doi%3D10.1007%2Fs10822-020-00337-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danelius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peintner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieske, L. H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdélyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Solution conformations explain the chameleonic behaviour of macrocyclic drugs</span>. <i>Chem.– Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5231</span>– <span class="NLM_lpage">5244</span>, <span class="refDoi"> DOI: 10.1002/chem.201905599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2Fchem.201905599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=32027758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVWmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=5231-5244&author=E.+Daneliusauthor=V.+Poongavanamauthor=S.+Peintnerauthor=L.+H.+E.+Wieskeauthor=M.+Erd%C3%A9lyiauthor=J.+Kihlberg&title=Solution+conformations+explain+the+chameleonic+behaviour+of+macrocyclic+drugs&doi=10.1002%2Fchem.201905599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Solution conformations explain the chameleonic behaviour of macrocyclic drugs</span></div><div class="casAuthors">Danelius, Emma; Poongavanam, Vasanthanathan; Peintner, Stefan; Wieske, Lianne H. E.; Erdelyi, Mate; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5231-5244</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">It has been hypothesised that drugs in the chem. space "beyond the rule of 5" (bRo5) must behave as mol. chameleons to combine otherwise conflicting properties, including aq. soly., cell permeability and target binding.  Evidence for this has, however, been limited to the cyclic peptide cyclosporine A.  Herein, we show that the non-peptidic and macrocyclic drugs roxithromycin, telithromycin and spiramycin behave as mol. chameleons, with rifampicin showing a less pronounced behavior.  In particular roxithromycin, telithromycin and spiramycin display a marked, yet limited flexibility and populate significantly less polar and more compact conformational ensembles in an apolar than in a polar environment.  In addn. to balancing of membrane permeability and aq. soly., this flexibility also allows binding to targets that vary in structure between species.  The drugs' passive cell permeability correlates to their 3D polar surface area and corroborate two theor. models for permeability, developed for cyclic peptides.  We conclude that mol. chameleonicity should be incorporated in the design of orally administered drugs in the bRo5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJsCKr3Rq-rVg90H21EOLACvtfcHk0ljEiFOuLXpCLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVWmsLo%253D&md5=353528feef6aa1130f8a16204a9f40ce</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fchem.201905599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201905599%26sid%3Dliteratum%253Aachs%26aulast%3DDanelius%26aufirst%3DE.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DPeintner%26aufirst%3DS.%26aulast%3DWieske%26aufirst%3DL.%2BH.%2BE.%26aulast%3DErd%25C3%25A9lyi%26aufirst%3DM.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DSolution%2520conformations%2520explain%2520the%2520chameleonic%2520behaviour%2520of%2520macrocyclic%2520drugs%26jtitle%3DChem.%25E2%2580%2593%2520Eur.%2520J.%26date%3D2020%26volume%3D26%26spage%3D5231%26epage%3D5244%26doi%3D10.1002%2Fchem.201905599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiano, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Impact of dynamically exposed polarity on permeability and solubility of chameleonic drugs beyond the Rule of 5</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4189</span>– <span class="NLM_lpage">4202</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4189-4202&author=M.+R.+Sebastianoauthor=B.+C.+Doakauthor=M.+Backlundauthor=V.+Poongavanamauthor=B.+Overauthor=G.+Ermondiauthor=G.+Caronauthor=P.+Matssonauthor=J.+Kihlberg&title=Impact+of+dynamically+exposed+polarity+on+permeability+and+solubility+of+chameleonic+drugs+beyond+the+Rule+of+5&doi=10.1021%2Facs.jmedchem.8b00347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00347%26sid%3Dliteratum%253Aachs%26aulast%3DSebastiano%26aufirst%3DM.%2BR.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DBacklund%26aufirst%3DM.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520dynamically%2520exposed%2520polarity%2520on%2520permeability%2520and%2520solubility%2520of%2520chameleonic%2520drugs%2520beyond%2520the%2520Rule%2520of%25205%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4189%26epage%3D4202%26doi%3D10.1021%2Facs.jmedchem.8b00347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenda, B.</span>; <span class="NLM_string-name">Quesnel, Y.</span>; <span class="NLM_string-name">Ates, A.</span>; <span class="NLM_string-name">Michel, P.</span>; <span class="NLM_string-name">Turet, L.</span>; <span class="NLM_string-name">Mercier, J.</span></span> <span> </span><span class="NLM_article-title">2-Oxo-1-pyrrolidine derivatives</span>. <span class="NLM_patent">WO2006/128692 A2</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+Kenda&author=Y.+Quesnel&author=A.+Ates&author=P.+Michel&author=L.+Turet&author=J.+Mercier&title=2-Oxo-1-pyrrolidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKenda%26aufirst%3DB.%26atitle%3D2-Oxo-1-pyrrolidine%2520derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swamy, K. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N. N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaraman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. V. P. P.</span></span> <span> </span><span class="NLM_article-title">Mitsunobu and related reactions: advances and applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2651</span>, <span class="refDoi"> DOI: 10.1021/cr800278z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr800278z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVagt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2551-2651&author=K.+C.+K.+Swamyauthor=N.+N.+B.+Kumarauthor=E.+Balaramanauthor=K.+V.+P.+P.+Kumar&title=Mitsunobu+and+related+reactions%3A+advances+and+applications&doi=10.1021%2Fcr800278z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mitsunobu and Related Reactions: Advances and Applications</span></div><div class="casAuthors">Swamy, K. C. Kumara; Kumar, N. N. Bhuvan; Balaraman, E.; Kumar, K. V. P. Pavan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2551-2651</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this review is an attempt to detail the Mitsunobu reaction, along with its modifications, which has been versatile and applicable for a variety of org. transformations.  The ease with which stereochem. at the chiral secondary alc. can be reversed is a valuable asset.  The large no. of publications, particularly in the area of nucleobase alkylation, reflects its popularity, mainly as a result of the mild conditions employed during the reaction.  It is expected that this aspect is going to be much sought after, particularly by the pharmaceutical industry.  Synthetic chemists tend to rely on its various facets, be it natural product synthesis or nucleobase alkylation or etherification.  As far as the future of this reaction is concerned, an efficient and inexpensive way to recycle the reagents or to make the reaction fully catalytic is desirable.  Another aspect worth looking into would be to synthesize a water sol. but degradable phosphine/phosphite of low toxicity, to simplify the purifn. process.  The aforesaid points become important if we desire to employ the Mitsunobu route for large scale synthesis.  Recoverable polymer bound phosphonium salts of type 565 that avoid the wastage of phosphine as well as azodicarboxylate, and hence make the system more atom economical and greener, also need to be considered in the future.  Finally, although a major part of the mechanistic pathways is fairly well understood, the complexity of the initial steps when different P precursors are used is intriguing.  This could also be a fruitful area for a phys. org. chemist to probe in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmJ2PTO4x-17Vg90H21EOLACvtfcHk0ljEiFOuLXpCLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVagt78%253D&md5=f7da5265d707fafe71cb40dea76dc1e9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fcr800278z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800278z%26sid%3Dliteratum%253Aachs%26aulast%3DSwamy%26aufirst%3DK.%2BC.%2BK.%26aulast%3DKumar%26aufirst%3DN.%2BN.%2BB.%26aulast%3DBalaraman%26aufirst%3DE.%26aulast%3DKumar%26aufirst%3DK.%2BV.%2BP.%2BP.%26atitle%3DMitsunobu%2520and%2520related%2520reactions%253A%2520advances%2520and%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2551%26epage%3D2651%26doi%3D10.1021%2Fcr800278z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grzegorz  Krzak</span>, <span class="hlFld-ContribAuthor ">Cory M.  Willis</span>, <span class="hlFld-ContribAuthor ">Jayden A.  Smith</span>, <span class="hlFld-ContribAuthor ">Stefano  Pluchino</span>, <span class="hlFld-ContribAuthor ">Luca  Peruzzotti-Jametti</span>. </span><span class="cited-content_cbyCitation_article-title">Succinate Receptor 1: An Emerging Regulator of Myeloid Cell Function in Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Trends in Immunology</span><span> <strong>2021,</strong> <em>42 </em>
                                    (1)
                                     , 45-58. <a href="https://doi.org/10.1016/j.it.2020.11.004" title="DOI URL">https://doi.org/10.1016/j.it.2020.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.it.2020.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.it.2020.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Immunology%26atitle%3DSuccinate%252BReceptor%252B1%25253A%252BAn%252BEmerging%252BRegulator%252Bof%252BMyeloid%252BCell%252BFunction%252Bin%252BInflammation%26aulast%3DKrzak%26aufirst%3DGrzegorz%26date%3D2021%26volume%3D42%26issue%3D1%26spage%3D45%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known SUCNR1 antagonist <b>1</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and HTS hit (<b>2</b>) to lead (<b>5</b>) optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Crystal structure of <b>8</b> in complex with factor D (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT">6QMT</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The protein is in surface representation, the ligand as well as amino acids/water involved in polar interactions with the ligand are shown as sticks. Yellow: polar interactions between the compound and the protein. Magenta: the distance between the phenyl carbon of <b>8</b> in the <i>para</i>-position to Ser190 side chain equals 3.4 Å. (b) <b>10</b> (yellow sticks) docked in factor D cavity (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT">6QMT</a>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> superimposed on the co-crystal structure of <b>8</b> (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key interactions of amide carbonyl and carboxylate in <b>7</b> with SUCNR1 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RNK">6RNK</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of the hydrochlorides of <b>10</b> (left) and <b>9</b> (right) in the crystal. Hydrogen bonds are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Minimum-energy conformation in water at the TZVPD-FINE19 level for (a) <b>14</b> and (b) <b>15</b> (first row) and associated σ-surfaces (second row). The (<i>R</i>)-enantiomer was modeled for <b>15</b>. The folded conformation observed for <b>15</b> with the intramolecular salt bridge leads to a drastic reduction in the overall polar surface area as quantified by COSMO-3D-PSA.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structure of the hydrochloride of compound <b>20</b> in the crystal. Hydrogen bonds are shown as dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) X-ray crystal structure of <b>20</b> (grey carbons) bound to humanized rat SUCNR1 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10">6Z10</a>) overlaid onto the top-scoring binding pose from docking (green carbons) forming salt bridge interaction with Glu18. (b) Electrostatic potential mapped onto the molecular surface for humanized rat SUCNR1 and (c) for wild-type rat SUCNR1 (model based on PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10">6Z10</a>) showing a large concentration of positively charged amino acid residues flanking the binding site. Calculations were done using the APBS plugin in PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Amide Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><i>Reagents and conditions:</i> (a) Et<sub>3</sub>N or <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 1 h (89–97%); (b) 10% NaOH (aq.), 100 °C, 16 h; (c) THF/H<sub>2</sub>O, 23 °C, 16 h (76–92% over 2 steps); (d) MeOH, HCl, 23 °C, 16 h (86–98%); (e) (PinB)<sub>2</sub>, PdCl<sub>2</sub>dppf, KOAc, dioxane, 110 °C, 2 h (62–94%).</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of C-Ring Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><i>Reagents and conditions:</i> (a) Boc<sub>2</sub>O, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 16 h (83%); (b) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 6 h (91%); (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 16 h (16–72%); (d) Ph<sub>3</sub>P, diisopropyl azodicarboxylate (DIAD), THF, 60 °C, 16 h (42–77%).</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/medium/jm0c01020_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Final Products<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c01020/20200903/images/large/jm0c01020_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01020&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><i>Reagents and conditions:</i> (a) (COCl)<sub>2</sub>, DMF (cat.), CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 2 h, then methyl 2-aminobenzoate, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 20 h (86%); (b) LiOH, H<sub>2</sub>O, MeOH, 50 °C, 3–18 h (45–89%); (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, 80 °C, 16 h (50–92%); (d) PdCl<sub>2</sub>dppf, Na<sub>2</sub>CO<sub>3</sub>, DMF/H<sub>2</sub>O, 80 °C, 0.5 h (87%); (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 4 h (57% over 2 steps); (f) HCl, dioxane/CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 16 h (53–95%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, F. J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D. C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwandner, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L.</span></span> <span> </span><span class="NLM_article-title">Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>429</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1038/nature02488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fnature02488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=15141213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVKgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2004&pages=188-193&author=W.+Heauthor=F.+J.-P.+Miaoauthor=D.+C.-H.+Linauthor=R.+T.+Schwandnerauthor=Z.+Wangauthor=J.+Gaoauthor=J.-L.+Chenauthor=H.+Tianauthor=L.+Ling&title=Citric+acid+cycle+intermediates+as+ligands+for+orphan+G-protein-coupled+receptors&doi=10.1038%2Fnature02488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors</span></div><div class="casAuthors">He, Weihai; Miao, Frederick J.-P.; Lin, Daniel C.-H.; Schwandner, Ralf T.; Wang, Zhulun; Gao, Jinhai; Chen, Jin-Long; Tian, Hui; Ling, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">6988</span>),
    <span class="NLM_cas:pages">188-193</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The citric acid cycle is central to the regulation of energy homeostasis and cell metab.  Mutations in enzymes that catalyze steps in the citric acid cycle result in human diseases with various clin. presentations.  The intermediates of the citric acid cycle are present at micromolar concn. in blood and are regulated by respiration, metab. and renal resorption/extrusion.  Here we show that GPR91, a previously orphan G-protein-coupled receptor (GPCR), functions as a receptor for the citric acid cycle intermediate succinate.  We also report that GPR99, a close relative of GPR91, responds to α-ketoglutarate, another intermediate in the citric acid cycle.  Thus by acting as ligands for GPCRs, succinate and α-ketoglutarate are found to have unexpected signaling functions beyond their traditional roles.  Furthermore, we show that succinate increases blood pressure in animals.  The succinate-induced hypertensive effect involves the renin-angiotensin system and is abolished in GPR91-deficient mice.  Our results indicate a possible role for GPR91 in renovascular hypertension, a disease closely linked to atherosclerosis, diabetes and renal failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqik8IPAYY4BrVg90H21EOLACvtfcHk0lgSrgFYyGlScw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVKgsLs%253D&md5=9b0fe4e5744f968d2999dccf591125a9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature02488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02488%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DF.%2BJ.-P.%26aulast%3DLin%26aufirst%3DD.%2BC.-H.%26aulast%3DSchwandner%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.-L.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DL.%26atitle%3DCitric%2520acid%2520cycle%2520intermediates%2520as%2520ligands%2520for%2520orphan%2520G-protein-coupled%2520receptors%26jtitle%3DNature%26date%3D2004%26volume%3D429%26spage%3D188%26epage%3D193%26doi%3D10.1038%2Fnature02488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Castro Fonseca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguiar, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Rocha Franco, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingold, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leite, M. F.</span></span> <span> </span><span class="NLM_article-title">GPR91: expanding the frontiers of Krebs cycle intermediates</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">3</span> <span class="refDoi"> DOI: 10.1186/s12964-016-0126-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1186%2Fs12964-016-0126-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=26759054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A280%3ADC%252BC28rpvVehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&author=M.+de%0ACastro+Fonsecaauthor=C.+J.+Aguiarauthor=J.+A.+da+Rocha+Francoauthor=R.+N.+Gingoldauthor=M.+F.+Leite&title=GPR91%3A+expanding+the+frontiers+of+Krebs+cycle+intermediates&doi=10.1186%2Fs12964-016-0126-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">GPR91: expanding the frontiers of Krebs cycle intermediates</span></div><div class="casAuthors">de Castro Fonseca Matheus; da Rocha Franco Joao Antonio; Gingold Rafael N; Leite M Fatima; Aguiar Carla J</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since it was discovered, the citric acid cycle has been known to be central to cell metabolism and energy homeostasis.  Mainly found in the mitochondrial matrix, some of the intermediates of the Krebs cycle are also present in the blood stream.  Currently, there are several reports that indicate functional roles for Krebs intermediates out of its cycle.  Succinate, for instance, acts as an extracellular ligand by binding to a G-protein coupled receptor, known as GPR91, expressed in kidney, liver, heart, retinal cells and possibly many other tissues, leading to a wide array of physiological and pathological effects.  Through GPR91, succinate is involved in functions such as regulation of blood pressure, inhibition of lipolysis in white adipose tissue, development of retinal vascularization, cardiac hypertrophy and activation of stellate hepatic cells by ischemic hepatocytes.  Along the current review, these new effects of succinate through GPR91 will be explored and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeyAmELi8DJq__Jf7-eMvJfW6udTcc2eZGG5OAr-WDkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rpvVehsA%253D%253D&md5=8bac2375e234a08e2495036dde6101a7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Fs12964-016-0126-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12964-016-0126-1%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastro%2BFonseca%26aufirst%3DM.%26aulast%3DAguiar%26aufirst%3DC.%2BJ.%26aulast%3Dda%2BRocha%2BFranco%26aufirst%3DJ.%2BA.%26aulast%3DGingold%26aufirst%3DR.%2BN.%26aulast%3DLeite%26aufirst%3DM.%2BF.%26atitle%3DGPR91%253A%2520expanding%2520the%2520frontiers%2520of%2520Krebs%2520cycle%2520intermediates%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2016%26volume%3D14%26doi%3D10.1186%2Fs12964-016-0126-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucino, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauro, C.</span></span> <span> </span><span class="NLM_article-title">Intermediates of metabolism: from bystanders to signalling molecules</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2016.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.tibs.2016.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=26935843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVCht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=460-471&author=R.+Haasauthor=D.+Cucchiauthor=J.+Smithauthor=V.+Pucinoauthor=C.+E.+Macdougallauthor=C.+Mauro&title=Intermediates+of+metabolism%3A+from+bystanders+to+signalling+molecules&doi=10.1016%2Fj.tibs.2016.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Intermediates of Metabolism: From Bystanders to Signalling Molecules</span></div><div class="casAuthors">Haas, Robert; Cucchi, Danilo; Smith, Joanne; Pucino, Valentina; MacDougall, Claire Elizabeth; Mauro, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">460-471</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The integration of biochem. into immune cell biol. has contributed immensely to our understanding of immune cell function and the assocd. pathologies.  So far, most studies have focused on the regulation of metabolic pathways during an immune response and their contribution to its success.  More recently, novel signalling functions of metabolic intermediates are being discovered that might play important roles in the regulation of immunity.  Here we describe the three long-known small metabolites lactate, acetyl-CoA, and succinate in the context of immunometabolic signalling.  Functions of these ubiquitous mols. are largely dependent on their intra- and extracellular concns. as well as their subcompartmental localisation.  Importantly, the signalling functions of these metabolic intermediates extend beyond self-regulatory roles and include cell-to-cell communication and sensing of microenvironmental conditions to elicit stress responses and cellular adaptation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdlTSqJS77KbVg90H21EOLACvtfcHk0li902a_x51-7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVCht7c%253D&md5=261e006174495a131197e0e18f5ae18f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2016.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2016.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DHaas%26aufirst%3DR.%26aulast%3DCucchi%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DPucino%26aufirst%3DV.%26aulast%3DMacdougall%26aufirst%3DC.%2BE.%26aulast%3DMauro%26aufirst%3DC.%26atitle%3DIntermediates%2520of%2520metabolism%253A%2520from%2520bystanders%2520to%2520signalling%2520molecules%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2016%26volume%3D41%26spage%3D460%26epage%3D471%26doi%3D10.1016%2Fj.tibs.2016.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tannahill, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palsson-McDermott, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGettrick, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jany, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corr, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haneklaus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beasley, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clish, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auron, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span> <span> </span><span class="NLM_article-title">Succinate is an inflammatory signal that induces IL-1β through HIF-1α</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1038/nature11986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fnature11986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=23535595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=238-242&author=G.+M.+Tannahillauthor=A.+M.+Curtisauthor=J.+Adamikauthor=E.+M.+Palsson-McDermottauthor=A.+F.+McGettrickauthor=G.+Goelauthor=C.+Frezzaauthor=N.+J.+Bernardauthor=B.+Kellyauthor=N.+H.+Foleyauthor=L.+Zhengauthor=A.+Gardetauthor=Z.+Tongauthor=S.+S.+Janyauthor=S.+C.+Corrauthor=M.+Haneklausauthor=B.+E.+Caffreyauthor=K.+Pierceauthor=S.+Walmsleyauthor=F.+C.+Beasleyauthor=E.+Cumminsauthor=V.+Nizetauthor=M.+Whyteauthor=C.+T.+Taylorauthor=H.+Linauthor=S.+L.+Mastersauthor=E.+Gottliebauthor=V.+P.+Kellyauthor=C.+Clishauthor=P.+E.+Auronauthor=R.+J.+Xavierauthor=L.+A.+J.+O%E2%80%99Neill&title=Succinate+is+an+inflammatory+signal+that+induces+IL-1%CE%B2+through+HIF-1%CE%B1&doi=10.1038%2Fnature11986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate is an inflammatory signal that induces IL-1β through HIF-1α</span></div><div class="casAuthors">Tannahill, G. M.; Curtis, A. M.; Adamik, J.; Palsson-McDermott, E. M.; McGettrick, A. F.; Goel, G.; Frezza, C.; Bernard, N. J.; Kelly, B.; Foley, N. H.; Zheng, L.; Gardet, A.; Tong, Z.; Jany, S. S.; Corr, S. C.; Haneklaus, M.; Caffrey, B. E.; Pierce, K.; Walmsley, S.; Beasley, F. C.; Cummins, E.; Nizet, V.; Whyte, M.; Taylor, C. T.; Lin, H.; Masters, S. L.; Gottlieb, E.; Kelly, V. P.; Clish, C.; Auron, P. E.; Xavier, R. J.; O'Neill, L. A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">7444</span>),
    <span class="NLM_cas:pages">238-242</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages activated by the Gram-neg. bacterial product lipopolysaccharide switch their core metab. from oxidative phosphorylation to glycolysis.  Here the authors show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1β but not tumor-necrosis factor-α in mouse macrophages.  A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows up-regulation of glycolytic and down-regulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites.  Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate.  Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (γ-aminobutyric acid) shunt' pathway also has a role.  Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1α, an effect that is inhibited by 2-deoxyglucose, with interleukin-1β as an important target.  Lipopolysaccharide also increases succinylation of several proteins.  The authors therefore identify succinate as a metabolite in innate immune signaling, which enhances interleukin-1β prodn. during inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppb1rAXukXlbVg90H21EOLACvtfcHk0li902a_x51-7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFyjsrk%253D&md5=e3da1ebd7b2b48cab60fc940de31a224</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature11986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11986%26sid%3Dliteratum%253Aachs%26aulast%3DTannahill%26aufirst%3DG.%2BM.%26aulast%3DCurtis%26aufirst%3DA.%2BM.%26aulast%3DAdamik%26aufirst%3DJ.%26aulast%3DPalsson-McDermott%26aufirst%3DE.%2BM.%26aulast%3DMcGettrick%26aufirst%3DA.%2BF.%26aulast%3DGoel%26aufirst%3DG.%26aulast%3DFrezza%26aufirst%3DC.%26aulast%3DBernard%26aufirst%3DN.%2BJ.%26aulast%3DKelly%26aufirst%3DB.%26aulast%3DFoley%26aufirst%3DN.%2BH.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DGardet%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DZ.%26aulast%3DJany%26aufirst%3DS.%2BS.%26aulast%3DCorr%26aufirst%3DS.%2BC.%26aulast%3DHaneklaus%26aufirst%3DM.%26aulast%3DCaffrey%26aufirst%3DB.%2BE.%26aulast%3DPierce%26aufirst%3DK.%26aulast%3DWalmsley%26aufirst%3DS.%26aulast%3DBeasley%26aufirst%3DF.%2BC.%26aulast%3DCummins%26aufirst%3DE.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DWhyte%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DC.%2BT.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DKelly%26aufirst%3DV.%2BP.%26aulast%3DClish%26aufirst%3DC.%26aulast%3DAuron%26aufirst%3DP.%2BE.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DSuccinate%2520is%2520an%2520inflammatory%2520signal%2520that%2520induces%2520IL-1%25CE%25B2%2520through%2520HIF-1%25CE%25B1%26jtitle%3DNature%26date%3D2013%26volume%3D496%26spage%3D238%26epage%3D242%26doi%3D10.1038%2Fnature11986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ariza, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deen, P. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robben, J. H.</span></span> <span> </span><span class="NLM_article-title">The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.3389/fendo.2012.00022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.3389%2Ffendo.2012.00022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=22649402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1-8&author=A.+C.+Arizaauthor=P.+M.+T.+Deenauthor=J.+H.+Robben&title=The+succinate+receptor+as+a+novel+therapeutic+target+for+oxidative+and+metabolic+stress-related+conditions&doi=10.3389%2Ffendo.2012.00022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2012.00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2012.00022%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DA.%2BC.%26aulast%3DDeen%26aufirst%3DP.%2BM.%2BT.%26aulast%3DRobben%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520succinate%2520receptor%2520as%2520a%2520novel%2520therapeutic%2520target%2520for%2520oxidative%2520and%2520metabolic%2520stress-related%2520conditions%26jtitle%3DFront.%2520Endocrinol.%26date%3D2012%26volume%3D3%26spage%3D1%26epage%3D8%26doi%3D10.3389%2Ffendo.2012.00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E.-H.</span></span> <span> </span><span class="NLM_article-title">Succinate as a regulator of hepatic stellate cells in liver fibrosis</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">455</span>, <span class="refDoi"> DOI: 10.3389/fendo.2018.00455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.3389%2Ffendo.2018.00455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=30186230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A280%3ADC%252BB3c3lvFagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=455&author=E.-H.+Cho&title=Succinate+as+a+regulator+of+hepatic+stellate+cells+in+liver+fibrosis&doi=10.3389%2Ffendo.2018.00455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis</span></div><div class="casAuthors">Cho Eun-Hee</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">455</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">The rapid increase of obesity rates worldwide is associated with chronic liver injury due to non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.  Chronic liver inflammation drives hepatic fibrosis, which is a highly conserved and coordinated protective response to tissue injury, and is a reversible process.  Hepatocytes, immune cells, and hepatic stellate cells (HSCs) have been identified as key players in the mechanisms of hepatic fibrosis and inflammation.  During the last decade, succinate, an intermediate of the tricarboxylic acid cycle in mitochondrial ATP production, has emerged as an important signaling molecule in various diseases.  Succinate acts as an extracellular ligand for G-protein coupled receptor 91, also known as succinate receptor 1, which is mainly expressed in the kidney, heart, liver, immune cells, and retinal cells, suggesting a widespread function in cellular metabolism.  Furthermore, succinate stabilizes hypoxia-inducible factor-1α in immune cells and tumors as a signaling molecule, and has been shown to post-translationally modify proteins.  This review summarizes the recent evidence pointing to an additional role of succinate in profibrotic signaling, along with its downstream signaling pathways, and updates the current state of knowledge on the role of succinate in liver fibrosis through its action on HSCs.  Further focus on this link can help identify succinate, its receptor, and its downstream signaling molecules as new targets for the treatment of liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1yNpWn_zQMIkFb3mqPUYDfW6udTcc2eaU9I0AFgA9Krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3lvFagtw%253D%253D&md5=3bbff83efa9c5eafdf090fe4d6545170</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2018.00455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2018.00455%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DE.-H.%26atitle%3DSuccinate%2520as%2520a%2520regulator%2520of%2520hepatic%2520stellate%2520cells%2520in%2520liver%2520fibrosis%26jtitle%3DFront.%2520Endocrinol.%26date%3D2018%26volume%3D9%26spage%3D455%26doi%3D10.3389%2Ffendo.2018.00455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macaulay, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tijssen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thijssen-Timmer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusnanto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langford, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudbridge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwaginga, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Schoot, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouwehand, W. H.</span></span> <span> </span><span class="NLM_article-title">Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">3260</span>– <span class="NLM_lpage">3269</span>, <span class="refDoi"> DOI: 10.1182/blood-2006-07-036269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1182%2Fblood-2006-07-036269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=17192395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=3260-3269&author=I.+C.+Macaulayauthor=M.+R.+Tijssenauthor=D.+C.+Thijssen-Timmerauthor=A.+Gusnantoauthor=M.+Stewardauthor=P.+Burnsauthor=C.+F.+Langfordauthor=P.+D.+Ellisauthor=F.+Dudbridgeauthor=J.+J.+Zwagingaauthor=N.+A.+Watkinsauthor=C.+E.+van+der+Schootauthor=W.+H.+Ouwehand&title=Comparative+gene+expression+profiling+of+in+vitro+differentiated+megakaryocytes+and+erythroblasts+identifies+novel+activatory+and+inhibitory+platelet+membrane+proteins&doi=10.1182%2Fblood-2006-07-036269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins</span></div><div class="casAuthors">Macaulay, Iain C.; Tijssen, Marloes R.; Thijssen-Timmer, Daphne C.; Gusnanto, Arief; Steward, Michael; Burns, Philippa; Langford, Cordelia F.; Ellis, Peter D.; Dudbridge, Frank; Zwaginga, Jaap-Jan; Watkins, Nicholas A.; van der Schoot, C. Ellen; Ouwehand, Willem H.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3260-3269</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">To identify previously unknown platelet receptors we compared the transcriptomes of in vitro differentiated megakaryocytes (MKs) and erythroblasts (EBs).  RNA was obtained from purified, biol. paired MK and EB cultures and compared using cDNA microarrays.  Bioinformatical anal. of MK-up-regulated genes identified 151 transcripts encoding transmembrane domain-contg. proteins.  Although many of these were known platelet genes, a no. of previously unidentified or poorly characterized transcripts were also detected.  Many of these transcripts, including G6b, G6f, LRRC32, LAT2, and the G protein-coupled receptor SUCNR1, encode proteins with structural features or functions that suggest they may be involved in the modulation of platelet function.  Immunoblotting on platelets confirmed the presence of the encoded proteins, and flow cytometric anal. confirmed the expression of G6b, G6f, and LRRC32 on the surface of platelets.  Through comparative anal. of expression in platelets and other blood cells we demonstrated that G6b, G6f, and LRRC32 are restricted to the platelet lineage, whereas LAT2 and SUCNR1 were also detected in other blood cells.  The identification of the succinate receptor SUCNR1 in platelets is of particular interest, because physiol. relevant concns. of succinate were shown to potentiate the effect of low doses of a variety of platelet agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKB0LzfekFebVg90H21EOLACvtfcHk0liExxz3Lfh-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWitbc%253D&md5=1309bbe914fcd74290b9d2a8e325772a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-036269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-036269%26sid%3Dliteratum%253Aachs%26aulast%3DMacaulay%26aufirst%3DI.%2BC.%26aulast%3DTijssen%26aufirst%3DM.%2BR.%26aulast%3DThijssen-Timmer%26aufirst%3DD.%2BC.%26aulast%3DGusnanto%26aufirst%3DA.%26aulast%3DSteward%26aufirst%3DM.%26aulast%3DBurns%26aufirst%3DP.%26aulast%3DLangford%26aufirst%3DC.%2BF.%26aulast%3DEllis%26aufirst%3DP.%2BD.%26aulast%3DDudbridge%26aufirst%3DF.%26aulast%3DZwaginga%26aufirst%3DJ.%2BJ.%26aulast%3DWatkins%26aufirst%3DN.%2BA.%26aulast%3Dvan%2Bder%2BSchoot%26aufirst%3DC.%2BE.%26aulast%3DOuwehand%26aufirst%3DW.%2BH.%26atitle%3DComparative%2520gene%2520expression%2520profiling%2520of%2520in%2520vitro%2520differentiated%2520megakaryocytes%2520and%2520erythroblasts%2520identifies%2520novel%2520activatory%2520and%2520inhibitory%2520platelet%2520membrane%2520proteins%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D3260%26epage%3D3269%26doi%3D10.1182%2Fblood-2006-07-036269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti-Peterdi, J.</span></span> <span> </span><span class="NLM_article-title">Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">2526</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1172/JCI33293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1172%2FJCI33293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=18535668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1OntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=2526-2534&author=I.+Tomaauthor=J.+J.+Kangauthor=A.+Siposauthor=S.+Vargasauthor=E.+Bansalauthor=F.+Hannerauthor=E.+Meerauthor=J.+Peti-Peterdi&title=Succinate+receptor+GPR91+provides+a+direct+link+between+high+glucose+levels+and+renin+release+in+murine+and+rabbit+kidney&doi=10.1172%2FJCI33293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney</span></div><div class="casAuthors">Toma, Ildiko; Kang, Jung Julie; Sipos, Arnold; Vargas, Sarah; Bansal, Eric; Hanner, Fiona; Meer, Elliott; Peti-Peterdi, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2526-2534</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Diabetes mellitus is the most common and rapidly growing cause of end-stage renal disease in developed countries.  A classic hallmark of early diabetes mellitus includes activation of the renin-angiotensin system (RAS), which may lead to hypertension and renal tissue injury, but the mechanism of RAS activation is elusive.  Here we identified a paracrine signaling pathway in the kidney in which high levels of glucose directly triggered the release of the prohypertensive hormone renin.  The signaling cascade involved the local accumulation of succinate and activation of the kidney-specific G protein-coupled metabolic receptor, GPR91, in the glomerular endothelium as obsd. in rat, mouse, and rabbit kidney sections.  Elements of signal transduction included endothelial Ca2+, the prodn. of NO and prostaglandin (PGE2), and their paracrine actions on adjacent renin-producing cells.  This GPR91 signaling cascade may serve to modulate kidney function and help remove metabolic waste products through renal hyperfiltration, and it could also link metabolic diseases, such as diabetes, or metabolic syndrome with RAS overactivation, systemic hypertension, and organ injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYiuLKXSyM67Vg90H21EOLACvtfcHk0liExxz3Lfh-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1OntLY%253D&md5=e46fdc0ede06f7a4f1d6064a2c014d27</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI33293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI33293%26sid%3Dliteratum%253Aachs%26aulast%3DToma%26aufirst%3DI.%26aulast%3DKang%26aufirst%3DJ.%2BJ.%26aulast%3DSipos%26aufirst%3DA.%26aulast%3DVargas%26aufirst%3DS.%26aulast%3DBansal%26aufirst%3DE.%26aulast%3DHanner%26aufirst%3DF.%26aulast%3DMeer%26aufirst%3DE.%26aulast%3DPeti-Peterdi%26aufirst%3DJ.%26atitle%3DSuccinate%2520receptor%2520GPR91%2520provides%2520a%2520direct%2520link%2520between%2520high%2520glucose%2520levels%2520and%2520renin%2520release%2520in%2520murine%2520and%2520rabbit%2520kidney%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D2526%26epage%3D2534%26doi%3D10.1172%2FJCI33293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meer, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peti-Peterdi, J.</span></span> <span> </span><span class="NLM_article-title">Activation of the succinate receptor GPR91 in macula densa cells causes renin release</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1002</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1681/ASN.2008070740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1681%2FASN.2008070740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=19389848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFKqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1002-1011&author=S.+L.+Vargasauthor=I.+Tomaauthor=J.+J.+Kangauthor=E.+J.+Meerauthor=J.+Peti-Peterdi&title=Activation+of+the+succinate+receptor+GPR91+in+macula+densa+cells+causes+renin+release&doi=10.1681%2FASN.2008070740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the succinate receptor GPR91 in macula densa cells causes renin release</span></div><div class="casAuthors">Vargas, Sarah Laurin; Toma, Ildiko; Kang, Jung Julie; Meer, Elliott James; Peti-Peterdi, Janos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1002-1011</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Macula densa (MD) cells of the juxtaglomerular app. (JGA) are salt sensors and generate paracrine signals that control renal blood flow, glomerular filtration, and release of the prohypertensive hormone renin.  We hypothesized that the recently identified succinate receptor GPR91 is present in MD cells and regulates renin release.  Using immunohistochem., we identified GPR91 in the apical plasma membrane of MD cells.  Treatment of MD cells with succinate activated mitogen-activated protein kinases (MAPKs; p38 and extracellular signal-regulated kinases 1/2) and cyclooxygenase 2 (COX-2) and induced the synthesis and release of prostaglandin E2, a potent vasodilator and classic paracrine mediator of renin release.  Using microperfused JGA and real-time confocal fluorescence imaging of quinacrinelabeled renin granules, we detected significant renin release in response to tubular succinate (EC50 350 μM).  Genetic deletion of GPR91 (GPR91-/- mice) or pharmacol. inhibition of MAPK or COX-2 blocked succinate-induced renin release.  Streptozotocin-induced diabetes caused GPR91-dependent upregulation of renal cortical phospho-p38, extracellular signal-regulated kinases 1/2, COX-2, and renin content.  Salt depletion for 1 wk increased plasma renin activity seven-fold in wild-type mice but only 3.4-fold in GPR91-/- mice.  In summary, MD cells can sense alterations in local tissue metab. via accumulation of tubular succinate and GPR91 signaling, which involves the activation of MAPKs, COX-2, and the release of prostaglandin E2.  This mechanism may be integral in the regulation of renin release and activation of the renin-angiotensin system in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DQZnZmyIgrVg90H21EOLACvtfcHk0li9FHzDiqtCKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFKqtr0%253D&md5=ce2d38b2f9299865bff97b69c8017e1c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1681%2FASN.2008070740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2008070740%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DS.%2BL.%26aulast%3DToma%26aufirst%3DI.%26aulast%3DKang%26aufirst%3DJ.%2BJ.%26aulast%3DMeer%26aufirst%3DE.%2BJ.%26aulast%3DPeti-Peterdi%26aufirst%3DJ.%26atitle%3DActivation%2520of%2520the%2520succinate%2520receptor%2520GPR91%2520in%2520macula%2520densa%2520cells%2520causes%2520renin%2520release%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2009%26volume%3D20%26spage%3D1002%26epage%3D1011%26doi%3D10.1681%2FASN.2008070740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCreath, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gálvez, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepúlveda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervera, A. M.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.2337/db14-0346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.2337%2Fdb14-0346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=25352636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslCjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=1154-1167&author=K.+J.+McCreathauthor=S.+Espadaauthor=B.+G.+G%C3%A1lvezauthor=M.+Benitoauthor=A.+de+Molinaauthor=P.+Sep%C3%BAlvedaauthor=A.+M.+Cervera&title=Targeted+disruption+of+the+SUCNR1+metabolic+receptor+leads+to+dichotomous+effects+on+obesity&doi=10.2337%2Fdb14-0346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity</span></div><div class="casAuthors">McCreath, Kenneth J.; Espada, Sandra; Galvez, Beatriz G.; Benito, Marina; de Molina, Antonio; Sepulveda, Pilar; Cervera, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1154-1167</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">A no. of metabolites have signaling properties by acting through G-protein-coupled receptors.  Succinate, a Krebs cycle intermediate, increases after dysregulated energy metab. and can bind to its cognate receptor succinate receptor 1 (Sucnr1, or GPR91) to activate downstream signaling pathways.  We show that Sucnr1 is highly expressed in the white adipose tissue (WAT) compartment of mice and regulates adipose mass and glucose homeostasis.  Sucnr1-/- mice were generated, and wt. gain was monitored under basal and nutritional stress (high-fat diet [HFD]) conditions.  On chow diet, Sucnr1-/- mice had increased energy expenditure, were lean with a smaller WAT compartment, and had improved glucose buffering.  Lipolysis measurements revealed that Sucnr1-/- mice were released from succinate-induced inhibition of lipolysis, demonstrating a function of Sucnr1 in adipose tissue.  Sucnr1 deletion also protected mice from obesity on HFD, but only during the initial period; at later stages, body wt. of HFD-fed Sucnr1-/- mice was almost comparable with wild-type (WT) mice, but WAT content was greater.  Also, these mice became progressively hyperglycemic and failed to secrete insulin, although pancreas architecture was similar to WT mice.  These findings suggest that Sucnr1 is a sensor for dietary energy and raise the interesting possibility that protocols to modulate Sucnr1 might have therapeutic utility in the setting of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2DcEVGYi717Vg90H21EOLACvtfcHk0li9FHzDiqtCKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslCjsLk%253D&md5=cd985279ea90837a66eb37b087ae2045</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2337%2Fdb14-0346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb14-0346%26sid%3Dliteratum%253Aachs%26aulast%3DMcCreath%26aufirst%3DK.%2BJ.%26aulast%3DEspada%26aufirst%3DS.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DB.%2BG.%26aulast%3DBenito%26aufirst%3DM.%26aulast%3Dde%2BMolina%26aufirst%3DA.%26aulast%3DSep%25C3%25BAlveda%26aufirst%3DP.%26aulast%3DCervera%26aufirst%3DA.%2BM.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520SUCNR1%2520metabolic%2520receptor%2520leads%2520to%2520dichotomous%2520effects%2520on%2520obesity%26jtitle%3DDiabetes%26date%3D2015%26volume%3D64%26spage%3D1154%26epage%3D1167%26doi%3D10.2337%2Fdb14-0346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapieha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirinyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaniolo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyal, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kermorvant-Duchemin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihakova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Polo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauséjour, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andelfinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sennlaub, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chemtob, S.</span></span> <span> </span><span class="NLM_article-title">The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1076</span>, <span class="refDoi"> DOI: 10.1038/nm.1873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fnm.1873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=18836459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1067-1076&author=P.+Sapiehaauthor=M.+Sirinyanauthor=D.+Hamelauthor=K.+Zanioloauthor=J.+S.+Joyalauthor=J.-H.+Choauthor=J.+C.+Honor%C3%A9author=E.+Kermorvant-Ducheminauthor=D.+R.+Varmaauthor=S.+Tremblayauthor=M.+Leducauthor=L.+Rihakovaauthor=P.+Hardyauthor=W.+H.+Kleinauthor=X.+Muauthor=O.+Mamerauthor=P.+Lachapelleauthor=A.+Di+Poloauthor=C.+Beaus%C3%A9jourauthor=G.+Andelfingerauthor=G.+Mitchellauthor=F.+Sennlaubauthor=S.+Chemtob&title=The+succinate+receptor+GPR91+in+neurons+has+a+major+role+in+retinal+angiogenesis&doi=10.1038%2Fnm.1873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis</span></div><div class="casAuthors">Sapieha, Przemyslaw; Sirinyan, Mirna; Hamel, David; Zaniolo, Karine; Joyal, Jean-Sebastien; Cho, Jang-Hyeon; Honore, Jean-Claude; Kermorvant-Duchemin, Elsa; Varma, Daya R.; Tremblay, Sophie; Leduc, Martin; Rihakova, Lenka; Hardy, Pierre; Klein, William H.; Mu, Xiuqian; Mamer, Orval; Lachapelle, Pierre; Di Polo, Adriana; Beausejour, Christian; Andelfinger, Gregor; Mitchell, Grant; Sennlaub, Florian; Chemtob, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1067-1076</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Vascularization is essential for tissue development and in restoration of tissue integrity after an ischemic injury.  In studies of vascularization, the focus has largely been placed on vascular endothelial growth factor (VEGF), yet other factors may also orchestrate this process.  Here we show that succinate accumulates in the hypoxic retina of rodents and, via its cognate receptor G protein-coupled receptor-91 (GPR91), is a potent mediator of vessel growth in the settings of both normal retinal development and proliferative ischemic retinopathy.  The effects of GPR91 are mediated by retinal ganglion neurons (RGCs), which, in response to increased succinate levels, regulate the prodn. of numerous angiogenic factors including VEGF.  Accordingly, succinate did not have proangiogenic effects in RGC-deficient rats.  Our observations show a pathway of metabolite signaling where succinate, acting through GPR91, governs retinal angiogenesis and show the propensity of RGCs to act as sensors of ischemic stress.  These findings provide a new therapeutic target for modulating revascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo836psMwLyH7Vg90H21EOLACvtfcHk0li9FHzDiqtCKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7rI&md5=234c8591c5c6036e126bc40198a9e518</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.1873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1873%26sid%3Dliteratum%253Aachs%26aulast%3DSapieha%26aufirst%3DP.%26aulast%3DSirinyan%26aufirst%3DM.%26aulast%3DHamel%26aufirst%3DD.%26aulast%3DZaniolo%26aufirst%3DK.%26aulast%3DJoyal%26aufirst%3DJ.%2BS.%26aulast%3DCho%26aufirst%3DJ.-H.%26aulast%3DHonor%25C3%25A9%26aufirst%3DJ.%2BC.%26aulast%3DKermorvant-Duchemin%26aufirst%3DE.%26aulast%3DVarma%26aufirst%3DD.%2BR.%26aulast%3DTremblay%26aufirst%3DS.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DRihakova%26aufirst%3DL.%26aulast%3DHardy%26aufirst%3DP.%26aulast%3DKlein%26aufirst%3DW.%2BH.%26aulast%3DMu%26aufirst%3DX.%26aulast%3DMamer%26aufirst%3DO.%26aulast%3DLachapelle%26aufirst%3DP.%26aulast%3DDi%2BPolo%26aufirst%3DA.%26aulast%3DBeaus%25C3%25A9jour%26aufirst%3DC.%26aulast%3DAndelfinger%26aufirst%3DG.%26aulast%3DMitchell%26aufirst%3DG.%26aulast%3DSennlaub%26aufirst%3DF.%26aulast%3DChemtob%26aufirst%3DS.%26atitle%3DThe%2520succinate%2520receptor%2520GPR91%2520in%2520neurons%2520has%2520a%2520major%2520role%2520in%2520retinal%2520angiogenesis%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1067%26epage%3D1076%26doi%3D10.1038%2Fnm.1873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lametschwandtner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinteregger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido-Perrig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwärzler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voshol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meingassner, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span> <span> </span><span class="NLM_article-title">Triggering the succinate receptor GPR91 on dendritic cells enhances immunity</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1269</span>, <span class="refDoi"> DOI: 10.1038/ni.1657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fni.1657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=18820681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1261-1269&author=T.+Rubicauthor=G.+Lametschwandtnerauthor=S.+Jostauthor=S.+Hintereggerauthor=J.+Kundauthor=N.+Carballido-Perrigauthor=C.+Schw%C3%A4rzlerauthor=T.+Juntauthor=H.+Vosholauthor=J.+G.+Meingassnerauthor=X.+Maoauthor=G.+Wernerauthor=A.+Rotauthor=J.+M.+Carballido&title=Triggering+the+succinate+receptor+GPR91+on+dendritic+cells+enhances+immunity&doi=10.1038%2Fni.1657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Triggering the succinate receptor GPR91 on dendritic cells enhances immunity</span></div><div class="casAuthors">Rubic, Tina; Lametschwandtner, Guenther; Jost, Sandra; Hinteregger, Sonja; Kund, Julia; Carballido-Perrig, Nicole; Schwaerzler, Christoph; Junt, Tobias; Voshol, Hans; Meingassner, Josef G.; Mao, Xiaohong; Werner, Gudrun; Rot, Antal; Carballido, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1261-1269</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Succinate acts as an extracellular mediator signaling through the G protein-coupled receptor GPR91.  Here the authors show that dendritic cells had high expression of GPR91.  In these cells, succinate triggered intracellular calcium mobilization, induced migratory responses and acted in synergy with Toll-like receptor ligands for the prodn. of proinflammatory cytokines.  Succinate also enhanced antigen-specific activation of human and mouse helper T cells.  GPR91-deficient mice had less migration of Langerhans cells to draining lymph nodes and impaired tetanus toxoid-specific recall T cell responses.  Furthermore, GPR91-deficient allografts elicited weaker transplant rejection than did the corresponding grafts from wild-type mice.  The results suggest that the succinate receptor GPR91 is involved in sensing immunol. danger, which establishes a link between immunity and a metabolite of cellular respiration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-oJPPLkVcp7Vg90H21EOLACvtfcHk0lhIDSYvQJtsYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrF&md5=56e7f2eb72deae72041d67bb196bcf1e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fni.1657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1657%26sid%3Dliteratum%253Aachs%26aulast%3DRubic%26aufirst%3DT.%26aulast%3DLametschwandtner%26aufirst%3DG.%26aulast%3DJost%26aufirst%3DS.%26aulast%3DHinteregger%26aufirst%3DS.%26aulast%3DKund%26aufirst%3DJ.%26aulast%3DCarballido-Perrig%26aufirst%3DN.%26aulast%3DSchw%25C3%25A4rzler%26aufirst%3DC.%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DVoshol%26aufirst%3DH.%26aulast%3DMeingassner%26aufirst%3DJ.%2BG.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DWerner%26aufirst%3DG.%26aulast%3DRot%26aufirst%3DA.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26atitle%3DTriggering%2520the%2520succinate%2520receptor%2520GPR91%2520on%2520dendritic%2520cells%2520enhances%2520immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1261%26epage%3D1269%26doi%3D10.1038%2Fni.1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veras, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peres, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luiz, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, F. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryffel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves-Filho, J. C.</span></span> <span> </span><span class="NLM_article-title">Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">6550</span>– <span class="NLM_lpage">6558</span>, <span class="refDoi"> DOI: 10.1096/fj.201800285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1096%2Ffj.201800285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjslSitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=6550-6558&author=A.+L.+Saraivaauthor=F.+P.+Verasauthor=R.+S.+Peresauthor=J.+Talbotauthor=K.+A.+de+Limaauthor=J.+P.+Luizauthor=J.+M.+Carballidoauthor=T.+M.+Cunhaauthor=F.+Q.+Cunhaauthor=B.+Ryffelauthor=J.+C.+Alves-Filho&title=Succinate+receptor+deficiency+attenuates+arthritis+by+reducing+dendritic+cell+traffic+and+expansion+of+Th17+cells+in+the+lymph+nodes&doi=10.1096%2Ffj.201800285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes</span></div><div class="casAuthors">Saraiva, Andre L.; Veras, Flavio P.; Peres, Raphael S.; Talbot, Jhimmy; de Lima, Kalil A.; Luiz, Joao P.; Carballido, Jose M.; Cunha, Thiago M.; Cunha, Fernando Q.; Ryffel, Bernhard; Alves-Filho, Jose C.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6550-6558</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Rheumatoid arthritis is a chronic inflammatory disease that leads to significant changes in metabolic activity.  Succinate, an intermediate of the tricarboxylic acid cycle, has emerged as ametabolicmediator of the innate immune response.  However, the involvement of succinate in the generation of the adaptive immune response and establishment of autoimmune response has not been addressed thus far.Here we demonstrated that the succinatesensing receptor (Sucnr1/GPR91) plays a crit. role in the development of immune-mediated arthritis.  We found that Sucnr1 acts as a chemotacticgradient sensor that guides dendritic cells (DCs) intothe lymphnodes,orchestrating the expansionof theThelper (Th)17-cellpopulation and thedevelopment of exptl. antigen-induced arthritis.Sucnr1-/- mice show reduced articul arhyperalgesia, neutrophil infiltration andinflammatory cytokines inthe joint, and reduced frequency of Th17 cells in draining lymph nodes.  Adoptive transfer of wild-type (WT) DCs into Sucnr1-/- mice restored the development of arthritis.  Moreover, DC-depletedmice transferredwith Sucnr1-/- DCs developed less arthritis than mice transferred with WT DCs.  In contrast, succinate given together with the immunization boosted the recruitment of DCs and the frequency of Th17 cells in draining lymph nodes, increasing arthritis severity.  Therefore, the blockade of Sucnr1may represent a novel therapeutic target of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy86VaIXji0rVg90H21EOLACvtfcHk0ljkfIM6If8HaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjslSitLs%253D&md5=457898569316d2912169082a9316d92a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1096%2Ffj.201800285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201800285%26sid%3Dliteratum%253Aachs%26aulast%3DSaraiva%26aufirst%3DA.%2BL.%26aulast%3DVeras%26aufirst%3DF.%2BP.%26aulast%3DPeres%26aufirst%3DR.%2BS.%26aulast%3DTalbot%26aufirst%3DJ.%26aulast%3Dde%2BLima%26aufirst%3DK.%2BA.%26aulast%3DLuiz%26aufirst%3DJ.%2BP.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26aulast%3DCunha%26aufirst%3DT.%2BM.%26aulast%3DCunha%26aufirst%3DF.%2BQ.%26aulast%3DRyffel%26aufirst%3DB.%26aulast%3DAlves-Filho%26aufirst%3DJ.%2BC.%26atitle%3DSuccinate%2520receptor%2520deficiency%2520attenuates%2520arthritis%2520by%2520reducing%2520dendritic%2520cell%2520traffic%2520and%2520expansion%2520of%2520Th17%2520cells%2520in%2520the%2520lymph%2520nodes%26jtitle%3DFASEB%2520J.%26date%3D2018%26volume%3D32%26spage%3D6550%26epage%3D6558%26doi%3D10.1096%2Ffj.201800285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span> <span> </span><span class="NLM_article-title">Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e97501</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0097501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1371%2Fjournal.pone.0097501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=24887281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKiu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=S.+Kimauthor=J.+Hwangauthor=J.+Xuanauthor=Y.+H.+Jungauthor=H.-S.+Chaauthor=K.+H.+Kim&title=Global+metabolite+profiling+of+synovial+fluid+for+the+specific+diagnosis+of+rheumatoid+arthritis+from+other+inflammatory+arthritis&doi=10.1371%2Fjournal.pone.0097501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis</span></div><div class="casAuthors">Kim, Sooah; Hwang, Jiwon; Xuan, Jinhua; Jung, Young Hoon; Cha, Hoon-Suk; Kim, Kyoung Heon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e97501/1-e97501/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Currently, reliable biomarkers that can be used to distinguish rheumatoid arthritis (RA) from other inflammatory diseases are unavailable.  To find possible distinctive metabolic patterns and biomarker candidates for RA, we performed global metabolite profiling of synovial fluid samples.  Synovial fluid samples from 38 patients with RA, ankylosing spondylitis, Behcet's disease, and gout were analyzed by gas chromatog./time-of-flight mass spectrometry (GC/TOF MS).  Orthogonal partial least-squares discriminant and hierarchical clustering analyses were performed for the discrimination of RA and non-RA groups.  Variable importance for projection values were detd., and the Wilcoxon-Mann-Whitney test and the breakdown and one-way anal. of variance were conducted to identify potential biomarkers for RA.  A total of 105 metabolites were identified from synovial fluid samples.  The score plot of orthogonal partial least squares discriminant anal. showed significant discrimination between the RA and non-RA groups.  The 20 metabolites, including citrulline, succinate, glutamine, octadecanol, isopalmitic acid, and glycerol, were identified as potential biomarkers for RA.  These metabolites were found to be assocd. with the urea and TCA cycles as well as fatty acid and amino acid metab.  The metabolomic anal. results demonstrated that global metabolite profiling by GC/TOF MS might be a useful tool for the effective diagnosis and further understanding of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCNQ5-IluY1bVg90H21EOLACvtfcHk0ljkfIM6If8HaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKiu7bP&md5=2b44186884ca717dccf690501bd18c6b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0097501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0097501%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DXuan%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DY.%2BH.%26aulast%3DCha%26aufirst%3DH.-S.%26aulast%3DKim%26aufirst%3DK.%2BH.%26atitle%3DGlobal%2520metabolite%2520profiling%2520of%2520synovial%2520fluid%2520for%2520the%2520specific%2520diagnosis%2520of%2520rheumatoid%2520arthritis%2520from%2520other%2520inflammatory%2520arthritis%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0097501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apfel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loesle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tigani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kneuer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valeaux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubic-Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span> <span> </span><span class="NLM_article-title">GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">1655</span>– <span class="NLM_lpage">1662</span>, <span class="refDoi"> DOI: 10.1084/jem.20160061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1084%2Fjem.20160061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=27481132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVyksr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2016&pages=1655-1662&author=A.+Littlewood-Evansauthor=S.+Sarretauthor=V.+Apfelauthor=P.+Loesleauthor=J.+Dawsonauthor=J.+Zhangauthor=A.+Mullerauthor=B.+Tiganiauthor=R.+Kneuerauthor=S.+Patelauthor=S.+Valeauxauthor=N.+Gommermannauthor=T.+Rubic-Schneiderauthor=T.+Juntauthor=J.+M.+Carballido&title=GPR91+senses+extracellular+succinate+released+from+inflammatory+macrophages+and+exacerbates+rheumatoid+arthritis&doi=10.1084%2Fjem.20160061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis</span></div><div class="casAuthors">Littlewood-Evans, Amanda; Sarret, Sophie; Apfel, Verena; Loesle, Perrine; Dawson, Janet; Zhang, Juan; Muller, Alban; Tigani, Bruno; Kneuer, Rainer; Patel, Saijel; Valeaux, Stephanie; Gommermann, Nina; Rubic-Schneider, Tina; Junt, Tobias; Carballido, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1655-1662</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">1540-9538</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">When SUCNR1/GPR91-expressing macrophages are activated by inflammatory signals, they change their metab. and accumulate succinate.  In this study, we show that during this activation, macrophages release succinate into the extracellular milieu.  They simultaneously up-regulate GPR91, which functions as an autocrine and paracrine sensor for extracellular succinate to enhance IL-1β prodn.  GPR91-deficient mice lack this metabolic sensor and show reduced macrophage activation and prodn. of IL-1β during antigen-induced arthritis.  Succinate is abundant in synovial fluids from rheumatoid arthritis (RA) patients, and these fluids elicit IL-1β release from macrophages in a GPR91-dependent manner.  Together, we reveal a GPR91/succinate-dependent feed-forward loop of macrophage activation and propose GPR91 antagonists as novel therapeutic principles to treat RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp51mM1dfvbeLVg90H21EOLACvtfcHk0ljkfIM6If8HaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVyksr3M&md5=65237378a1e94906ee0d486c1211b5fb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20160061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20160061%26sid%3Dliteratum%253Aachs%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DSarret%26aufirst%3DS.%26aulast%3DApfel%26aufirst%3DV.%26aulast%3DLoesle%26aufirst%3DP.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DTigani%26aufirst%3DB.%26aulast%3DKneuer%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DValeaux%26aufirst%3DS.%26aulast%3DGommermann%26aufirst%3DN.%26aulast%3DRubic-Schneider%26aufirst%3DT.%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26atitle%3DGPR91%2520senses%2520extracellular%2520succinate%2520released%2520from%2520inflammatory%2520macrophages%2520and%2520exacerbates%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2016%26volume%3D213%26spage%3D1655%26epage%3D1662%26doi%3D10.1084%2Fjem.20160061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umrani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salunke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukreja, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naykodi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitole, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurhade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shejul, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palle, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, T.-Q.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective small molecule hGPR91 antagonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3596</span>– <span class="NLM_lpage">3602</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.bmcl.2011.04.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=21571530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3596-3602&author=D.+Bhuniyaauthor=D.+Umraniauthor=B.+Daveauthor=D.+Salunkeauthor=G.+Kukrejaauthor=J.+Gunduauthor=M.+Naykodiauthor=N.+S.+Shaikhauthor=P.+Shitoleauthor=S.+Kurhadeauthor=S.+Deauthor=S.+Majumdarauthor=S.+B.+Reddyauthor=S.+Tambeauthor=Y.+Shejulauthor=A.+Chughauthor=V.+P.+Palleauthor=K.+A.+Mookhtiarauthor=D.+Cullyauthor=J.+Vaccaauthor=P.+K.+Chakravartyauthor=R.+P.+Nargundauthor=S.+D.+Wrightauthor=M.+P.+Grazianoauthor=S.+B.+Singhauthor=S.+Royauthor=T.-Q.+Cai&title=Discovery+of+a+potent+and+selective+small+molecule+hGPR91+antagonist&doi=10.1016%2Fj.bmcl.2011.04.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and selective small molecule hGPR91 antagonist</span></div><div class="casAuthors">Bhuniya, Debnath; Umrani, Dhananjay; Dave, Bhavesh; Salunke, Deepak; Kukreja, Gagan; Gundu, Jayasagar; Naykodi, Minakshi; Shaikh, Nadim S.; Shitole, Prasad; Kurhade, Santosh; De, Siddhartha; Majumdar, Sreemita; Reddy, Srinivasa B.; Tambe, Suhas; Shejul, Yogesh; Chugh, Anita; Palle, Venkata P.; Mookhtiar, Kasim A.; Cully, Doris; Vacca, Joseph; Chakravarty, Prasun K.; Nargund, Ravi P.; Wright, Samuel D.; Graziano, Michael P.; Singh, Sheo B.; Roy, Sophie; Cai, Tian-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3596-3602</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR91, a 7TM G-Protein-Coupled Receptor, has been recently deorphanized with succinic acid as its endogenous ligand.  Current literature indicates that GPR91 plays role in various pathophysiol. including renal hypertension, autoimmune disease and retinal angiogenesis.  Starting from naphthyridine-contg. small mol. high-throughput screening hit I (hGPR91 IC50: 0.8 μM)-originally synthesized at Merck for a Bradykinin B1 Receptor (BK1R) program, a systematic structure-activity relationship study led to the discovery of potent and selective hGPR91 antagonists e.g. II, III, and IV (IC50: 7-35 nM; >1000 fold selective against hGPR99, a closest related GPCR; >100 fold selective in Drug Matrix screening).  This initial work also led to identification of two structurally distinct and orally bio-available lead compds.: IV (%F: 26) and V (IC50: 180 nM; >100 fold selective against hGPR99; %F: 87).  A rat pharmacodynamic assay was developed to characterize the antagonists in vivo using succinate induced increase in blood pressure.  Using two representative antagonists, II and III, the GPR91 target engagement was subsequently demonstrated using the designed pharmacodynamic assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-All39--H7Vg90H21EOLACvtfcHk0lhSvqQiCjsFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhsrk%253D&md5=39579730e461de19ec78ecae37581c64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.091%26sid%3Dliteratum%253Aachs%26aulast%3DBhuniya%26aufirst%3DD.%26aulast%3DUmrani%26aufirst%3DD.%26aulast%3DDave%26aufirst%3DB.%26aulast%3DSalunke%26aufirst%3DD.%26aulast%3DKukreja%26aufirst%3DG.%26aulast%3DGundu%26aufirst%3DJ.%26aulast%3DNaykodi%26aufirst%3DM.%26aulast%3DShaikh%26aufirst%3DN.%2BS.%26aulast%3DShitole%26aufirst%3DP.%26aulast%3DKurhade%26aufirst%3DS.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DS.%2BB.%26aulast%3DTambe%26aufirst%3DS.%26aulast%3DShejul%26aufirst%3DY.%26aulast%3DChugh%26aufirst%3DA.%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26aulast%3DCully%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%26aulast%3DChakravarty%26aufirst%3DP.%2BK.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DWright%26aufirst%3DS.%2BD.%26aulast%3DGraziano%26aufirst%3DM.%2BP.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DT.-Q.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520small%2520molecule%2520hGPR91%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3596%26epage%3D3602%26doi%3D10.1016%2Fj.bmcl.2011.04.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trauelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hjorth, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brvar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1585</span>– <span class="NLM_lpage">1596</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2017.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.molmet.2017.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=29157600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1ars7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=1585-1596&author=M.+Trauelsenauthor=E.+R.+Ulvenauthor=S.+A.+Hjorthauthor=M.+Brvarauthor=C.+Monacoauthor=T.+M.+Frimurerauthor=T.+W.+Schwartz&title=Receptor+structure-based+discovery+of+non-metabolite+agonists+for+the+succinate+receptor+GPR91&doi=10.1016%2Fj.molmet.2017.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor structure-based discovery of non-metabolite agonists for the succinate receptor gpr91</span></div><div class="casAuthors">Trauelsen, Mette; Rexen Ulven, Elisabeth; Hjorth, Siv A.; Brvar, Matjaz; Monaco, Claudia; Frimurer, Thomas M.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1585-1596</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Besides functioning as an intracellular metabolite, succinate acts as a stress-induced extracellular signal through activation of GPR91 (SUCNR1) for which we lack suitable pharmacol. tools.  Here we first detd. that the cis conformation of the succinate backbone is preferred and that certain backbone modifications are allowed for GPR91 activation.  Through receptor modeling over the X-ray structure of the closely related P2Y1 receptor, we discovered that the binding pocket is partly occupied by a segment of an extracellular loop and that succinate therefore binds in a very different mode than generally believed.  Importantly, an empty side-pocket is identified next to the succinate binding site.  All this information formed the basis for a substructure-based search query, which, combined with mol. docking, was used in virtual screening of the ZINC database to pick two serial mini-libraries of a total of only 245 compds. from which sub-micromolar, selective GPR91 agonists of unique structures were identified.  The best compds. were backbone-modified succinate analogs in which an amide-linked hydrophobic moiety docked into the side-pocket next to succinate as shown by both loss- and gain-of-function mutagenesis.  These compds. displayed GPR91-dependent activity in altering cytokine expression in human M2 macrophages similar to succinate, and importantly were devoid of any effect on the major intracellular target, succinate dehydrogenase.  These novel, synthetic non-metabolite GPR91 agonists will be valuable both as pharmacol. tools to delineate the GPR91-mediated functions of succinate and as leads for the development of GPR91-targeted drugs to potentially treat low grade metabolic inflammation and diabetic complications such as retinopathy and nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4X9H6LZ_ah7Vg90H21EOLACvtfcHk0lhSvqQiCjsFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1ars7vE&md5=0cd72477f109c9ee657e3d719ae4dfa6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2017.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2017.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DTrauelsen%26aufirst%3DM.%26aulast%3DUlven%26aufirst%3DE.%2BR.%26aulast%3DHjorth%26aufirst%3DS.%2BA.%26aulast%3DBrvar%26aufirst%3DM.%26aulast%3DMonaco%26aufirst%3DC.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DReceptor%2520structure-based%2520discovery%2520of%2520non-metabolite%2520agonists%2520for%2520the%2520succinate%2520receptor%2520GPR91%26jtitle%3DMol.%2520Metab.%26date%3D2017%26volume%3D6%26spage%3D1585%26epage%3D1596%26doi%3D10.1016%2Fj.molmet.2017.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trauelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brvar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lückmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielefeldt, LØ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity investigations and optimisations of nonmetabolite agonists for the Succinate Receptor 1</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="NLM_elocation-id">10010</span> <span class="refDoi"> DOI: 10.1038/s41598-018-28263-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fs41598-018-28263-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=29968758" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=E.+R.+Ulvenauthor=M.+Trauelsenauthor=M.+Brvarauthor=M.+L%C3%BCckmannauthor=L%C3%98.+Bielefeldtauthor=L.+K.+I.+Jensenauthor=T.+W.+Schwartzauthor=T.+M.+Frimurer&title=Structure-activity+investigations+and+optimisations+of+nonmetabolite+agonists+for+the+Succinate+Receptor+1&doi=10.1038%2Fs41598-018-28263-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-28263-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-28263-7%26sid%3Dliteratum%253Aachs%26aulast%3DUlven%26aufirst%3DE.%2BR.%26aulast%3DTrauelsen%26aufirst%3DM.%26aulast%3DBrvar%26aufirst%3DM.%26aulast%3DL%25C3%25BCckmann%26aufirst%3DM.%26aulast%3DBielefeldt%26aufirst%3DL%25C3%2598.%26aulast%3DJensen%26aufirst%3DL.%2BK.%2BI.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26atitle%3DStructure-activity%2520investigations%2520and%2520optimisations%2520of%2520nonmetabolite%2520agonists%2520for%2520the%2520Succinate%2520Receptor%25201%26jtitle%3DSci.%2520Rep.%26date%3D2018%26doi%3D10.1038%2Fs41598-018-28263-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geubelle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilissen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laschet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouret, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirotte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span> <span> </span><span class="NLM_article-title">Identification and pharmacological characterization of succinate receptor agonists</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.1111/bph.13738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1111%2Fbph.13738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=28160606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVKns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=796-808&author=P.+Geubelleauthor=J.+Gilissenauthor=S.+Dillyauthor=L.+Pomaauthor=N.+Dupuisauthor=C.+Laschetauthor=D.+Abboudauthor=A.+Inoueauthor=F.+Jouretauthor=B.+Pirotteauthor=J.+Hanson&title=Identification+and+pharmacological+characterization+of+succinate+receptor+agonists&doi=10.1111%2Fbph.13738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and pharmacological characterization of succinate receptor agonists</span></div><div class="casAuthors">Geubelle, Pierre; Gilissen, Julie; Dilly, Sebastien; Poma, Laurence; Dupuis, Nadine; Laschet, Celine; Abboud, Dayana; Inoue, Asuka; Jouret, Francois; Pirotte, Bernard; Hanson, Julien</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">796-808</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The succinate receptor (formerly GPR91 or SUCNR1) is described as a metabolic sensor that may be involved in homeostasis.  Notwithstanding its implication in important (patho)physiol. processes, the function of succinate receptors has remained ill-defined because no pharmacol. tools were available.  We report on the discovery of the first family of potent synthetic agonists.  Exptl. Approach : We screened a library of succinate analogs and analyzed their activity on succinate receptors.  Also, we modelled a pharmacophore and a binding site for this receptor.  New agonists were identified based on the information provided by these two approaches.  Their activity was studied in various bioassays, including measurement of cAMP levels, [Ca2+]i mobilization, TGF-α shedding and recruitment of arrestin 3.  The in vivo effects of activating succinate receptors with these new agonists was evaluated on rat BP.  Key Results : We identified cis-epoxysuccinic acid and cis-1,2-cyclopropanedicarboxylic acid as agonists with an efficacy similar to that of succinic acid.  Interestingly, cis-epoxysuccinic acid was 10- to 20-fold more potent than succinic acid on succinate receptors.  For example, cis-epoxysuccinic acid reduced cAMP levels with a pEC50 = 5.57 ± 0.02 (EC50 = 2.7 μM), compared with succinate pEC50 = 4.54 ± 0.08 (EC50 = 29 μM).  The rank order of potency of the three agonists was the same in all in vitro assays.  Both cis-epoxysuccinic and cis-1,2-cyclopropanedicarboxylic acid were as potent as succinate in increasing rat BP.  Conclusions and Implications : We describe new agonists at succinate receptors that should facilitate further research on this understudied receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaDo2EIERJSbVg90H21EOLACvtfcHk0lgVJZhDYJzjLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVKns7c%253D&md5=5c5836e816fbbbd6a8f094e4ce63b715</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fbph.13738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13738%26sid%3Dliteratum%253Aachs%26aulast%3DGeubelle%26aufirst%3DP.%26aulast%3DGilissen%26aufirst%3DJ.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DPoma%26aufirst%3DL.%26aulast%3DDupuis%26aufirst%3DN.%26aulast%3DLaschet%26aufirst%3DC.%26aulast%3DAbboud%26aufirst%3DD.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DJouret%26aufirst%3DF.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DHanson%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520pharmacological%2520characterization%2520of%2520succinate%2520receptor%2520agonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D796%26epage%3D808%26doi%3D10.1111%2Fbph.13738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haffke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehlmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rummel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivineau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckely, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirockin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V.-P.</span></span> <span> </span><span class="NLM_article-title">Structural basis of species-selective antagonist binding to the succinate receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>574</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1663-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1038%2Fs41586-019-1663-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=31645725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVagsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=574&publication_year=2019&pages=581-585&author=M.+Haffkeauthor=D.+Fehlmannauthor=G.+Rummelauthor=J.+Boivineauauthor=M.+Duckelyauthor=N.+Gommermannauthor=S.+Cotestaauthor=F.+Sirockinauthor=F.+Freulerauthor=A.+Littlewood-Evansauthor=K.+Kaupmannauthor=V.-P.+Jaakola&title=Structural+basis+of+species-selective+antagonist+binding+to+the+succinate+receptor&doi=10.1038%2Fs41586-019-1663-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of species-selective antagonist binding to the succinate receptor</span></div><div class="casAuthors">Haffke, Matthias; Fehlmann, Dominique; Rummel, Gabriele; Boivineau, Jacques; Duckely, Myriam; Gommermann, Nina; Cotesta, Simona; Sirockin, Finton; Freuler, Felix; Littlewood-Evans, Amanda; Kaupmann, Klemens; Jaakola, Veli-Pekka</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">574</span>
        (<span class="NLM_cas:issue">7779</span>),
    <span class="NLM_cas:pages">581-585</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The tricarboxylic acid cycle intermediate succinate is involved in metabolic processes and plays a crucial role in the homeostasis of mitochondrial reactive oxygen species1.  The receptor responsible for succinate signalling, SUCNR1 (also known as GPR91), is a member of the G-protein-coupled-receptor family2 and links succinate signalling to renin-induced hypertension, retinal angiogenesis and inflammation3-5.  Because SUCNR1 senses succinate as an immunol. danger signal6-which has relevance for diseases including ulcerative colitis, liver fibrosis7, diabetes and rheumatoid arthritis3,8-it is of interest as a therapeutic target.  Here we report the high-resoln. crystal structure of rat SUCNR1 in complex with an intracellular binding nanobody in the inactive conformation.  Structure-based mutagenesis and radioligand-binding studies, in conjunction with mol. modeling, identified key residues for species-selective antagonist binding and enabled the detn. of the high-resoln. crystal structure of a humanized rat SUCNR1 in complex with a high-affinity, human-selective antagonist denoted NF-56-EJ40.  We anticipate that these structural insights into the architecture of the succinate receptor and its antagonist selectivity will enable structure-based drug discovery and will further help to elucidate the function of SUCNR1 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9By42eRbVnrVg90H21EOLACvtfcHk0lgVJZhDYJzjLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVagsbzL&md5=7a76c0a8fef43a8ccb968f8e5c3334ac</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1663-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1663-8%26sid%3Dliteratum%253Aachs%26aulast%3DHaffke%26aufirst%3DM.%26aulast%3DFehlmann%26aufirst%3DD.%26aulast%3DRummel%26aufirst%3DG.%26aulast%3DBoivineau%26aufirst%3DJ.%26aulast%3DDuckely%26aufirst%3DM.%26aulast%3DGommermann%26aufirst%3DN.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DSirockin%26aufirst%3DF.%26aulast%3DFreuler%26aufirst%3DF.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DJaakola%26aufirst%3DV.-P.%26atitle%3DStructural%2520basis%2520of%2520species-selective%2520antagonist%2520binding%2520to%2520the%2520succinate%2520receptor%26jtitle%3DNature%26date%3D2019%26volume%3D574%26spage%3D581%26epage%3D585%26doi%3D10.1038%2Fs41586-019-1663-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span> <i>Drug-like Properties: Concepts, Structure Design
and Methods from
ADME to Toxicity Optimization</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E.</span></span>, Eds.; <span class="NLM_publisher-name">Academic press</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+Di&author=E.+Kerns&title=Drug-like+Properties%3A+Concepts%2C+Structure+Design%0Aand+Methods+from%0AADME+to+Toxicity+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%2520Design%250Aand%2520Methods%2520from%250AADME%2520to%2520Toxicity%2520Optimization%26aulast%3DDi%26aufirst%3DL.%26pub%3DAcademic%2520press%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohnsland, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span> <span> </span><span class="NLM_article-title">High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1021/jm001020e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&author=F.+Wohnslandauthor=B.+Faller&title=High-throughput+permeability+pH+profile+and+high-throughput+alkane%2Fwater+log+P+with+artificial+membranes&doi=10.1021%2Fjm001020e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Permeability pH Profile and High-Throughput Alkane/Water log P with Artificial Membranes</span></div><div class="casAuthors">Wohnsland, Frank; Faller, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-930</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study reports on a novel, high-throughput assay, designed to predict passive, transcellular permeability in early drug discovery.  The assay is carried out in 96-well microtiterplates and measures the ability of compds. to diffuse from a donor to an acceptor compartment which are sepd. by a 9-10 μm hexadecane liq. layer.  A set of 32 well-characterized, chem. diverse drugs was used to validate the method.  The permeability values derived from the flux factors between donor and acceptor compartments show a good correlation with gastrointestinal absorption in humans.  For comparison, correlations based on exptl. or calcd. octanol/water distribution coeffs. (log Do/w,6.8) were significantly lower.  In addn., this simple and robust assay allows detn. of pH permeability profiles, crit. information to predict gastrointestinal absorption of ionizable drugs and difficult to obtain from cell culture expts.  Correction for the unstirred water layer effect allows to differentiate between effective and intrinsic membrane permeability and opens up the dynamic range of the method.  In addn., alkane/water partition coeffs. can be derived from intrinsic membrane permeabilities, making this assay the first high-throughput method able to measure alkane/water log P in the microtiterplate format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXoYADWFOUn7Vg90H21EOLACvtfcHk0lhRQBy4qlfvMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFSltA%253D%253D&md5=de19e881e03d62d48a8acfea729790b4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh-throughput%2520permeability%2520pH%2520profile%2520and%2520high-throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D923%26epage%3D930%26doi%3D10.1021%2Fjm001020e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Low, Y. W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span> <span> </span><span class="NLM_article-title">Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2016.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.ejps.2016.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=27373604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKrsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=110-116&author=Y.+W.+I.+Lowauthor=F.+Blascoauthor=P.+Vachaspati&title=Optimised+method+to+estimate+octanol+water+distribution+coefficient+%28logD%29+in+a+high+throughput+format&doi=10.1016%2Fj.ejps.2016.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Optimised method to estimate octanol water distribution coefficient (logD) in a high throughput format</span></div><div class="casAuthors">Low, Ying Wei; Blasco, Francesca; Vachaspati, Prakash</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lipophilicity is one of the mol. properties assessed in early drug discovery.  Direct measurement of the octanol-water distribution coeff. (logD) requires an anal. method with a large dynamic range or multistep dilns., as the analyte's concns. span across several orders of magnitude.  In addn., water/buffer and octanol phases which have very different polarity could lead to matrix effects and affect the LC-MS response, leading to erroneous logD values.  Most compd. libraries use DMSO stocks as it greatly reduces the sample requirement but the presence of DMSO has been shown to underestimate the lipophilicity of the analyte.  The present work describes the development of an optimized shake flask logD method using deepwell 96 well plate that addresses the issues related to matrix effects, DMSO concn. and incubation conditions and is also amenable to high throughput.  Our results indicate that the equil. can be achieved within 30 min by flipping the plate on its side while even 0.5% of DMSO is not tolerated in the assay.  This study uses the matched matrix concept to minimise the errors in analyzing the two phases namely buffer and octanol in LC-MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQW7-Y-gkR7Vg90H21EOLACvtfcHk0lhRQBy4qlfvMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKrsr%252FI&md5=97b8c5312efc8b7f535332af1c0d9cab</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DLow%26aufirst%3DY.%2BW.%2BI.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DVachaspati%26aufirst%3DP.%26atitle%3DOptimised%2520method%2520to%2520estimate%2520octanol%2520water%2520distribution%2520coefficient%2520%2528logD%2529%2520in%2520a%2520high%2520throughput%2520format%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D92%26spage%3D110%26epage%3D116%26doi%3D10.1016%2Fj.ejps.2016.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lhRQBy4qlfvMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velcicky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflieger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawtin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppertz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feifel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersperger, R.</span></span> <span> </span><span class="NLM_article-title">Modulating ADME properties by fluorination: MK2 inhibitors with improved oral exposure</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltV2jsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=392-396&author=J.+Velcickyauthor=A.+Schlapbachauthor=R.+Hengauthor=L.+Reveszauthor=D.+Pfliegerauthor=E.+Blumauthor=S.+Hawtinauthor=C.+Huppertzauthor=R.+Feifelauthor=R.+Hersperger&title=Modulating+ADME+properties+by+fluorination%3A+MK2+inhibitors+with+improved+oral+exposure&doi=10.1021%2Facsmedchemlett.8b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral Exposure</span></div><div class="casAuthors">Velcicky, Juraj; Schlapbach, Achim; Heng, Richard; Revesz, Laszlo; Pflieger, Daniel; Blum, Ernst; Hawtin, Stuart; Huppertz, Christine; Feifel, Roland; Hersperger, Rene</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-396</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MAP-activated protein kinase 2 (MK2) plays an important role in the regulation of innate immune response as well as in cell survival upon DNA damage.  Despite its potential for the treatment of inflammation and cancer, to date no MK2 low mol. wt. inhibitors have reached the clinic, mainly due to inadequate absorption, distribution, metab., and excretion (ADME) properties.  We describe here an approach based on specifically placed fluorine within a recently described pyrrole-based MK2 inhibitor scaffold for manipulation of its physicochem. and ADME properties.  While preserving target potency, the novel fluoro-derivs. showed greatly improved permeability as well as enhanced soly. and reduced in vivo clearance leading to significantly increased oral exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDrifcJh5ef7Vg90H21EOLACvtfcHk0lhRQBy4qlfvMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltV2jsLY%253D&md5=6dca69f60838d59b87c90a936682b13a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00098%26sid%3Dliteratum%253Aachs%26aulast%3DVelcicky%26aufirst%3DJ.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DPflieger%26aufirst%3DD.%26aulast%3DBlum%26aufirst%3DE.%26aulast%3DHawtin%26aufirst%3DS.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DHersperger%26aufirst%3DR.%26atitle%3DModulating%2520ADME%2520properties%2520by%2520fluorination%253A%2520MK2%2520inhibitors%2520with%2520improved%2520oral%2520exposure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D392%26epage%3D396%26doi%3D10.1021%2Facsmedchemlett.8b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, K.</span></span> <span> </span><span class="NLM_article-title">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.2533/chimia.2014.356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.2533%2Fchimia.2014.356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=25198745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=356-362&author=K.+M%C3%BCller&title=Simple+vector+considerations+to+assess+the+polarity+of+partially+fluorinated+alkyl+and+alkoxy+groups&doi=10.2533%2Fchimia.2014.356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups</span></div><div class="casAuthors">Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-362</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  While H/F exchange at aryl groups or introduction of CF3 units have dominated medicinal chem. for decades, the use of partially fluorinated alkyl and alkoxy groups has come into focus more recently.  A simple bond vector anal. scheme, based on the assumption of context-independent bond polarities as well as idealized configurational and conformational geometries, is applied to small alkyl and alkoxy groups with prototypic fluorination patterns for qual. assessments of relative polarities as well as polarity modulation by conformational change.  Combined with a const. vol. increase for each hydrogen/fluorine exchange these polarity ests. can be translated into expected lipophilicity shifts (ΔlogP), using a simple parameterization scheme derived from exptl. logP values.  While terminal monofluoro- and gem-difluoromethyl groups in small aliph. units are correctly predicted to show lower lipophilicity compared to their tri- or non-fluorinated congeners, vicinal difluoro and bis-vicinal trifluoro patterns are identified to exhibit significantly lower lipophilicities than their resp. geminal di- and trifluoro substituted counterparts.  The trifluoromethoxy group is diagnosed as an intrinsically lipophilic unit compared to the parent methoxy group.  The difluoromethoxy group is of particular interest as it can easily interconvert between a highly lipophilic and a polar conformation, thus enabling this unit to adjust to polarity changes of the mol. environment.  For di- and trifluoroalkoxy groups, again the vic-difluoro and bis-vic-trifluoro substitution patterns stand out as most promising to keep lipophilicity low.  The 1,3-difluoro pattern next to an ether moiety shows an interesting conformational dependence of polarity, similar to the difluoromethoxy group.  While very qual. in nature, the simple bond vector anal. promises to be a useful tool for the identification of lipophilicity-lowering fluorinated alkyl or alkoxy groups and particularly those groups that display marked conformation-dependent lipophilicity and thus potentially serve as 'environmental adaptors'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yZ2IogEjkrVg90H21EOLACvtfcHk0lj3pZcu_Cdceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1emsLrI&md5=073bd4a2d1d9dcc5f1540296263dda62</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.356%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DSimple%2520vector%2520considerations%2520to%2520assess%2520the%2520polarity%2520of%2520partially%2520fluorinated%2520alkyl%2520and%2520alkoxy%2520groups%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D356%26epage%3D362%26doi%3D10.2533%2Fchimia.2014.356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecours, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marta, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillion, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keddie, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, T. B.</span></span> <span> </span><span class="NLM_article-title">Janus face aspect of all-cis 1,2,3,4,5,6-hexafluorocyclohexane dictates remarkable anion and cation interactions in the gas phase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">7460</span>– <span class="NLM_lpage">7463</span>, <span class="refDoi"> DOI: 10.1021/jacs.6b02856</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.6b02856" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=7460-7463&author=B.+E.+Zieglerauthor=M.+Lecoursauthor=R.+A.+Martaauthor=J.+Featherstoneauthor=E.+Fillionauthor=W.+S.+Hopkinsauthor=V.+Steinmetzauthor=N.+S.+Keddieauthor=D.+O%E2%80%99Haganauthor=T.+B.+McMahon&title=Janus+face+aspect+of+all-cis+1%2C2%2C3%2C4%2C5%2C6-hexafluorocyclohexane+dictates+remarkable+anion+and+cation+interactions+in+the+gas+phase&doi=10.1021%2Fjacs.6b02856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Janus Face Aspect of All-cis 1,2,3,4,5,6-Hexafluorocyclohexane Dictates Remarkable Anion and Cation Interactions In the Gas Phase</span></div><div class="casAuthors">Ziegler, Blake E.; Lecours, Michael; Marta, Rick A.; Featherstone, Joshua; Fillion, Eric; Hopkins, W. Scott; Steinmetz, Vincent; Keddie, Neil S.; O'Hagan, David; McMahon, Terrance B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7460-7463</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Expts. were carried out in which electrospray ionization was used to generate ionic complexes of all-cis-1,2,3,4,5,6-hexafluorocyclohexane.  These complexes were subsequently mass isolated in a quadrupole ion trap mass spectrometer and then irradiated by the tunable IR output of a free electron laser in the 800-1600 cm-1 range.  From the frequency dependence of the fragmentation of the complexes, vibrational signatures of the complexes were obtained.  Computational work carried out in parallel reveals that the complexes formed are very strongly bound and are among the most strongly bound complexes of Na+ and Cl- ever obsd. with mol. species.  The dipole moment calcd. for the heaxafluorocyclohexane is very large (∼7 D), and apparently the bonding in each of the complexes has a significant electrostatic contribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOcxldRsWtLVg90H21EOLACvtfcHk0lj3pZcu_Cdceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCmurY%253D&md5=cc190a84a0a188ba31223d86e68ebfdf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjacs.6b02856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.6b02856%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DB.%2BE.%26aulast%3DLecours%26aufirst%3DM.%26aulast%3DMarta%26aufirst%3DR.%2BA.%26aulast%3DFeatherstone%26aufirst%3DJ.%26aulast%3DFillion%26aufirst%3DE.%26aulast%3DHopkins%26aufirst%3DW.%2BS.%26aulast%3DSteinmetz%26aufirst%3DV.%26aulast%3DKeddie%26aufirst%3DN.%2BS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%26aulast%3DMcMahon%26aufirst%3DT.%2BB.%26atitle%3DJanus%2520face%2520aspect%2520of%2520all-cis%25201%252C2%252C3%252C4%252C5%252C6-hexafluorocyclohexane%2520dictates%2520remarkable%2520anion%2520and%2520cation%2520interactions%2520in%2520the%2520gas%2520phase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2016%26volume%3D138%26spage%3D7460%26epage%3D7463%26doi%3D10.1021%2Fjacs.6b02856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainolfi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jendza, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solovay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prentiss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradoux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Erkenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogi, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and preclinical characterization of selective Factor D inhibitors targeting the alternative complement pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4656</span>– <span class="NLM_lpage">4668</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00271</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00271" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnslalsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4656-4668&author=R.+G.+Karkiauthor=J.+Powersauthor=N.+Mainolfiauthor=K.+Andersonauthor=D.+B.+Belangerauthor=D.+Liuauthor=N.+Jiauthor=K.+Jendzaauthor=C.+F.+Gelinauthor=A.+Mac+Sweeneyauthor=C.+Solovayauthor=O.+Delgadoauthor=M.+Crowleyauthor=S.+M.+Liaoauthor=U.+A.+Argikarauthor=S.+Flohrauthor=L.+R.+La+Bonteauthor=E.+L.+Lorthioisauthor=A.+Vulpettiauthor=A.+Brownauthor=D.+Longauthor=M.+Prentissauthor=N.+Gradouxauthor=A.+de+Erkenezauthor=F.+Cuminauthor=C.+Adamsauthor=B.+Jaffeeauthor=M.+Mogi&title=Design%2C+synthesis%2C+and+preclinical+characterization+of+selective+Factor+D+inhibitors+targeting+the+alternative+complement+pathway&doi=10.1021%2Facs.jmedchem.9b00271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway</span></div><div class="casAuthors">Karki, Rajeshri G.; Powers, James; Mainolfi, Nello; Anderson, Karen; Belanger, David B.; Liu, Donglei; Ji, Nan; Jendza, Keith; Gelin, Christine F.; Mac Sweeney, Aengus; Solovay, Catherine; Delgado, Omar; Crowley, Maura; Liao, Sha-Mei; Argikar, Upendra A.; Flohr, Stefanie; La Bonte, Laura R.; Lorthiois, Edwige L.; Vulpetti, Anna; Brown, Ann; Long, Debby; Prentiss, Melissa; Gradoux, Nathalie; de Erkenez, Andrea; Cumin, Frederic; Adams, Christopher; Jaffee, Bruce; Mogi, Muneto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4656-4668</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system.  Dysregulation of AP activity predisposes individuals to diverse disorders such as age-related macular degeneration, atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis type II, and paroxysmal nocturnal hemoglobinuria.  Previously, the authors have reported the screening efforts and identification of reversible benzylamine-based FD inhibitors (I and II) binding to the open active conformation of FD.  In continuation of the authors' drug discovery program, the authors designed compds. applying structure-based approaches to improve interactions with FD and gain selectivity against S1 serine proteases.  The authors report herein the design, synthesis, and medicinal chem. optimization of the benzylamine series culminating in the discovery of (S)-2-(2-((3'-(1-Amino-2-hydroxyethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic acid, an orally bioavailable and selective FD inhibitor.  (S)-2-(2-((3'-(1-Amino-2-hydroxyethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic acid demonstrated systemic suppression of AP activation in a lipopolysaccharide-induced AP activation model as well as local ocular suppression in intravitreal injection-induced AP activation model in mice expressing human FD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov5uolWfBzK7Vg90H21EOLACvtfcHk0lhNe44sbkcJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnslalsbw%253D&md5=a4a56886a758093516952737306a5d8a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00271%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DR.%2BG.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DMainolfi%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DBelanger%26aufirst%3DD.%2BB.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DN.%26aulast%3DJendza%26aufirst%3DK.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DSolovay%26aufirst%3DC.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DCrowley%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DLorthiois%26aufirst%3DE.%2BL.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DLong%26aufirst%3DD.%26aulast%3DPrentiss%26aufirst%3DM.%26aulast%3DGradoux%26aufirst%3DN.%26aulast%3Dde%2BErkenez%26aufirst%3DA.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DMogi%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preclinical%2520characterization%2520of%2520selective%2520Factor%2520D%2520inhibitors%2520targeting%2520the%2520alternative%2520complement%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4656%26epage%3D4668%26doi%3D10.1021%2Facs.jmedchem.9b00271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roache, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes-Seeman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassiepen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvadie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiering, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weihofen, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perruccio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dentel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zessis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis-Symynkywicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghausen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruedisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C. M.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and pre-clinical characterization of selective and orally bioavailable Factor XIa inhibitors: Demonstrating the power of an integrated S1 protease family approach in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8113</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFymu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8088-8113&author=E.+Lorthioisauthor=J.+Roacheauthor=D.+Barnes-Seemanauthor=E.+Altmannauthor=U.+Hassiepenauthor=G.+Turnerauthor=R.+Duvadieauthor=V.+Hornakauthor=R.+G.+Karkiauthor=N.+Schieringauthor=W.+A.+Weihofenauthor=F.+Perruccioauthor=A.+Calhounauthor=T.+Fazalauthor=D.+Dedicauthor=C.+Durandauthor=S.+Dussaugeauthor=K.+Fettisauthor=F.+Tritschauthor=C.+Dentelauthor=A.+Druetauthor=D.+Liuauthor=L.+Kirmanauthor=J.+Lachalauthor=K.+Namotoauthor=D.+Bevanauthor=R.+Moauthor=G.+Monnetauthor=L.+Mullerauthor=R.+Zessisauthor=X.+Huangauthor=L.+Lindsleyauthor=T.+Currieauthor=Y.-H.+Chiuauthor=C.+Fridrichauthor=P.+Delgadoauthor=S.+Wangauthor=M.+Hollis-Symynkywiczauthor=J.+Berghausenauthor=E.+Williamsauthor=H.+Liuauthor=G.+Liangauthor=H.+Kimauthor=P.+Hoffmannauthor=A.+Heinauthor=P.+Ramageauthor=A.+D%E2%80%99Arcyauthor=S.+Harlfingerauthor=M.+Renatusauthor=S.+Ruedisserauthor=D.+Feldmanauthor=J.+Elliottauthor=R.+Sedraniauthor=J.+Maibaumauthor=C.+M.+Adams&title=Structure-based+design+and+pre-clinical+characterization+of+selective+and+orally+bioavailable+Factor+XIa+inhibitors%3A+Demonstrating+the+power+of+an+integrated+S1+protease+family+approach+in+drug+discovery&doi=10.1021%2Facs.jmedchem.0c00279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach</span></div><div class="casAuthors">Lorthiois, Edwige; Roache, James; Barnes-Seeman, David; Altmann, Eva; Hassiepen, Ulrich; Turner, Gordon; Duvadie, Rohit; Hornak, Viktor; Karki, Rajeshri G.; Schiering, Nikolaus; Weihofen, Wilhelm A.; Perruccio, Francesca; Calhoun, Amy; Fazal, Tanzina; Dedic, Darija; Durand, Corinne; Dussauge, Solene; Fettis, Kamal; Tritsch, Fabien; Dentel, Celine; Druet, Adelaide; Liu, Donglei; Kirman, Louise; Lachal, Julie; Namoto, Kenji; Bevan, Douglas; Mo, Rose; Monnet, Gabriela; Muller, Lionel; Zessis, Richard; Huang, Xueming; Lindsley, Loren; Currie, Treeve; Chiu, Yu-Hsin; Fridrich, Cary; Delgado, Peter; Wang, Shuangxi; Hollis-Symynkywicz, Micah; Berghausen, Joerg; Williams, Eric; Liu, Hong; Liang, Guiqing; Kim, Hyungchul; Hoffmann, Peter; Hein, Andreas; Ramage, Paul; D'Arcy, Allan; Harlfinger, Stefanie; Renatus, Martin; Ruedisser, Simon; Feldman, David; Elliott, Jason; Sedrani, Richard; Maibaum, Juergen; Adams, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8088-8113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The serine protease factor XI (FXI) is a prominent drug target as it holds promise to deliver efficacious anticoagulation without an enhanced risk of major bleeds.  Several efforts have been described targeting the active form of the enzyme, FXIa.  Herein, we disclose our efforts to identify potent, selective, and orally bioavailable inhibitors of FXIa.  Compd. 1, identified from a diverse library of internal serine protease inhibitors, was originally designed as a complement factor D inhibitor and exhibited submicromolar FXIa activity and an encouraging absorption, distribution, metab., and excretion (ADME) profile while being devoid of a peptidomimetic architecture.  Optimization of interactions in the S1, S1β, and S1' pockets of FXIa through a combination of structure-based drug design and traditional medicinal chem. led to the discovery of compd. 23 with subnanomolar potency on FXIa, enhanced selectivity over other coagulation proteases, and a preclin. pharmacokinetics (PK) profile consistent with bid dosing in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrysqlO_YjosbVg90H21EOLACvtfcHk0lhNe44sbkcJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFymu7%252FO&md5=e2b187ccf8c81b83acd31db1320842bc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00279%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DRoache%26aufirst%3DJ.%26aulast%3DBarnes-Seeman%26aufirst%3DD.%26aulast%3DAltmann%26aufirst%3DE.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DTurner%26aufirst%3DG.%26aulast%3DDuvadie%26aufirst%3DR.%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DKarki%26aufirst%3DR.%2BG.%26aulast%3DSchiering%26aufirst%3DN.%26aulast%3DWeihofen%26aufirst%3DW.%2BA.%26aulast%3DPerruccio%26aufirst%3DF.%26aulast%3DCalhoun%26aufirst%3DA.%26aulast%3DFazal%26aufirst%3DT.%26aulast%3DDedic%26aufirst%3DD.%26aulast%3DDurand%26aufirst%3DC.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DTritsch%26aufirst%3DF.%26aulast%3DDentel%26aufirst%3DC.%26aulast%3DDruet%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DKirman%26aufirst%3DL.%26aulast%3DLachal%26aufirst%3DJ.%26aulast%3DNamoto%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DD.%26aulast%3DMo%26aufirst%3DR.%26aulast%3DMonnet%26aufirst%3DG.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DZessis%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLindsley%26aufirst%3DL.%26aulast%3DCurrie%26aufirst%3DT.%26aulast%3DChiu%26aufirst%3DY.-H.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DDelgado%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHollis-Symynkywicz%26aufirst%3DM.%26aulast%3DBerghausen%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DHein%26aufirst%3DA.%26aulast%3DRamage%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DHarlfinger%26aufirst%3DS.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DRuedisser%26aufirst%3DS.%26aulast%3DFeldman%26aufirst%3DD.%26aulast%3DElliott%26aufirst%3DJ.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DC.%2BM.%26atitle%3DStructure-based%2520design%2520and%2520pre-clinical%2520characterization%2520of%2520selective%2520and%2520orally%2520bioavailable%2520Factor%2520XIa%2520inhibitors%253A%2520Demonstrating%2520the%2520power%2520of%2520an%2520integrated%2520S1%2520protease%2520family%2520approach%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8088%26epage%3D8113%26doi%3D10.1021%2Facs.jmedchem.0c00279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüdisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and design of first benzylamine-based ligands binding to an unlocked conformation of the Complement Factor D</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00104</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00104" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=490-495&author=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=T.+Yoonauthor=A.+Mac+Sweeneyauthor=F.+Cuminauthor=E.+Lorthioisauthor=S.+R%C3%BCdisserauthor=P.+Erbelauthor=J.+Maibaum&title=Discovery+and+design+of+first+benzylamine-based+ligands+binding+to+an+unlocked+conformation+of+the+Complement+Factor+D&doi=10.1021%2Facsmedchemlett.8b00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D</span></div><div class="casAuthors">Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Yoon, Taeyoung; MacSweeney, Aengus; Cumin, Frederic; Lorthiois, Edwige; Rudisser, Simon; Erbel, Paul; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complement Factor D, a serine protease of the S1 family and key component of the alternative pathway amplification loop, represents a promising target for the treatment of several prevalent and rare diseases linked to the innate immune system.  Previously reported FD inhibitors have been shown to bind to the FD active site in its self-inhibited conformation characterized by the presence of a salt bridge at the bottom of the S1 pocket between Asp189 and Arg218.  We report herein a new set of small-mol. FD ligands that harbor a basic S1 binding moiety directly binding to the carboxylate of Asp189, thereby displacing the Asp189-Arg218 ionic interaction and significantly changing the conformation of the self-inhibitory loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRdpNj9LCQYrVg90H21EOLACvtfcHk0lidFj4DYFrJ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D&md5=c24dccac197253f882e3a38a86a597ed</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00104%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DR%25C3%25BCdisser%26aufirst%3DS.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520design%2520of%2520first%2520benzylamine-based%2520ligands%2520binding%2520to%2520an%2520unlocked%2520conformation%2520of%2520the%2520Complement%2520Factor%2520D%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D490%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.8b00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmonson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastracchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beconi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colwell, L. F.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habulihaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmee, E. R.</span></span> <span> </span><span class="NLM_article-title">Potent and selective proline derived dipeptidyl peptidase IV inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5151</span>– <span class="NLM_lpage">5155</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.07.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.bmcl.2004.07.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=15380217" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5151-5155&author=S.+D.+Edmonsonauthor=A.+Mastracchioauthor=M.+Beconiauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=S.+Kumarauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=A.+Maoauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Potent+and+selective+proline+derived+dipeptidyl+peptidase+IV+inhibitors&doi=10.1016%2Fj.bmcl.2004.07.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.07.056%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonson%26aufirst%3DS.%2BD.%26aulast%3DMastracchio%26aufirst%3DA.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DPotent%2520and%2520selective%2520proline%2520derived%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5151%26epage%3D5155%26doi%3D10.1016%2Fj.bmcl.2004.07.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathvink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leiting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2533</span>– <span class="NLM_lpage">2536</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1016%2Fj.bmcl.2005.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=15863311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2533-2536&author=J.+Xuauthor=L.+Weiauthor=R.+Mathvinkauthor=J.+Heauthor=Y.+J.+Parkauthor=H.+Heauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Discovery+of+potent+and+selective+phenylalanine+based+dipeptidyl+peptidase+IV+inhibitors&doi=10.1016%2Fj.bmcl.2005.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Xu, Jinyou; Wei, Lan; Mathvink, Robert; He, Jiafang; Park, You-Jung; He, Huaibing; Leiting, Barbara; Lyons, Kathryn A.; Marsilio, Frank; Patel, Reshma A.; Wu, Joseph K.; Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2533-2536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anti-Substituted β-methylphenylalanine derived amides have been shown to be potent DPP-IV inhibitors exhibiting excellent selectivity over both DPP8 and DPP9.  These are among the most potent compds. reported to date lacking an electrophilic trap.  The most potent compd. among these is 5-oxo-1,2,4-oxadiazole I, which is a 3 nM DPP-IV inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRQ1sHQJH4ebVg90H21EOLACvtfcHk0lidFj4DYFrJ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D&md5=14bb621ee7b95eb2e00ac0bd5c8c99eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520phenylalanine%2520based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2533%26epage%3D2536%26doi%3D10.1016%2Fj.bmcl.2005.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caudana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span> <span> </span><span class="NLM_article-title">Permeability prediction for zwitterions via chromatographic indexes and classification into ‘certain’ and ‘uncertain’</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1553</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.4155/fmc-2019-0071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.4155%2Ffmc-2019-0071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=31240942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1553-1563&author=F.+Caudanaauthor=G.+Ermondiauthor=M.+Vallaroauthor=M.+Shalaevaauthor=G.+Caron&title=Permeability+prediction+for+zwitterions+via+chromatographic+indexes+and+classification+into+%E2%80%98certain%E2%80%99+and+%E2%80%98uncertain%E2%80%99&doi=10.4155%2Ffmc-2019-0071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Permeability prediction for zwitterions via chromatographic indexes and classification into 'certain' and 'uncertain'</span></div><div class="casAuthors">Caudana, Francesco; Ermondi, Giuseppe; Vallaro, Maura; Shalaeva, Marina; Caron, Giulia</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1553-1563</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: The development of zwitterions to a drug is likely to be more challenging than compds. of other charge types.  Results: Two chromatog. indexes (log k'80 PLRP-S and log KWIAM) can be successfully used as permeability classifiers of ampholytes.  Moreover, a pragmatic classification into ordinary ampholytes; zwitterions 'certain' (i.e., the zwitterionic species is dominant in the physiol. pH range); and zwitterions 'uncertain' (multiple species are present in the physiol. pH range) enables to study the permeability of ampholytic compds. in relation to species distribution.  Methodol.: Potentiometry (pKa), reversed-phase (RP)-chromatog., tri-layer parallel artificial membrane permeability assays, quant. structure-property relationships (QSPR) and block relevance (BR) anal., receiver operating characteristic (ROC) curves.  Conclusion: Structures considered as poorly permeable like zwitterions can be integrated in drug discovery programs by applying ad hoc exptl. and computational tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohpo5wES8SnrVg90H21EOLACvtfcHk0lidFj4DYFrJ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1yhtrzF&md5=3da20dc0eb7f47762ec64f0fa639061b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2019-0071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2019-0071%26sid%3Dliteratum%253Aachs%26aulast%3DCaudana%26aufirst%3DF.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DVallaro%26aufirst%3DM.%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DG.%26atitle%3DPermeability%2520prediction%2520for%2520zwitterions%2520via%2520chromatographic%2520indexes%2520and%2520classification%2520into%2520%25E2%2580%2598certain%25E2%2580%2599%2520and%2520%25E2%2580%2598uncertain%25E2%2580%2599%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D1553%26epage%3D1563%26doi%3D10.4155%2Ffmc-2019-0071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.-S.</span></span> <span> </span><span class="NLM_article-title">Plasma protein binding: from discovery to development</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">2953</span>– <span class="NLM_lpage">2994</span>, <span class="refDoi"> DOI: 10.1002/jps.23614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2Fjps.23614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=23798314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=2953-2994&author=T.+Bohnertauthor=L.-S.+Gan&title=Plasma+protein+binding%3A+from+discovery+to+development&doi=10.1002%2Fjps.23614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma protein binding: From discovery to development</span></div><div class="casAuthors">Bohnert, Tonika; Gan, Liang-Shang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2953-2994</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The importance of plasma protein binding (PPB) in modulating the effective drug concn. at pharmacol. target sites has been the topic of significant discussion and debate amongst drug development groups over the past few decades.  Free drug theory, which states that in absence of energy-dependent processes, after steady state equil. has been attained, free drug concn. in plasma is equal to free drug concn. at the pharmacol. target receptor(s) in tissues, has been used to explain pharmacokinetics/pharmacodynamics relationships in a large no. of cases.  Any sudden increase in free concn. of a drug could potentially cause toxicity and may need dose adjustment.  Free drug concn. is also helpful to est. the effective concn. of drugs that potentially can ppt. metab. (or transporter)-related drug-drug interactions.  Disease models are extensively validated in animals to progress a compd. into development.  Unbound drug concn., and therefore PPB information across species is very informative in establishing safety margins and guiding selection of First in Human (FIH) dose and human efficacious dose.  The scope of this review is to give an overview of reported role of PPB in several therapeutic areas, highlight cases where PPB changes are clin. relevant, and provide drug metab. and pharmacokinetics recommendations in discovery and development settings. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqobJp8eG98XrVg90H21EOLACvtfcHk0lif1481L9fldQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymt7c%253D&md5=d676f7490c6e0f09c8acf7cce5183b17</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.23614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23614%26sid%3Dliteratum%253Aachs%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DGan%26aufirst%3DL.-S.%26atitle%3DPlasma%2520protein%2520binding%253A%2520from%2520discovery%2520to%2520development%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D2953%26epage%3D2994%26doi%3D10.1002%2Fjps.23614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span> <span> </span><span class="NLM_article-title">Zwitterionic structures: from physicochemical properties toward computer-aided drug designs</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2262</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.4155%2Ffmc-2016-0176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=27874291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCjsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=2245-2262&author=Z.+Yangauthor=Q.+Liauthor=G.+Yang&title=Zwitterionic+structures%3A+from+physicochemical+properties+toward+computer-aided+drug+designs&doi=10.4155%2Ffmc-2016-0176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Zwitterionic structures: from physicochemical properties toward computer-aided drug designs</span></div><div class="casAuthors">Yang, Zhiwei; Li, Qinyi; Yang, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2245-2262</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Zwitterions, used widely in chem., biol. and medicinal fields, show distinct physicochem. properties relative to ordinary ampholytes, which largely decide their bioavailability and biol. activities.  In the present manuscript, these properties are discussed in order to facilitate our understanding of zwitterionic structures, followed by various examples of zwitterionic drugs and the crit. role these properties play.  We specifically focus our discussions on neuraminidase inhibitors (NAIs), which are used in the treatment and prevention of influenza, covering their computer-assisted design, transformation to zwitterionic isomers and interaction mechanisms of NAIs with proteins.  The discovery and development of NAIs provide useful insights that may assist in the exploration of new zwitterionic drugs.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxfDWrce1a7Vg90H21EOLACvtfcHk0lif1481L9fldQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCjsLbE&md5=66a234e03eedf85e908515e9cd43b181</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0176%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DG.%26atitle%3DZwitterionic%2520structures%253A%2520from%2520physicochemical%2520properties%2520toward%2520computer-aided%2520drug%2520designs%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D2245%26epage%3D2262%26doi%3D10.4155%2Ffmc-2016-0176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berellini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span> <span> </span><span class="NLM_article-title">Benefit of retraining pKa models studied using internally measured data</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1459</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1449-1459&author=P.+Gedeckauthor=Y.+Luauthor=S.+Skolnikauthor=S.+Roddeauthor=G.+Dollingerauthor=W.+Jiaauthor=G.+Berelliniauthor=R.+Vianelloauthor=B.+Fallerauthor=F.+Lombardo&title=Benefit+of+retraining+pKa+models+studied+using+internally+measured+data&doi=10.1021%2Facs.jcim.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of Retraining pKa Models Studied Using Internally Measured Data</span></div><div class="casAuthors">Gedeck, Peter; Lu, Yipin; Skolnik, Suzanne; Rodde, Stephane; Dollinger, Gavin; Jia, Weiping; Berellini, Giuliano; Vianello, Riccardo; Faller, Bernard; Lombardo, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ionization state of drugs influences many pharmaceutical properties such as their soly., permeability, and biol. activity.  It is therefore important to understand the structure property relation for the acid-base dissocn. const. pKa during the lead optimization process to make better-informed design decisions.  Computational approaches, such as implemented in MoKa, can help with this; however, they often predict with too large error esp. for proprietary compds.  In this contribution, the authors look at how retraining helps to greatly improve prediction error.  Using a longitudinal study with data measured over 15 years in a drug discovery environment, the authors assess the impact of model training on prediction accuracy and look at model degrdn. over time.  Using the MoKa software, regular retraining is required to address changes in chem. space leading to model degrdn. over six to nine months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCUz-ylPu6bVg90H21EOLACvtfcHk0lif1481L9fldQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ&md5=6a178b50d5ac0a597391cc2b19af8e32</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DDollinger%26aufirst%3DG.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DBenefit%2520of%2520retraining%2520pKa%2520models%2520studied%2520using%2520internally%2520measured%2520data%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D1449%26epage%3D1459%26doi%3D10.1021%2Facs.jcim.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsinman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, N.</span></span> <span> </span><span class="NLM_article-title">The permeation of amphoteric drugs through artificial membranes - An in combo absorption model based on paracellular and transmembrane permeability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1021/jm901421c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901421c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2hurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=392-401&author=K.+Y.+Tamauthor=A.+Avdeefauthor=O.+Tsinmanauthor=N.+Sun&title=The+permeation+of+amphoteric+drugs+through+artificial+membranes+-+An+in+combo+absorption+model+based+on+paracellular+and+transmembrane+permeability&doi=10.1021%2Fjm901421c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The Permeation of Amphoteric Drugs through Artificial Membranes - An in Combo Absorption Model Based on Paracellular and Transmembrane Permeability</span></div><div class="casAuthors">Tam, Kin Y.; Avdeef, Alex; Tsinman, Oksana; Sun, Na</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The permeability characteristics of 33 amphoteric drugs (about 64% zwitterions at physiol. pH) were studied using the parallel artificial membrane permeability assay (PAMPA) at pH 6.5.  The PAMPA data were modified to include the paracellular permeability component found in cellular monolayers based on a newly generalized version of a popular model devised for Caco-2 cells.  These "in combo" PAMPA data were used to predict the human abs. bioavailability of the ampholytes.  The anal. produced a good fit, with only five outliers whose transport properties, could be rationalized by (a) nonpassive permeability processes, (b) metabolic instability, and (c) the possible sensitivity to microclimate pH effects in the case of acidic ampholytes.  With the exception of two compds., all of the ampholytes with bioavailability <50% were predominantly transported by the paracellular route, surprisingly with several of the compds. having mol. wts. exceeding 350 Da.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAna98uyyUs7Vg90H21EOLACvtfcHk0lh3rfPm2clZgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2hurjO&md5=93344e87f7a783144a1f57bcafbfa6ca</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901421c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901421c%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DK.%2BY.%26aulast%3DAvdeef%26aufirst%3DA.%26aulast%3DTsinman%26aufirst%3DO.%26aulast%3DSun%26aufirst%3DN.%26atitle%3DThe%2520permeation%2520of%2520amphoteric%2520drugs%2520through%2520artificial%2520membranes%2520-%2520An%2520in%2520combo%2520absorption%2520model%2520based%2520on%2520paracellular%2520and%2520transmembrane%2520permeability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D392%26epage%3D401%26doi%3D10.1021%2Fjm901421c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoermer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Orally absorbed cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">8094</span>– <span class="NLM_lpage">8128</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00838</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=8094-8128&author=D.+S.+Nielsenauthor=N.+E.+Shepherdauthor=W.+Xuauthor=A.+J.+Luckeauthor=M.+J.+Stoermerauthor=D.+P.+Fairlie&title=Orally+absorbed+cyclic+peptides&doi=10.1021%2Facs.chemrev.6b00838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Absorbed Cyclic Peptides</span></div><div class="casAuthors">Nielsen, Daniel S.; Shepherd, Nicholas E.; Xu, Weijun; Lucke, Andrew J.; Stoermer, Martin J.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8094-8128</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptides and proteins are not orally bioavailable in mammals, although a few peptides are intestinally absorbed in small amts.  Polypeptides are generally too large and polar to passively diffuse through lipid membranes, while most known active transport mechanisms facilitate cell uptake of only very small peptides.  Systematic evaluations of peptides with mol. wts. above 500 Da are needed to identify parameters that influence oral bioavailability.  Here we describe 125 cyclic peptides contg. four to thirty-seven amino acids that are orally absorbed by mammals.  Cyclization minimizes degrdn. in the gut, blood and tissues by removing cleavable N- and C-termini and by shielding components from metabolic enzymes.  Cyclization also folds peptides into bioactive conformations that det. exposure of polar atoms to solvation by water and lipids, and therefore should influence oral bioavailability.  Key chem. properties thought to influence oral absorption and bioavailability are analyzed, including mol. wt., octanol-water partitioning, hydrogen bond donors/acceptors, rotatable bonds and polar surface area.  The cyclic peptides violated to different degrees all of the limits traditionally considered to be important for oral bioavailability of drug-like small mols., although fewer hydrogen bond donors and reduced flexibility generally favored oral absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHf1YVkf7ErVg90H21EOLACvtfcHk0lh3rfPm2clZgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D&md5=38af1945471e5ddffd3ae630ebbe129b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00838%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DD.%2BS.%26aulast%3DShepherd%26aufirst%3DN.%2BE.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLucke%26aufirst%3DA.%2BJ.%26aulast%3DStoermer%26aufirst%3DM.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DOrally%2520absorbed%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D8094%26epage%3D8128%26doi%3D10.1021%2Facs.chemrev.6b00838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussinov, R.</span></span> <span> </span><span class="NLM_article-title">Close-range electrostatic interactions in proteins</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">604</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=12324994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1Kmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=604-617&author=S.+Kumarauthor=R.+Nussinov&title=Close-range+electrostatic+interactions+in+proteins&doi=10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Close-range electrostatic interactions in proteins</span></div><div class="casAuthors">Kumar, Sandeep; Nussinov, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">604-617</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review with 59 refs.  Two types of noncovalent bonding interactions are present in protein structures, specific and nonspecific.  Nonspecific interactions are mostly hydrophobic and van der Waals.  Specific interactions are largely electrostatic.  Whereas the hydrophobic effect is the major driving force in protein folding, electrostatic interactions are important in protein folding, stability, flexibility, and function.  Here, the authors review the role of close-range electrostatic interactions (salt bridges) and their networks in proteins.  Salt bridges are formed by spatially proximal pairs of oppositely charged residues in native protein structures.  Often salt-bridging residues are also close in the protein sequence and fall in the same secondary structural element, building block, autonomous folding unit, domain, or subunit, consistent with the hierarchical model for protein folding.  Recent evidence also suggests that charged and polar residues in largely hydrophobic interfaces may act as hot spots for binding.  Salt bridges are rarely found across protein parts which are joined by flexible hinges, a fact suggesting that salt bridges constrain flexibility and motion.  Whereas conventional chem. intuition expects that salt bridges contribute favorably to protein stability, recent computational and exptl. evidence shows that salt bridges can be either stabilizing or destabilizing.  Due to systemic protein flexibility, reflected in small-scale side-chain and backbone atom motions, salt bridges and their stabilities fluctuate in proteins.  At the same time, genome-wide, amino acid sequence compn., structural, and thermodn. comparisons of thermophilic and mesophilic proteins indicate that specific interactions, such as salt bridges, may contribute significantly toward the thermophilic-mesophilic protein stability differential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRHG8yeknSJLVg90H21EOLACvtfcHk0lh3rfPm2clZgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1Kmtbw%253D&md5=ca8b51ea594b21580d716f3efe9cf92b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820020703%25293%253A7%253C604%253A%253AAID-CBIC604%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DNussinov%26aufirst%3DR.%26atitle%3DClose-range%2520electrostatic%2520interactions%2520in%2520proteins%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D604%26epage%3D617%26doi%3D10.1002%2F1439-7633%2820020703%293%3A7%3C604%3A%3AAID-CBIC604%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1707</span>– <span class="NLM_lpage">1729</span>, <span class="refDoi"> DOI: 10.1002/med.21562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2Fmed.21562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=30659634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1707-1729&author=G.+Caronauthor=J.+Kihlbergauthor=G.+Ermondi&title=Intramolecular+hydrogen+bonding%3A+An+opportunity+for+improved+design+in+medicinal+chemistry&doi=10.1002%2Fmed.21562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry</span></div><div class="casAuthors">Caron, Giulia; Kihlberg, Jan; Ermondi, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1707-1729</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Recent literature shows that intramol. hydrogen bond (IMHB) formation can pos. impact upon the triad of permeability, soly., and potency of drugs and candidates.  IMHB modulation can be applied to compds. in any chem. space as a means for discovering drug candidates with both acceptable potency and absorption, distribution, metab., and excretion-Tox profiles.  Integrating IMHB formation in design of drugs is, therefore, an exciting and timely challenge for modern medicinal chem.  In this review, we first provide some background about IMHBs from the medicinal chemist's point of view and highlight some IMHB-assocd. misconceptions.  Second, we propose a classification of IMHBs for drug discovery purposes, review the most common in silico tactics to include IMHBs in lead optimization and list some exptl. physicochem. descriptors, which quantify the propensity of compds. to form IMHBs.  By focusing on the compds. size and the no. of IMHBs that can potentially be formed, we also outline the major difficulties encountered when designing compds. based on the inclusion of IMHBs.  Finally, we discuss recent case studies illustrating the application of IMHB to optimize cell permeability and physicochem. properties of small mols., cyclic peptides and macrocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUDeUtYxxbaLVg90H21EOLACvtfcHk0lhIwYZt4DaKRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOjtbnF&md5=8c0b208b54443ac2ebe6f241183e5348</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fmed.21562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21562%26sid%3Dliteratum%253Aachs%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DKihlberg%26aufirst%3DJ.%26aulast%3DErmondi%26aufirst%3DG.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%253A%2520An%2520opportunity%2520for%2520improved%2520design%2520in%2520medicinal%2520chemistry%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1707%26epage%3D1729%26doi%3D10.1002%2Fmed.21562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1021/ci7002494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.+A.+Brameldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis&doi=10.1021%2Fci7002494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule conformational preferences derived from crystal structure data. a medicinal chemistry focused analysis</span></div><div class="casAuthors">Brameld, Ken A.; Kuhn, Bernd; Reuter, Deborah C.; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Based on torsion angle distributions of frequently occurring substructures, conformation preferences of druglike mols. are presented, accompanied by a review of the relevant literature.  First, the relevance of the Cambridge Structural Database (CSD) for drug design is demonstrated by comparing substructures present in compds. entering clin. trials with those found in the CSD and protein-bound ligands in the Protein Data Bank (PDB).  Next, we briefly highlight preferred conformations of elementary acyclic systems, followed by a discussion of sulfonamide conformations.  Due to their central role in medicinal chem., we discuss properties of aryl ring substituents in depth, including biaryl systems and systems of two aryl rings connected by two acyclic bonds.  For a subset of torsion motifs, we also compare torsion angle histograms derived from CSD structures with those derived from ligands in the PDB.  Furthermore, selected properties of some six- and seven-membered ring systems are discussed.  The article closes with a section on attractive sulfur-oxygen contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBrdvMrRvKirVg90H21EOLACvtfcHk0lhIwYZt4DaKRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D&md5=289969338dcb94a145ce736d19d05cf4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24%26doi%3D10.1021%2Fci7002494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vashchenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, E.</span></span> <span> </span><span class="NLM_article-title">Unusual structure of a biphenyl fragment: the important role of weak interactions</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1454</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.1107/S2053229619012567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1107%2FS2053229619012567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=31686653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2gtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2019&pages=1454-1458&author=A.+Vashchenkoauthor=V.+Smirnovauthor=N.+Semenovaauthor=E.+Schmidt&title=Unusual+structure+of+a+biphenyl+fragment%3A+the+important+role+of+weak+interactions&doi=10.1107%2FS2053229619012567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual structure of a biphenyl fragment: the important role of weak interactions</span></div><div class="casAuthors">Vashchenko, Alexander; Smirnov, Vladimir; Semenova, Nadezhda; Schmidt, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1454-1458</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">1,5-Bis([1,1'-biphenyl]-4-yl)-5-hydroxy-3-methylheptane-1,6-dione, C32H30O3, was investigated by X-ray anal., quantum chem. calcns. and AIM (atoms in mols.) anal.  It was shown that four intramol. C-H···π forces are established between the two biphenyl fragments.  C-H···π interactions lead to a bending of the biphenyl part.  The energy of the intramol. interactions was estd. and the exclusive role of the moment of force was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx1Y0mN6s4PrVg90H21EOLACvtfcHk0lhIwYZt4DaKRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2gtL%252FI&md5=df57c783b0699409a9cc5606f2f9ebc9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS2053229619012567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229619012567%26sid%3Dliteratum%253Aachs%26aulast%3DVashchenko%26aufirst%3DA.%26aulast%3DSmirnov%26aufirst%3DV.%26aulast%3DSemenova%26aufirst%3DN.%26aulast%3DSchmidt%26aufirst%3DE.%26atitle%3DUnusual%2520structure%2520of%2520a%2520biphenyl%2520fragment%253A%2520the%2520important%2520role%2520of%2520weak%2520interactions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2019%26volume%3D75%26spage%3D1454%26epage%3D1458%26doi%3D10.1107%2FS2053229619012567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1039/c1md00093d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space&doi=10.1039%2Fc1md00093d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674%26doi%3D10.1039%2Fc1md00093d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Udvarhelyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcken, R.</span></span> <span> </span><span class="NLM_article-title">ReSCoSS: A flexible quantum chemistry workflow identifying relevant solution conformers of drug-like molecules</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1007/s10822-020-00337-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1007%2Fs10822-020-00337-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=32803515" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=A.+Udvarhelyiauthor=S.+Roddeauthor=R.+Wilcken&title=ReSCoSS%3A+A+flexible+quantum+chemistry+workflow+identifying+relevant+solution+conformers+of+drug-like+molecules&doi=10.1007%2Fs10822-020-00337-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs10822-020-00337-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-020-00337-7%26sid%3Dliteratum%253Aachs%26aulast%3DUdvarhelyi%26aufirst%3DA.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DWilcken%26aufirst%3DR.%26atitle%3DReSCoSS%253A%2520A%2520flexible%2520quantum%2520chemistry%2520workflow%2520identifying%2520relevant%2520solution%2520conformers%2520of%2520drug-like%2520molecules%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2020%26doi%3D10.1007%2Fs10822-020-00337-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danelius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peintner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieske, L. H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdélyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Solution conformations explain the chameleonic behaviour of macrocyclic drugs</span>. <i>Chem.– Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5231</span>– <span class="NLM_lpage">5244</span>, <span class="refDoi"> DOI: 10.1002/chem.201905599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=10.1002%2Fchem.201905599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=32027758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVWmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=5231-5244&author=E.+Daneliusauthor=V.+Poongavanamauthor=S.+Peintnerauthor=L.+H.+E.+Wieskeauthor=M.+Erd%C3%A9lyiauthor=J.+Kihlberg&title=Solution+conformations+explain+the+chameleonic+behaviour+of+macrocyclic+drugs&doi=10.1002%2Fchem.201905599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Solution conformations explain the chameleonic behaviour of macrocyclic drugs</span></div><div class="casAuthors">Danelius, Emma; Poongavanam, Vasanthanathan; Peintner, Stefan; Wieske, Lianne H. E.; Erdelyi, Mate; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5231-5244</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">It has been hypothesised that drugs in the chem. space "beyond the rule of 5" (bRo5) must behave as mol. chameleons to combine otherwise conflicting properties, including aq. soly., cell permeability and target binding.  Evidence for this has, however, been limited to the cyclic peptide cyclosporine A.  Herein, we show that the non-peptidic and macrocyclic drugs roxithromycin, telithromycin and spiramycin behave as mol. chameleons, with rifampicin showing a less pronounced behavior.  In particular roxithromycin, telithromycin and spiramycin display a marked, yet limited flexibility and populate significantly less polar and more compact conformational ensembles in an apolar than in a polar environment.  In addn. to balancing of membrane permeability and aq. soly., this flexibility also allows binding to targets that vary in structure between species.  The drugs' passive cell permeability correlates to their 3D polar surface area and corroborate two theor. models for permeability, developed for cyclic peptides.  We conclude that mol. chameleonicity should be incorporated in the design of orally administered drugs in the bRo5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJsCKr3Rq-rVg90H21EOLACvtfcHk0lh5P6aIxnWlTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVWmsLo%253D&md5=353528feef6aa1130f8a16204a9f40ce</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fchem.201905599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201905599%26sid%3Dliteratum%253Aachs%26aulast%3DDanelius%26aufirst%3DE.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DPeintner%26aufirst%3DS.%26aulast%3DWieske%26aufirst%3DL.%2BH.%2BE.%26aulast%3DErd%25C3%25A9lyi%26aufirst%3DM.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DSolution%2520conformations%2520explain%2520the%2520chameleonic%2520behaviour%2520of%2520macrocyclic%2520drugs%26jtitle%3DChem.%25E2%2580%2593%2520Eur.%2520J.%26date%3D2020%26volume%3D26%26spage%3D5231%26epage%3D5244%26doi%3D10.1002%2Fchem.201905599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiano, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Over, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Impact of dynamically exposed polarity on permeability and solubility of chameleonic drugs beyond the Rule of 5</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4189</span>– <span class="NLM_lpage">4202</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4189-4202&author=M.+R.+Sebastianoauthor=B.+C.+Doakauthor=M.+Backlundauthor=V.+Poongavanamauthor=B.+Overauthor=G.+Ermondiauthor=G.+Caronauthor=P.+Matssonauthor=J.+Kihlberg&title=Impact+of+dynamically+exposed+polarity+on+permeability+and+solubility+of+chameleonic+drugs+beyond+the+Rule+of+5&doi=10.1021%2Facs.jmedchem.8b00347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00347%26sid%3Dliteratum%253Aachs%26aulast%3DSebastiano%26aufirst%3DM.%2BR.%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DBacklund%26aufirst%3DM.%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DOver%26aufirst%3DB.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DMatsson%26aufirst%3DP.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520dynamically%2520exposed%2520polarity%2520on%2520permeability%2520and%2520solubility%2520of%2520chameleonic%2520drugs%2520beyond%2520the%2520Rule%2520of%25205%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4189%26epage%3D4202%26doi%3D10.1021%2Facs.jmedchem.8b00347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenda, B.</span>; <span class="NLM_string-name">Quesnel, Y.</span>; <span class="NLM_string-name">Ates, A.</span>; <span class="NLM_string-name">Michel, P.</span>; <span class="NLM_string-name">Turet, L.</span>; <span class="NLM_string-name">Mercier, J.</span></span> <span> </span><span class="NLM_article-title">2-Oxo-1-pyrrolidine derivatives</span>. <span class="NLM_patent">WO2006/128692 A2</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+Kenda&author=Y.+Quesnel&author=A.+Ates&author=P.+Michel&author=L.+Turet&author=J.+Mercier&title=2-Oxo-1-pyrrolidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKenda%26aufirst%3DB.%26atitle%3D2-Oxo-1-pyrrolidine%2520derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swamy, K. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N. N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaraman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. V. P. P.</span></span> <span> </span><span class="NLM_article-title">Mitsunobu and related reactions: advances and applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2651</span>, <span class="refDoi"> DOI: 10.1021/cr800278z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr800278z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVagt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2551-2651&author=K.+C.+K.+Swamyauthor=N.+N.+B.+Kumarauthor=E.+Balaramanauthor=K.+V.+P.+P.+Kumar&title=Mitsunobu+and+related+reactions%3A+advances+and+applications&doi=10.1021%2Fcr800278z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mitsunobu and Related Reactions: Advances and Applications</span></div><div class="casAuthors">Swamy, K. C. Kumara; Kumar, N. N. Bhuvan; Balaraman, E.; Kumar, K. V. P. Pavan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2551-2651</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this review is an attempt to detail the Mitsunobu reaction, along with its modifications, which has been versatile and applicable for a variety of org. transformations.  The ease with which stereochem. at the chiral secondary alc. can be reversed is a valuable asset.  The large no. of publications, particularly in the area of nucleobase alkylation, reflects its popularity, mainly as a result of the mild conditions employed during the reaction.  It is expected that this aspect is going to be much sought after, particularly by the pharmaceutical industry.  Synthetic chemists tend to rely on its various facets, be it natural product synthesis or nucleobase alkylation or etherification.  As far as the future of this reaction is concerned, an efficient and inexpensive way to recycle the reagents or to make the reaction fully catalytic is desirable.  Another aspect worth looking into would be to synthesize a water sol. but degradable phosphine/phosphite of low toxicity, to simplify the purifn. process.  The aforesaid points become important if we desire to employ the Mitsunobu route for large scale synthesis.  Recoverable polymer bound phosphonium salts of type 565 that avoid the wastage of phosphine as well as azodicarboxylate, and hence make the system more atom economical and greener, also need to be considered in the future.  Finally, although a major part of the mechanistic pathways is fairly well understood, the complexity of the initial steps when different P precursors are used is intriguing.  This could also be a fruitful area for a phys. org. chemist to probe in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmJ2PTO4x-17Vg90H21EOLACvtfcHk0lh5P6aIxnWlTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVagt78%253D&md5=f7da5265d707fafe71cb40dea76dc1e9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fcr800278z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800278z%26sid%3Dliteratum%253Aachs%26aulast%3DSwamy%26aufirst%3DK.%2BC.%2BK.%26aulast%3DKumar%26aufirst%3DN.%2BN.%2BB.%26aulast%3DBalaraman%26aufirst%3DE.%26aulast%3DKumar%26aufirst%3DK.%2BV.%2BP.%2BP.%26atitle%3DMitsunobu%2520and%2520related%2520reactions%253A%2520advances%2520and%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2551%26epage%3D2651%26doi%3D10.1021%2Fcr800278z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT','PDB','6QMT'); return false;">PDB: 6QMT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RNK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6RNK','PDB','6RNK'); return false;">PDB: 6RNK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10','PDB','6Z10'); return false;">PDB: 6Z10</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01020">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56488"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01020?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01020</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC and NMR charts and X-ray crystallographic data for compounds <b>9</b>, <b>10</b>, and <b>20</b> as well as SUCNR1-bound <b>20</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_001.pdf">jm0c01020_si_001.pdf (0.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01020/suppl_file/jm0c01020_si_002.csv">jm0c01020_si_002.csv (1.92 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the crystal structures of compounds <b>9</b>, <b>10</b>, and <b>20</b> can be accessed using the following codes: CCDC 2009710 (<b>9</b>), CCDC 2009711 (<b>10</b>), and CCDC 2009712 (<b>20</b>). For compound <b>20</b> bound to humanized rat SUCNR1, the PDB code is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Z10">6Z10</a>. The authors will release the atomic coordinates upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01020&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01020%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01020" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9eab9ada3c5e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
